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Abstract 
Glucosyl and galactosyl bearing methacrylates were synthesised using a combination 
of well known carbohydrate chemistry and ultrasonic chemistry. Polymerisation of 
these monomers by aqueous reversible addition-fragmentation chain transfer poly-
merisation yielded glycosylated polymers in high yield with a high degree of control 
over molecular weight and narrow polydispersity. Polymers of varying levels of gly-
cosylation could be achieved through addition of a comonomer. Block copolymers 
were synthesised through sequential monomer addition. 
Binding studies of these polymers to Ricinus communis agglutinin 120 by both 
isothermal titration calorimetry and surface plasmon resonance found a high degree 
of molecular weight dependence on avidity. Studies also suggest that the increase 
in avidity through multivalency is due to both simultaneous binding to multiple 
receptors and the increased probability of binding due to the high local concentration 
of ligands. 
Polymers synthesised have been used in the synthesis of glycosylated gold nano-
particles. Some degree of control over nanoparticle size was achieved through ad just-
iv 
ment of the gold:polymer ratio but was found to be limited. Agglutination assays 
show the particles display specific lectin binding but in vitro cell studies were unable 
to give conclusive information regarding the uptake of particles into cells. 
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1.1. Carbohydrates and Glycobiology 
1.1 Carbohydrates and Glycobiology 
Carbohydrates are ubiquitous throughout Nature. Although traditionally defined 
by the general formula C„(H20),„ , carbohydrates are now considered to be a far 
wider ranging family of compounds as defined by lUPAC. [1] 
" . . . includes monosaccharides, oligosaccharides and polysaccharides as 
well as substances derived from monosaccharides by reduction of the 
carbonyl group (alditols), by oxidation of one or more terminal groups 
to carboxylic acids, or by replacement of one or more hydroxy group(s) by 
a hydrogen atom, an amino group, a thiol group or similar heteroatomic 
groups. I t also includes derivatives of these compounds. The term 'sugar' 
is frequently applied to monosaccharides and lower oligosaccharides." 
The study of carbohydrates has been central to both biological and chemical 
research for over a century, but early research was generally limited to the eluci-
dation of the structure of simple sugars and the role of polysaccharides as in vivo 
energy sources (glycogen and starch) or structural materials (cellulose and chitin). 
In the latter half of the twentieth century important discoveries, such as Watkins 
and Morgan's recognition that blood group antigens were oligosaccharides, [2] led to 
carbohydrates being held in higher regard in biochemical fields. Today the biological 
significance of carbohydrates is well realised and carbohydrates are known to be in-
volved in biological processes as diverse as their structures including, but not limited 
to, fertilisation and embryogenesis, [3] protein folding, [4-6] cell-cell recognition and 
the proliferation and organisation of cells in tissues. The latter was demonstrated 
most elegantly by Popescu and Misevic by the aggregation of coloured sponges in a 
2 
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Figure 1.1: Self recognition in glyconcctins: (a) Discrete aggregation of 3 species 
of marine sponge in the presence of Ca^^ ions; (b) aggregation of coloured beads 
coated in different glyconectins; (c) Control experiment where all beads are coated 
in the same glyconectin. Reprinted with permission from Macmillan Fublishers Ltd: 
Nature. 1997. [7] 
species specific manner via a Ca^+-mcdiatcd carbohydrate-carbohydrate recognition 
process (Fig. 1.1). [7] 
1.1.1 The 'Glycocode' 
The prevalence of carbohydrates throughout complex biological roles, particularly 
those involving recognition, can be attributed to the vast quantity of information 
that can be conveyed within their structures. Other biopolymers. the nucleic acids 
and proteins, only possess one linkage type between a pair of residues: the phospho-
diester and amide Unks respectively. Conversely carbohydrates can form 1—2. 1^3, 
1^4 and 1—>-6 glycosidic linkages, thus introducing the possibility of branching, in 
both o and J configurations. The huge complexity of structure is well demonstrated 
when you consider the number of possible structures for a hexamer of nucleotides. 
1.1. Carbohydrates and Glycobiology 
amino acids or saccharides; for nucleic acids (base set = 4) there are 4096 structures, 
for peptides (base set = 20) there are 6.4x10'', but for carbohydrates there are in 
excess of 1.05x10'^. This figure is for a hexasaccharide featuring only hydroxy! 
groups, add to this the permutations available through modification of a hydroxyl 
group, through sulfation, alkylation, phosphorylation or acylation and the figures 
start to become unfathomable. [8] This information is the language of carbohydrate 
structure and has come to be known as the glycocode. 
1.1.2 Lectins and multivalency 
Like all ciphers, the glycocode requires a method of interpretation and such a role is 
chiefly performed by a group of carbohydrate complexing proteins known as lectins. 
Like carbohydrates, lectins are ubiquitous throughout nature being present in almost 
all organisms and viruses. Traditionally, lectins have been categorised based upon 
their source and/or carbohydrate specificity. Improved analytical techniques have 
allowed the determination of several hundred lectin amino acid sequences as well 
as tens of crystallographic structures, subsequently lectins may now be grouped by 
similarities in their structure: simple, mosaic (or raultidomain) and macromolecular 
assemblies. These groups may be further sub-divided into discrete families which 
share particular sequence and structural motifs. Such subdivisions are not nec-
essarily linked to genetic similarities between the parent organisms with seemingly 
unrelated species, such as plants and animals, producing lectins with high structural 
similarity. [9] 
Simple lectins are currently the biggest family: including almost all plant lectins 
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and the galectins, a sub-family of /3-galactoside binding mammalian proteins. Sim-
ple lectins consist of a small number of subunits, that may or may not be identical, 
with molecular weights < 40 kDa and may contain a domain that is not involved in 
carbohydrate-binding. Mosaic, or multidomain, lectins are a diverse family where 
the lectins are composed of several differing subunits only one of which contains a 
carbohydrate recognition domain (CRD). Typically they are monovalent, but are 
often membrane bound to form multivalent arrays such as those of influenza haD-
magglutinin. Macromolecular assembly lectins are commonly found in bacteria and 
consist of a large number of individual protein subunits that assemble into helical 
fimbri(£ wi th CRDs arranged at specific intervals. 
Typically lectin-carbohydrate binding is rather weak, K'd is usually 10"^ -10"^ M, 
when compared to other biological avidities. Avidin-biot in , for example, displays 
one of the strongest interactions found in Nature wi th ~ 10"^^ M . [10,11] At first 
glance the weak interaction between lectins and carbohydrates appears to make it a 
poor cousin compared to others found in Nature. Their weakness may be attributed 
to the typically shallow nature of the carbohydrate recognition domain, which leaves 
it prone to exposure to solvent, resulting in few direct lectin-carbohydrate contacts. 
Despite this low affinity lectins display remarkable selectivity wi th respect to the 
saccharide moieties they bind and it is rare, for example, to find a lectin that binds 
both glucose and galactose or mannose and galactose. Some structural variation is 
tolerated, particularly around C-2, so it is fairly common for lectins to bind both 
galactose and A^-acetylgalactosamine. [12] 
Lectin-carbohydrate recognition has been identified as potentially useful for the 
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targeting of drugs. [13] I f the specificity of lectin-carbohydrate interactions are to 
be exploited for such means then an increase in avidity is required. Here, as is often 
the case. Nature has already provided us with a solution - multivalency - lectins 
and their corresponding carbohydrate ligands are usually presented on cell surfaces 
in clusters of high valency. The increased avidity through multivalency is unusual 
as the relationship is non-linear and thus not an artefact of increased local concen-
tration. This was well illustrated by Lee et al. who found that lectin binding of 
lactosamine derivatives increased lO'^-fold when the number of lactosamine moieties 
rose from 1 to 4. This unusual non-linear avidity increase has been dubbed the clus-
ter glycoside effect. [14] Similarly lectins are often oligomeric, each subunit having a 
carbohydrate recognition domain, and these oligomers may also aggregate, further 
increasing their capacity for binding. [15] A good example is influenza hemagglu-
tinin of which approximately 500 trimers are found on the virus surface. [16] Similar 
effects have also been demonstrated in non-carbohydrate systems; Whitesides et al. 
demonstrated an avidity increase of 10 orders of magnitude between a trivalent van-
comycin derivative and trivalent dipeptide compared to a monovalent analogue. The 
resulting binding, = 4x10"^^ M , is stronger than that of avidin-biotin. [17] 
1.1.3 Receptor-mediated endocytosis 
Eucaryotic cells use two main methods for the assimilation of molecules: diffusion 
through the lipid bilayer, which may or may not be facilitated by membrane pro-
teins, and endocytosis. Endocytosis is the act of a cell enveloping external material 
by deformation of the cell membrane allowing hydrophilic molecules, which are of-
1.1. Carbohydrates and Glycobiology 
ten important but cannot diffuse through the cell membrane easily, to enter the 
cell. In order to maintain the cell size the opposite process, exocytosis. occurs si-
multaneously. There are three forms of endocytosis: phagocytosis, pinocytosis and 
receptor-mediated endocytosis (RME) (Fig. 1.2). Phagocytosis, or "cellular-eating', 
Receptor-mediated 
endocytosis 
Phagocytosis Pinocytosis 
Extracellular fluid 
solid particle 
Coated pit ^Receptor 
Coat protein 
Vesicle 
cytoplasm 
membrane 
Pseudopodium 
Pliagosome 
(food vacuole) 
Coated vesicle 
Figure 1,2: Schematic representation of the three forms of endocytosis: phagocyto-
sis, pinocytosis and receptor-mediated endocytosis. Modified wi th permission from 
rcf. [18 
is confined to certain cell lines, typically those involved in immune response, and 
allows a cell to consume large particles, such as a whole bacterium, and then destroy 
them within the cell. Pinocytosis, or 'ceffular-drinking', is where the ceff membrane 
indiscriminately internalises small vesicles of cxtraceffular fluid and dehvers them to 
the lysosome for digestion. Receptor-mediated endocytosis is similar to pinocytosis 
but only internaUses molecules that bind specifically to a membrane surface recep-
tor. [19] The addition of specificity to the process means that receptor-mediated 
endocytosis is a good candidate for targeted dehvery of drugs to specific cell fines. 
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Examples of receptor-mediated endocytosis include the uptake of cholesterol to 
cells and the clearance of old erythrocytes, red blood cells, f rom the bloodstream. 
Cholesterol is an extremely hydrophobic steroid that is required by animal cells 
to produce plasma membrane. Its insolubility means that i t must be transported 
by the bloodstream as particles known as low density lipoproteins (LDL) which 
bind to receptors in clathrin-coated pits on the cell surface. From here they are 
internalised via RME and then degraded in the lysosome to yield free cholesterol; 
the L D L receptors are returned to the cell membrane. Asialoglycoprotein receptors 
(ASGPRs), found on hepatocytic cells and elsewhere, are galactose-binding lectins 
that are responsible for the removal of desialylated glycoproteins. For example, 
as erythrocytes age they become increasingly desialylated resulting in exposure of 
galactosyl residues. ASGPRs bind the resulting galactosides, internalise the cell, 
thus removing i t f rom the circulatory system, and destroy i t . This is also a further 
example of the usefulness of multivalency: older cells present more galactosides and 
thus have an increased likelihood of being bound and destroyed. 
1.2 Neoglyconjugates: Elucidating and exploiting 
the glycocode 
With such varied and complex roles in vivo, combined with the unfathomable num-
ber of potential structures that carbohydrates can form, tools are required to allow 
science to probe glycofunction further and potentially exploit it for biomedical gain. 
Extraction and purification of glycoconjugates from natural sources can be a labo-
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rious task often resulting in minute quantities of materials that may or may not be 
pure. This is further complicated by microheterogeneity within these products. This 
heterogeneity is prevalent in glycoproteins where i t is common to find several glyco-
forms which share identical protein components but differ in the site or nature of 
glycosylation. [20] Synthetic, neoglycoconjugates allow for true uniformity of struc-
ture where recjuired and the production of (relatively) large quantities of material. 
One of the more obvious but oft overlooked benefits of neoglycoconjugates is the 
ability to augment binding affinity through multivalency and the cluster glycoside 
effect. Additionally during synthesis it is possible to add further functionality as 
required; for example, a fluorescent marker may be incorporated for easy detection 
via fluorescence/confocal microscopy. 
The potential applications of neoglycoconjugates are as vast and varied as the 
field of glycoscience itself. Here, one class of neoglycoconjugates will be concentrated 
upon - glycopolymers. Glycopolymers are synthetic polymers, typically with a car-
bon backbone, featuring pendant and/or terminal saccharide moieties. [21] Previ-
ously, glycopolymers have been linked to many applications in biosciences including; 
macromolecular drugs [22-25] and drug-delivery systems, [26-29] biocatalytic [30] 
and biosensitive [31] hydrogels and matrices for controlled cell culture. [32-34] Some 
of these applications are expanded upon below. 
1.2.1 Glycopolymeric drugs 
Considering the biological significance of carbohydrates i t should be unsurprising 
that polymers featuring multiple saccharide residues along their backbones could 
1.2. Neoglyconjugates: Elucidating and exploiting the glycocode 10 
act as drugs. The ubiquitous nature of lectins within recognition and binding events 
suggests great potential for their exploitation as drug targets and at least one review 
on the subject has already be published. [13] Several targets for glycopolymeric drugs 
have been identified including influenza, Alzheimer's disease and some cancers. 
1.2.1.1 Influenza haemagglutinin and neuraminidase inhibitors 
One class of disease-carrying agent that has received considerable attention as a 
target for glycopolymeric treatments are the influenza viruses. Considering their 
abundance and the number of fatalities that these viruses can cause, tens of thou-
sands of deaths are attributed to influenza each year in the USA alone, [35] the 
search for effective treatments is unsurprising. 
Influenza infection is a multistep process: initially the virus binds to a-siaUc acid 
(N'-acetylneuraminic acid) residues on the target cell via haemagglutinin (HA) fingers 
on its capsid and the virus enters the cell via endocytosis. Wi th in the endosome 
the virus releases its RNA and other molecules into the cytoplasm which are then 
transported into the nucleus and the process of virus replication begins. I f initial 
binding of the virus to the cell can be prevented subsequent uptake and replication 
can also be halted. A molecule that could block HA binding efficiently could prove a 
useful prophylactic during influenza epidemics. Influenza haemagglutinin, like most 
lectins, has a shallow binding site and its interaction with monovalent sialosides 
is typically weak ( A j ~ 2 mM) [36] and thus multivalent ligands should provide 
improved avidity. To complicate matters further the surface of influenza viruses 
also present neuraminidase (NA) and consequently hasmagglutinin inhibitors need 
to be stable wi th respect to neuraminidase action. 
10 
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Figure 1..3: Synthesis of polymeric multivalent sialosides as used by Bovin et al. [37] 
The first example of an influenza hasmagglutinin inhibitor (HAI) based around 
a glycopolymer was reported by Bovin et al. in 1990. Polymeric sialosides of 
varying carbohydrate densities were synthesised by the reaction between poly[4-
nitrophenylacrylate] wi th monosialosides wi th amino-terminated linkers (Fig. 1.3). 
As would be expected litt le or no inhibition was seen for monovalent sialosides. 0-
sialosides, or polymers carrying low quantities of a-sialoside residues (~5 % ) . Upon 
increasing the sialoside density from 10 through to 30 % a maximum in inhibition 
was seen at 20 % with 30 % having a lower inhibitory effect than the 10 % sialylated 
polymer. [37] 
The main contributors to the field of glycopolymeric HAIs are Whitesides and 
collaborators. Throughout the 1990s Whitesides et al. published several studies on 
the inhibition activity of polymeric sialosides synthesised by both polymerisation of 
sialylated monomers and post-polymerisation functionalisation of reactive polymers. 
[22,38-43] Init ial studies involved copolymers of acrylamido a-O-sialoside 1.2 with 
various A'^-substituted acrylamides. As Bovin et al. had seen previously, [37] a 
maximum level of inhibition was seen at intermediate levels of sialylation. This may 
be rationalised by the competition between cooperative and efficient binding of the 
sialic acid groups: at low SA levels the groups are well separated and thus binding 
11 
1.2. Neoglyconjugates: Elucidating and exploiting the glycocode 12 
of one residue does not increase the likelihood of a subsequent groups binding, with 
high SA levels binding may be limited as the steric bulk of the groups overcrowd one 
another. I t was also noted that bulky or charged groups on the comonomer tended 
to reduce the binding efficiency and, in turn, inhibition. [38,40] Although copolymers 
of 1.2 resulted in highly effective HAIs, inhibition constants (A'" '^ ' ) were typically 
10''-10^ fold greater than monomeric equivalents on a per sugar basis, the O-linked 
SA made them susceptible to cleavage by neuraminidases. In order to alleviate 
this problem acrylamido a-C-sialoside 1.1 was synthesised and copolymerised with 
acrylamide. Polymers with C-linked SA groups were found to have a maximum 
inhibitory effect comparable to that of their O-linked equivalents and had a far 
greater effect at low SA concentrations, probably due to their ability to interact 
wi th neuraminidase without deactivation. [39 
Despite high levels of inhibition displayed by polymers synthesised from sialy-
lated monomers they were stil l less efficient than either non-polymeric synthetic 
HAIs, such as sialylated liposomes, [44] or naturally occurring HAIs, such as equine 
a2-macroglobulin, [45] whose A'"'^' ~ 100-200 nM: instead Whitesides et al. turned 
their attention to the sialylation of reactive polymer backbones. The reasons for 
this are three-fold: firstly, due to differing monomer reactivities, i t is unlikely that 
sialosides wi l l be statistically placed along a polymer based upon feed ratio. If the 
comonomer is of higher reactivity i t is likely that, especially at the low feed level of 
SA monomers, the resulting polymer chains wil l be more Hke block copolymers with 
a short gradient section between blocks. Secondly, if the polymer can be too heavily 
functionalised, as appears to be the case, then sterics should prevent over function-
12 
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Figure 1.4: Sialic acid derived monomers and amines as used by Whitesides et al. 
in the synthesis of glycopolymeric influenza haemagglutinin inhibitors. 
alisation of a reactive polymer as reactive sites become crowded out by their already 
functionalised neighbours. Finally, polymers may be more directly compared; a sin-
gle batch of a precursor polymer results in all derivative polymers having the same 
polydispersity and degree of polymerisation. 
The precursor polymers of choice were those featuring activated esters, such as 
poly[A/'-(acryloyloxy)succinimide] (pNAS) or poly[acrylic anhydride] (pAAn), which 
13 
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were reacted with amino-terminated sialosides including 1.3 and 1.4. pNAS was 
treated with a varying number of equivalents of 1.3 from 0.2-1.2 with respect to 
the number of succinimide groups: the level of sialoside incorporation was found to 
correlate directly wi th the number of sialoside equivalents up the maximum value of 
1. After reaction of the sialoside, any remaining succinimide groups were function-
alised by addition of an excess of a second amine or ammonia to yield copolymers 
of various yV-substituted acrylamides. As was seen with the previous polymers, 
addition of charged groups had a negative effect on the inhibition, particularly pos-
itive charges where a singly positively charged side group has a more detrimental 
effect than a tr iply negatively charged side group; neutral, polar side groups also 
reduced inhibition wi th increasing steric bulk. Hydrophobic side groups increased or 
decreased inhibition depending on the steric bulk. Benzylamine, for example, was 
found to improve efficacy as its level of incorporation was increased; presumably 
through increased hydrophobic-hydrophobic interactions between the polymer and 
virus surface. Conversel}', hexylamine resulted in reduced inhibition. [41] Overall 
polymers wi th sub-nanomolar values of /C"'^' could be produced. Polymers synthe-
sised by similar methods from pAAn gave similar results. [22] I t was also determined 
that a synergistic treatment combining C-sialoside-acrylamide copolymers and low 
molecular monomeric neuraminidase inhibitors resulted in even greater inhibition 
of haemagglutination. Although the mechanism of this synergy was not confirmed 
it is thought that the NA inhibitor displaces the polymer from the NA sites either 
allowing more SA residues to bind to HA sites or increasing the overall steric bulk 
of the polymer around the virus. [42 
14 
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In addition to ha^magglutinins the neuraminidases are also targets for influenza 
treatment; in fact the currently preferred influenza antivirals, such as oseltamivir 
(Tamiflu®, Hoffman-La Roche) and zanamivir (Relenza®, GlaxoSmithKhne), act 
as transition state analogues of sialic acid cleavage. [46] The presence of NAs on in-
fluenza at first seems counterproductive for the virus, NAs cleave sialic acid residues 
which would, in effect, reduce the chances of viral binding to the cell surface. In 
fact the neuraminidases are essential for spread of the virus and infection of further 
host cells. Once a replicated virus has matured and budded off from the cell i t once 
again binds to the cell surface via the hasmagglutinin molecules, the neuraminidases 
cleave the cell surface sialic acid groups releasing the new virus. [47] Multivalent 
sialosides that are resistant to NAs have the potential of binding to these receptors 
and preventing the release of the virus from the host cell and therefore limiting the 
infection. 
1.6 1.7 
Figure 1.5: Polymeric neuraminidase inhibitors as synthesised by Linhardt et al. 
(1.5 and 1.6) and Matsuoka et al (1.7). SA = a-sialoside. 
Linhardt et al, synthesised C-hnked glycopolymers 1.5 and 1.6 (fig. 1.5 and 
tested them with respect to their ability to inhibit neuraminidase from Clostridium 
15 
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perfnngens, a common bacterium. 1.5 was synthesised by enzymatic polymerisation 
of the monomeric aromatic by soy bean peroxidase in the presence of hydrogen 
peroxide; 1.6 was synthesised by radical polymerisation of an allyl precursor. 1.5 
was seen to inhibit neuraminidase 10-fold greater than monomeric equivalents. [48] 
Matsuoka et al. synthesised 1.7 as a copolymer by radical polymerisation of an 
acetate-protected vinyl precursor with vinyl acetate; after treatment with NaOH 
sialylated poly[vinyl alcohol] was isolated. In preUminary tests polymers were shown 
to have an inhibitory effect against influenza neuraminidases in the millimolar range. 
49] Dendritic sialosides synthesised by the same group display similar levels of 
inhibition. [50] 
1.2.1.2 H u m a n immunodeficiency virus 
Human immunodeficiency virus (HIV) infection is now a major international pan-
demic and is estimated to have killed 25 million people through progression to 
acquired immunodeficiency syndrome (AIDS). I t is estimated that between 33 and 
46 million people are currently infected with H I V and between 3.4 and 6.4 million 
people were infected in 2005 alone. [51] One area of interest for the development 
of improved H I V treatments is the use of anionic polysaccharides which have been 
shown to prevent H I V binding to the CD-4 receptor, and thus its entrance to the host 
cell, in vitro. [52] Yoshida et al. synthesised methacrylate polymer 1.8 wi th malto-
heptaose pendant groups by polymerisation of the peracetylated monomer followed 
by deacetylation and sulfation with either piperidine-A'-sulfonic acid or SO.j-DMF 
complex. The polymers were assayed for the their ability to inhibit the infection of 
MT-4 cells by HIV and as blood anti-coagulant. HIV inhibition was seen to increase 
16 
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with increasing polymer chain length and degree of sulfation for homopolymers but 
was poor compared to naturally derived polysaccharides such as dextran and curd-
Ian sulfates. Copolymers with methyl methacrylate ( M M A ) increased in inhibitory 
effect as the number of maltoheptaose groups was reduced. At approximately 80 % 
M M A the copolymers displayed inhibition in the same order of magnitude as the 
polysaccharides. Although the level of inhibition is still 2 orders of magnitude worse 
than that of A Z T these materials display reduced cytotoxicity in comparison and 
may have potential in the future. [24 
OR 
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Figure 1.6: Sulfated maltoheptaose derived methacrylatc glycopolymers as synthe-
sised by Yoshida et al. 
1.2.1.3 Alzheimer's Disease 
Alzheimer's disease (AD) is a neurodegenerative disorder that is the leading cause 
of dementia of which there are an estimated 24 million sufferers worldwide, a fig-
ure that is expected to rise to over 80 million by 2040. [53] Alzheimer's disease is 
characterised pathologically by the accumulation of 'senile plaques' - insoluble ag-
gregates of misfolded amyloid /^-peptide (A/?). One of the current hypotheses for 
17 
1.2. Neoglyconjugates: Elucidating and exploiting the glycocode 18 
the progression of A D is that these plaques, [54] or smaller soluble precursors, [55] 
are neurotoxic resulting in atrophy of brain tissue: k(3 itself is harmless. Preven-
tion of amyloid-/? aggregation may slow, or stop, brain degeneration. Although 
the underlying cause and mechanism of A/? misfolding and plaque formation is still 
the subject of debate there have been several reports of glycoconjugates, such as 
gangliosides and glycosaminoglycans accelerating aggregation of A/? potentially by 
acting as templates on which the process may occur. [56-60] In an attempt to un-
derstand further the interaction between glycosaminoglycans and A/?, Miura et al. 
synthesised glycopolymeric mimics by copolymerisation of glycomonomers 1.9 and 
1.10 wi th acrylamide. Polymers containing relatively small quantities of monomer 
1.10 (10-30 %) were seen to reduce the level of A/3 aggregation and the morphology 
of those aggregates that did form; no appreciable effect was observed for polymers 
of 1.9. Cytotoxicity of A,/? to HeLa cells was found to be significantly reduced by 
addition of a copolymer containing 11 % of 1.10; the polymer itself was found to 
be non-cytotoxic. [61 
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Figure 1.7: Glucosamine based glycomonomers as synthesised by Miura et al. 
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1.2.2 Glycopolymeric drug-delivery 
One of the greatest problems facing pharmaceutical development is the production 
of an efficacious drug that does not produce undesirable side effects; patient death 
being the least desirable of all. Side effects are usually the product of a drug having 
little or no selectivity with regard to its site of action, the drug can affect more 
than the desired target, or poor pharmacokinetics, the drug is cleared from the 
body too quickly requiring either larger doses or regular administration in order to 
keep the treatment at an adequate level. Poor pharmacokinetics are a particular 
problem with anti-tumour drugs which, by their very nature, are usually cytotoxic 
and thus doses must be accurately controlled in order to destroy the tumour without 
disrupting healthy cells. The importance of dosage is clear when one considers 
methotrexate, a widely used anti-tumour drug, the use of which often requires the 
subsequent administration of a 'rescue drug', folinic acid or its salts, to prevent 
methotrexate toxicity. [62] Another major obstacle in drug delivery is the blood-
brain barrier (BBB), which is remarkably efficient at preventing the diffusion of 
molecules into the brain. The walls of the majority of the capillaries in the body 
consist of endothelial cells with small pores between, known as fenestras, which allow 
small molecules to diffuse between the blood stream and surrounding tissues and 
vice versa. The capillary walls of the blood brain barrier have no such fenestrae and 
consequently transport through the BBB must be via the lipid membrane or some 
form of transport protocol. This is well demonstrated in fig. 1.8 which shows a ful l 
body radiogram of a mouse 30 min. after injection with radiolabelled histamine: 
the histamine enters all organs of the body except the brain and spinal column, [63] 
19 
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Glycosylation has recently been shown to be effective at enabling drugs to cross the 
BBB. [64] In order to combat these problems methodologies for site-specific dchvery 
of drugs are required. 
brain 
Figure 1.8: Autoradiogram of an adult mouse 30 min. after intravenous injection 
of radiolabelled histamine. The dark regions show where the histamine is located 
- none is detected in the brain and spinal cord regions. Reprinted with permission 
from ref. [63]. 
1.2.2.1 Carbohydrate targeting 
In the mid-19 70s Ringsdorf introduced a simplistic model for the polymeric delivery 
of drugs, a so-called 'magic bullet' method. The Ringsdorf model is remarkably 
simple. Attached to a polymer backbone are three types of group: a targeting 
moiety, a solubilising moiety and, via a cleavable linker, the drug to be delivered 
(see fig. 1.9). [65] In the case of glycopolymers the carbohydrate moieties may act 
as both the targeting vector, specific to a lectin on the surface of the tissue to be 
treated, as well as aiding solubility. There are now approximately 20 drugs either 
on the market or in clinical trials based upon this type of model. [66 
20 
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Figure 1.9: The Ringsdorf model for drug dehvery by poh-mers. The model features 
three species of pendant group on a polymer backbone: a targeting species (blue), 
a solubilising species (green) and the drug itself (red) attached by a cleavable hnker 
The field of glycopolymcrs as targeting vectors for drug delivery has been domi-
nated b}- work of Duncan and Kopccck. Typically thc\- s>-nthcsiscd copol>'mcrs of 
iV-(2-hydroxypropyl)methacrylamide (HPMA) and a second monomer featuring an 
active ester, such as a p-nitrophenyl ester, as a pendant group; the active ester was 
linked to the polymerisable moiety by a peptide linker. Gly-Gly or Gly-Phe-Leu-
Gly for example. These polymers were then reacted with the 'drug' to be delivered 
and a glycosamine in order to provide targeting. Init ial studies used model drug 
compounds such as tyrosinamide which were radiolabelled to allow easy detection of 
their relative biodistribution. The radiolabellcd polymers were administered intra-
venously to rats and blood radioactivity levels were measured at regular intervals. 
After a set time (1 or 5 hours) the rats were sacrificed and radioactivity levels of 
individual organs assayed. When the polymers beared galactosamine moieties, 90 % 
clearance of the polymer from the bloodstream was seen within 1 hour and nearly 
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70 % was seen to be present in the liver. Polymers featuring gluco- or mannosamine 
moieties, or control polymers with a simple amine, were seen to be cleared from the 
bloodstream more slowly with ~10 % accumulating in the liver. For all polymers, 
after 5 h > 80 % of radioactivity was to be found in the urine and faeces. [67,68] 
This approach was developed further by replacing tyrosinamide with anti-tumour 
drugs such as daunomycin and doxorubicin, the resulting polymers being candi-
dates in phase 1 chnical trials for the treatment of hepatic tumours. Poly[HPMA 
featuring pendant galactosamine and doxorubicin, as well as trace quantities of 
^^^I-labelled tyrosinamide, were administered to patients wi th liver malignancies. 
Blood and urine samples were analysed to determine the level of polymer-bound 
and free doxorubicin and metabolites; distribution of the polymer was determined 
by fu l l body imaging of ^ ^ ^ I using single photon emission computed tomography. 
The galactosamine-polymer-doxorubicin conjugate was seen to be rapidly cleared 
from the bloodstream with 15-20 % of the administered dose accumulating in the 
liver after 24 h. A control polymer, identical except for the absence of galactosamine 
residues, was seen to remain in the bloodstream for longer and was found to have a 
general body distribution with no organ specificity. Despite a large accumulation of 
the polymer in the liver the majority was found in healthy hepatic cells rather than 
in the tumours themselves, although the accumulation was stil l significant compared 
to background. The reduced uptake to cancerous cells was rationalised by the re-
duced levels of ASGPR that hepatoma cells are known to express compared to their 
healthy counterparts. [69-72] The increased uptake compared to other tissues may 
instead be due to the enhanced permeability and retention effect and not a result of 
22 
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lectin targeting. [73 
Although attempts at specifically targeting hepatic tumours were not a complete 
success the ability to target normal hepatocytes may allow the targeted treatment 
of other liver diseases such as cirrhosis or viral hepatitis. An example of such a 
treatment has been demonstrated by Hashida et al. in mice. The K vitamins are 
a family of hydrophobic molecules required for the synthesis of the proteins in-
volved in blood coagulation. [74] The denotation of ' K ' vitamins derives from the 
German naming koagulations vitamin, [75] consequently vitamin K deficiency may 
lead to hemorrhaging. I t is common for expectant mothers and newborns to be 
administered vitamin K as a prophylatic but this has found controversy due to its 
administration having been linked to childhood cancers and other side effects. [76] 
The majori ty of coagulating proteins are synthesised in the liver and thus targeted 
delivery of vitamin K to the liver may allow suitable prophylaxis with reduced side 
effects. Hashida et al. synthesised terpolymers based upon a poly[L-glutamic acid 
(PLGA) backbone (fig. 1.10) by reaction with ethylenediamine followed by 2-imino-
2-methoxyethyl 1-thiogalactoside to produce galactosylated PLGA. In turn, this 
was reacted wi th vitamin K 5 , a synthetic K vitamin analogue, to yield a galactosyl-
PLGA-vi t . K 5 conjugate. The anti-hemorhaggic effect of such polymers was deter-
mined in mice models by comparison of the prothrombin time, a measure of coag-
ulation efficiency, after systemic treatment with warfarin. As expected, in all cases 
prothrombin time was increased for warfarin treated mice compared with untreated. 
Warfarin treated mice that received intravenous, unconjugated vitamin K only had 
a statistically significant reduction in prothrombin time 4 h after treatment, those 
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receiving I V galactose-PLGA-Ks conjugate had a significant reduction at 2, 3 and 
4 h time points. [77] 
Figure 1.10: Anti-hemorhaggic, poly[L-glutamic acid] based terpolymers as synthe-
sised by Hashida et al. 
Similarly Fleming et al. have targeted boar spermatozoa, which are known 
to display a galactose-binding lectin with great similarity to the hepatic ASGPR, 
with galactosyl polymers in vitro. They synthesised terpolymers of 2-(/3-D-galacto-
syloxy)ethyl methacrylate, 2-(dimethylamino)ethyl methacrylate ( D M A E M A ) and 
a methacrylate featuring an a-tocopherol functionality. The resulting polymers 
were incubated with spermatozoa in an attempt to deliver the a-tocopherol, an 
antioxidant, to the cells to reduce oxidative damage during storage. Although the 
polymers appeared to have some protective effect to confirm their entrance into the 
cells, rather than acting as an extra-cellular protectant, the cv-tocopherol monomer 
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was replaced by a lluorcsccnt monomer, horitasol mell iaervlate . and pol\-nier 
inside the cell \'isualised b>' conlocal mitroseupy ( l ig . 1.11 ). '7S| 
• 
\ 
Figure 1.11: C'onfocal micrograph of boar spermatozoa after incubat ion w i t h a 
po ly jGa lEMA-I3 ] \ lAE. \ ' lA-hos t a so l methacrylate | terpolvmer. j7<Sj Image provided 
b\- the author. 
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1.2.2.2 Glycopolymeric Chaperones 
The difficulties in effective drug-delivery are apparent when the payload to be de-
livered is a protein or nucleic acid for which the immune system is a veritable 
minefield. Ideally, a suitable drug-delivery system for such molecules would pro-
vide protection from degradation and a means of targeting the payload to a specific 
site. The simplest method of introducing a gene or other biomolecule into a cell is 
direct microinjection but this is hardly practical for the treatment of large multicel-
lular organisms such as humans. The use of viruses, modified to carry the nucleic 
acid sequence of choice, allows efficient delivery but involves the use of potentially 
pathogenic precursors and nucleic acid strand length may be limited. Non-viral de-
livery vectors have the potential to replace viral vectors with non-immunogenic, low 
cost and easily produced materials. [79] 
The use of glycopolymers as molecular chaperones for proteins has been demon-
strated by Chaikof et al. They utilised cyanoxyl-mediated polymerisation [80,81] for 
the synthesis of several biomimetic glycopolymer species from alkenyl, acryloyl and 
acrylamido glycomonomers, often in their sulfated form (fig. 1.12). [82-85] Several 
of these polymers were tested with respect to their ability to act as mimics of hep-
aran sulfates. [84] In vivo, fibroblast growth factor 2 (FGF-2) is bound by heparan 
sulfate, an anionic polysaccharide, which acts as a molecular chaperone protecting 
FGF-2 from deactivation and facilitating its binding to FGF receptor-1 (FGFR-
1). [86] Binding assays found that polymers featuring Af-acetylglucosamine residues 
did bind, but weakly compared to heparan sulfate, the linker length was seen to have 
no efl^ect. Sulfated sugars bound more strongly than their non-sulfated equivalents, 
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particularly for polymers featuring pendant lactose groups. Further investigation 
into the FGF-2 chaperone role of glycopolymers featuring lactose sulfate residues 
found that low molecular weight (~10 kDa) polymers containing ca. 10 % of the 
glycomonomer were nearly as effective as heparin in dimerising FGF-2 and binding 
i t to FGFR-1. The chaperone qualities of the polymer were also demonstrated by 
the extra stability that i t gave FGF-2 with respect to degradation by acid, heat and 
trypsin. [87] The glycosyl functionalised polymers were also compared to heparin 
in anticoagulant activity assays. Polymers featuring monosaccharides had no anti-
coagulant activity, those featuring lactosyl groups displayed interesting anticoagu-
lant activity dependent on polymer composition and functionalisation. Non-sulfatcd 
polymers, like the monosaccharide polymers, had no activity, sulfated polymers were 
active but homopolymers less so than copolymers wi th acrylamide. 
NHAc 
R 
O 
R R 
O 
R = OH, OSO3 
O 
Figure 1.12: Glycosylated monomers as used by Chaikof et al. for the synthesis of 
heparin mimics via cyanoxyl-mediated polymerisation. 
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1.2.3 Glycohydrogels 
Glycohydrogels, chemically or physically crosslinked polymeric materials, have been 
linked to a variety of therapeutic and drug-delivery applications. Nakamae et al. 
synthesised glycohydrogels by polymerising the glycosylated monomer 2-{(j-D-g\uco-
syloxy)ethyl methacrylate in the presence of a divinyl crosslinker and the lectin 
concanavalin A (Con A ) . In addition to the chemical crosslinking provided by the 
divinyl monomer, physical crosslinking is provided by Con A. The presence of Con A 
leads to gels displaying sensitivity to glucose (and mannose) with swelling increasing 
with glucose concentration as this displaces the polymeric ligand from the Con A 
binding site resulting in a loss of crosslinking. Consequently such materials display 
promise as either glucose sensors or as drug-delivery devices for insulin as increased 
glucose levels would promote the release of the drug. [88,89] 
Wang et al. have produced glycohydrogels for the treatment of norovirus infec-
tion, one of the main causes of gastroenteritis. Noroviruses have been demonstrated 
to bind to the surface glycans on erythrocytes that determine the blood group. 
They synthesised the monomer l-acrylamido-3,6-dioxa-8-octyl-0-(Q:-L-fucopyrano-
syl)-(l—>2)-0-(Q-D-galactopyranosyl)-(1^3)-/i/-D-galactoside (1.11) and subsequen-
tly polymerised i t in the presence of acrylamide, diallyldimethylammonium chloride 
and A^jA^^'-methylene bisacrylamide to yield hydrogels of the type shown in fig. 1.13. 
The entrapment ability of the glycohydrogels with respect to norovirus was deter-
mined using recombinant virus-like particles, virus particles that carry no payload, 
and ELISA assays. Glycohydrogels were seen to reduce dramatically the solution 
virus concentration compared to hydrogels prepared in the absence of the glycosy-
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lated monomer. [90] 
HN ^ N ^ H2N ^ O u K i 
I Q \ 
Glycoside CI / 
O .. . , 
^0 J HN 
I HO CI® ^ 
OH + 
^•^^ acrylamide 
Figure 1.13: Synthesis of glycohydrogels capable of binding norovirus as synthesised 
by Wang et al. 
Novick and Dordick synthesised biocatalytic glycohydrogels by polymerisation of 
acrylamido-functionalised enzymes with sucrose I'-acrylate in the presence of 1,2-
dihydroxyethylene-bis-acrylamide crosslinker. Here, the carbohydrate residues are 
not used for their bioactivity. Instead, they are utilised to impart a high degree 
of hydophilicity whilst minimising the non-specific adsorption of biomolecules; a 
potential problem that is often seen with the charged groups that are often used. The 
resulting gels were seen to improve the thermal stability of the contained enzymes 
as well as enhancing their catalytic ability. [30 
Akashi et al. investigated glycohydrogels featuring glucosyl moieties and their 
sulfated derivatives as potential substrates for cell culture, The role of heparin 
mimics in the stabilisation of fibroblast growth factors has already been discussed 
and sulfated glycosyl hydrogels may act similarly. Glycohydrogels were swollen in a 
solution of basic fibroblast growth factor (bFGF) and, although the matrices were 
unable to allow slow release of bFGF over time, they were seen to increase cell 
viability and adhesion compared to standard tissue culture plastic suggesting an 
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increaise in bFGF activity. [34] 
1.3 Reversible addition-fragmentation chain 
transfer polymerisation 
1.3.1 Controlled radical polymerisation 
Free-radical polymerisation is of great industrial importance, being used for the 
manufacture of tons of polymers per annum. Its ubiquity throughout industry is 
due to its ability to polymerise an almost limitless number of monomers, aided by 
its compatibility wi th many functional groups, and its tolerance to a wide range of 
polymerisation conditions and impurities. Despite its widespread use, free radical 
polymerisation has, unti l recently, had limited application in the synthesis of well-
defined polymeric materials. 
Free radical polymerisations are known to proceed by a mechanism that may be 
divided into three distinct stages: initiation, propagation and termination. Initiation 
involves the production of active radical centres. This is a two-step process, involving 
the formation of free radicals followed by addition of these radicals to a monomer 
species to produce an initial propagating radical. The first step may be achieved in 
several ways including thermal, redox and photochemical reactions. Most commonly 
these primary radicals are produced by homolytic bond cleavage of a peroxide or azo 
compound to form a pair of radicals. Homolytic cleavage is usually slow compared 
to addition to monomer and is consequently rate l imiting. 
Propagation is the successive addition of monomer molecules to a radical that is 
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not initiator derived. Each addition results in a radical identical to the previously 
except that i t the chain is longer by one monomer unit. Propagation is extremely 
rapid. 
Termination is the irreversible reaction of a propagating polymer chain that 
results in the loss of its radical. This usually occurs by one of two mechanisms: 
recombination whereby a pair of propagating chains react to form a single chain 
of their combined lengths, and disproportionation whereby one propagating chain 
abstracts a hydrogen from another resulting in two terminated chains, one with an 
unsaturated end-group, the other saturated. 
Although these stages are often written separately, in reality they all occur si-
multaneously soon after the beginning of the polymerisation. The fast rate of prop-
agation compared to initiation results in long chain lengths even at low monomer 
conversion which, combined with termination processes, results in polymers poorly 
defined in molecular weight and polydispersity - controlled free radical polymerisa-
tions aim to alleviate these problems. 
Controlled polymerisation has recently been defined as a process to produce 
polymers that are well-defined with respect to: 
• macromolecular architecture, e.g. hnear, star, comb, etc., 
• terminal functionality 
• monomer composition 
and must also have molecular weights predetermined by the ratio of the monomer 
and initiator feed concentrations and narrow, unimodal molecular weight distribu-
tions. [91 
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Controlled radical polymerisations all share one theme: they reduce the immedi-
ate radical concentration thus reducing the rate of propagation and any other radical 
reactions. This has a particular effect on the rate of bimolecular termination as: 
Rt (X [Radicnlsf (1.1) 
If the rate of propagation can be reduced to below that of initiation then all polymer 
chains can be considered to have been initiated simultaneously, and all have an equal 
chance of growing, resulting in product of definable molecular weight and narrow 
polydispersity. To reduce the radical concentration a mediating agent is added to 
the polymerisation. The role of this agent is to allow propagating polymer chains to 
be reversibly capped, creating an equilibrium between reactive propagating chains 
and unreactive 'dormant' chains. In a well controlled system this equihbrium is 
weighted towards the dormant chains, resulting in a greatly reduced immediate 
radical concentration and thus drastically reduced termination at the expense of a 
reduced rate of propagation. 
The earliest attempt at controlled radical polymerisation (CRP) was introduced 
by Otsu in the early 1980s. [92] Otsu's iniferter (zmtiator-trans/er agent-ierminator) 
concept involved the use of some compound, the iniferter, that was capable of ther-
mal (or photo-) initiation and also able to react reversibly with the propagating 
chain end; thus, by choosing the iniferter carefully end-functionalisation could be 
achieved. Reversible chain capping also allowed for the synthesis of block copolymers 
by sequential monomer addition. [93] Overall control by iniferters was, unfortunately, 
limited and i t took a further ten years before CRP really began to gain recognition 
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as a useful technique to the polymer chemist. Although many systems have been 
developed, wi th varying degrees of success, three main systems have dominated the 
field, namely nitroxide-mediated polymerisation (NMP), [94] atom transfer radical 
polymerisation (ATRP) [95] and reversible addition-fragmentation chain transfer 
(RAFT) polymerisation. [96 
Reversible addition-fragmentation chain transfer polymerisation is the most re-
cently developed CRP system to have gained widespread popularity. Developed by 
Chiefari et al. in the late 1990s, [97] RAFT polymerisations are generally performed 
under standard free radical conditions with the addition of a chain transfer agent 
(CTA or R A F T agent); usually thiocarbonylthio compounds such as dithioesters, 
dithiocarbamates, trithiocarbonates and xanthates. In the latter case the technique 
is usually referred to as M A D I X : MAcromolecular Design through the Interchange 
of Xanthates. Considering its relative youth, the use of R A F T has grown rapidly 
(see fig. 1.14). Such rapid adoption can be attributed to RAFT's incredible versa-
t i l i ty wi th respect to both reaction conditions and monomer functionalities. Styryl, 
(meth)acryloyl and (meth)acrylamido monomers are readily polymerised and poly-
mers featuring a range of functional side groups, including C O 2 H , SOsNa, OH and 
N R 2 , can be synthesised wi th only minor or no adjustments to the reaction condi-
tions. [97-103] Even highly reactive monomers, such as vinyl acetate, can be poly-
merised in a controlled manner through careful selection of an appropriate RAFT 
agent. [104,105] As well as common bulk and solution phase polymerisation, RAFT 
may be conducted in emulsions [106] and a variety of more esoteric solvents such as 
ionic liquids, [107] supercritical C O 2 [108,109] and aqueous solutions. [110] Careful 
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selection of CTA and initiator allows reaction temperature to be reduced to am-
bient [111,112] and microwave-aided synthesis has been demonstrated for several 
monomers. [113,114] 
c o 
o 
3 
D-
500-^ 
400-J 
350 H 
300 H 
200 ^ 
1 s o -
loes 
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 
Year (1998 to 2008) 
Figure 1.14: Number of scientific publications on R A F T / M A D I X polymerisation 
(Source: Scifinder®) 
1.3.2 Mechanism and subsequent considerations 
The mechanism of R A F T polymerisation is considerably different to that of the other 
common controlled radical polymerisation techniques, namely ATRP and NMP, 
which operate via reversible homolytic bond cleavage. In a R A F T system chain 
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growth is regulated by exchange of the chain transfer agent (CTA) between a low 
concentration of propagating chains and a higher concentration of 'dormant' chains; 
the accepted mechanism is shown in fig. 1.15. 
(i) r (Initiator) . m (Monomer) ^ Pn 
( l l ) Pn * ' ^^ ri T K - ^^ n r . R 
z '-"^ z z 
(iii) R * M • Pn, 
M Z Z Z M 
(v) Recombination/disproportionation of radicals »- Dead Polymer 
Figure 1.15: General mechanism of reversible addition fragmentation chain transfer 
polymerisation. 
Standard free radical initiation and propagation (i) are followed by rapid addition 
of the propagating chain to the C=S bond of the CTA to give a radical adduct 
that may fragment to either reform the CTA and propagating radical, or to form a 
macro-CTA and a new initiating radical R ' ( i i ) . The new radical may then reinitiate 
polymerisation by addition to monomer, resulting in a new propagating chain (iii), 
or react back on the macro-CTA. Once all of the original CTA is consumed and 
only the macro-CTA moieties are present the reaction enters equilibrium (iv). This 
is the main equilibrium in the system and, when the exchange between active and 
dormant chains is rapid, all chains have an equal probability of growth and thus a 
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narrow molecular weight distribution. As with all radical polymerisation systems 
some bimolecular termination via recombination or disproportionation of radicals 
is inevitable (v); although, if conditions are chosen carefully, this may be kept to 
neghgible levels. The number of chains in a R A F T polymerisation is equal to the 
total number of radicals derived from both the fragmentation of the R A F T agent and 
those from the initiator. To keep the number of initiator derived, and consequently 
dead, chains to a minimum, the ratio of the R A F T agent to consumed initiator in 
the reaction timescale must be kept high. Assuming that the fraction of initiator 
derived chains is kept low, then the molecular weight of the polymers formed is given 
by: 
Mn = MM • X • J ' ^ p T ^ ^ + ^'^RAFT (1.2) 
where M ^ , M M , MRAFT are the molecular weights of the polymer, monomer and 
R A F T agent respectively; [M]() and [RAFT]o are the init ial monomer and RAFT 
agent concentrations and x is the monomer conversion. At the end of the polymeri-
sation all chains wi l l be end-capped with the thiocarbonylthio moiety, except those 
terminated by initiator derived radicals. The end-capped chains can then be used 
as macroRAFT agents in the polymerisation of a second monomer resulting in block 
copolymers by sequential monomer addition. 
1.3.3 R A F T agent selection 
The series of equilibria in the RAFT mechanism means that the structure of the 
R A F T agent can have a great effect on the control in a polymerisation. A l l RAFT 
agents may generally be represented as Z-(C=S)-S-R, where the Z-group improves 
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Figure 1.16; (a) General structure of a R A F T agent and (b) canonical forms of 
xanthates and dithiocarbamates. 
stability of the radical intermediate (fig. 1.15, step i i . ) and R is a fragment capable 
of acting as a reinitiating radical. 
1.3.3.1 Effect of the Z-group 
The choice of Z-group has a large influence on the stability of the intermediate radical 
adduct, thus i t follows that a good stabilising group wi l l increase the reactivity of the 
C—S bond towards a propagating radical. Unfortunately, Z-group selection is not 
as straight-forward as choosing a strongly stabilising group as, if the intermediate 
radical is too stable, i t will not fragment to expel an initiating radical. Several 
systematic studies into Z-group choice have been published and, in the vast majority 
of cases, a phenyl group has been found to be suitable. W i t h a benzyl group the 
intermediate stability is reduced. For more reactive monomers, such as acrylates and 
acrylamides, this results in increased polymerisation rates; for bulkier monomers, 
such as methacrylates, the reduced intermediate stability results in a loss of control 
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over the polymerisation. 
When the Z-group is bonded through a heteroatom, such O (xanthates) or N 
(dithiocarbamates), a lone pair is delocalised with the C=S bond, increasing its 
stability and reducing its reactivity towards radical addition (see fig. 1.16b). For 
the majority of monomers this results in poor control over the polymerisation and 
an ill-defined product. For highly reactive monomers, such as vinyl acetate, the low 
C=S reactivity is beneficial as control is achieved without large retardation of the 
polymerisation rate. 
The other class of CTAs are those where the Z-group is bonded through a sulfur 
atom, trithiocarbonates. In this case the C=S bond is reactive enough for interme-
diate formation but fragments quickly enough to give lit t le or no induction period 
on the polymerisation; unfortunately the C=S bond is usually too unreactive to 
control the polymerisation of methacrylates. [96] 
1.3.3.2 Effect of the R-group 
The R-group, like the Z-group, has an effect on the stability of the intermediate 
radical but this effect is generally negligible in comparison. Consequently the R-
group should be chosen such that i t is both a good leaving group compared to the 
propagating polymer chain and a good re-initiating species for the monomer being 
polymerised. As wi th Z-group selection this requires a compromise, now between 
having a radical that is stable enough to make a good leaving group but reactive 
enough to re-initiate polymerisation. Equally, the R-group can be used to tailor 
the CTA to the reaction conditions required by, for example, improving solubility. 
Because of these factors i t is unsurprising that many of the fragments used as the 
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R-group bear more than a passing resemblance to the initiating fragments of azo 
initiators (see fig. 1.17). 
- C N 
Figure 1.17: Common radical fragments used as R A F T agent R-groups. Cumyl 
radical, cyanoisopropyl radical, 4-cyanopentanoic acid radical. 
In addition to providing efficient reinitiating radicals the use of such fragments 
can also simplify understanding of the polymerisation system as, if the appropriate 
initiator is used, chains wil l all be initiated by the same radical fragment whether 
CTA derived or not. Fig. 1.17 shows the structures of some common radical frag-
ments used as R A F T agent R-groups. Both cumyl and cyanoisopropyl groups are 
commonly used as the initiating fragment of radical initiators as the radical is reac-
tive enough to initiate polymerisation but stable enough not to abstract hydrogen 
indiscriminantly; the result of which is usually polymer branching or termination. 
The 4-cyanopentanoic acid radical is fundamentally a cyanoisopropyl radical with 
an additional functionality and is commonly used, in the form of (4-cyanopentanoic 
acid)-4-dithiobenzoate, as the CTA in aqueous polymerisation: the carboxyl group 
improving solubility. 
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1.4 Conclusions 
Despite its relative youth the field of glycobiology is of increasing importance and 
further understanding is required to exploit it to its full potential. Glycopolymers 
have great potential as both drug delivery systems and as therapeutics themselves. 
Many of these applications rely on the cluster glycoside effect. To further define 
the factors that are important for this effect greater control over the synthesis of 
glycopolymers is required. Reversible addition-fragmentation chain transfer poly-
merisation ability to polymerise highly functional monomers in a controlled manner 
makes it an ideal choice for the synthesis of polymeric neoglycoconjugates. 
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Neoglycoconjugates: Controlled Synthesis 
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2.1 Introduction 
The potential uses of glycopolymers has already been outlined in section 1.2. In order 
to investigate further and improve upon these applications, methods of synthesising 
glycopolymers that are controlled with respect to i) the carbohydrate moiety - both 
its type and anomeric configuration; ii) the length and macromolecular architecture 
of the polymeric backbone and iii) the site and density of glycosylation, are required. 
The first of these requires knowledge of carbohydrate chemistry to provide regio-
and stereoselective synthesis of any glycosylated precursors. The second requires 
advanced polymerisation techniques that allow control over molecular weight and 
architecture. The third is the most challenging and will not be dealt with here. 
The synthesis of glycopolymers falls into two main groups: polymerisation of a 
glycosylated monomer (glycomonomer), with or without a comonomer(s), or post-
polymerisation glycosylation of a reactive polymer; [115,116] several examples of 
both techniques have been mentioned previously. Historically, the former method of 
synthesis has been the most widespread as quantitative glycosylation of large macro-
molecules is not facile. However, recent advances in organic synthesis, such as 'click' 
chemistry, [117] and the realisation that complete glycosylation is not necessarily 
advantageous has resulted in an increase in post-polymerisation functionalisation. 
The polymerisation of glycosylated monomers has been achieved using all com-
mon techniques including ionic, ring-opening metathesis, free radical and controlled 
radical polymerisations. It has previously been demonstrated that the polymerisa-
tion of protected glycomonomers followed by post-polymerisation deprotection can 
lead to products with ill-defined saccharide moieties; [118] consequently the use of 
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unprotected monomers is preferable. Hereby, ionic polymerisations are unsuitable 
as the nature of the propagating polymers requires the use of protected monomers as 
well as stringent control over reaction conditions. [119-124] Similar problems were 
initially encountered with the use of ring-opening metathesis polymerisations [125] 
but were quickly overcome through careful selection of catalyst and reaction condi-
tions. [126,127] Unfortunately, due to the use of heavy metal catalysts, glycopoly-
mers synthesised via ROMP would require thorough purification before they can be 
used for many biomedical applications. The recent development of controlled rad-
ical polymerisation techniques has increased the armoury of the polymer chemist 
drastically. The ability to produce polymers of predictable molecular weight and 
low polydispersity, under relatively facile conditions, has resulted in a wealth of 
interesting polymers being reported. The three most common controlled radical 
polymerisation techniques, namely nitroxide-mediated, [94] atom transfer [95] and 
reversible addition-fragmentation chain transfer polymerisations, [96] have all been 
applied to the synthesis of glycopolymers with varying degrees of success. [115 
Here it was desired that glycopolymers were synthesised from anomerically pure, 
biologically active, glycosylated monomers. Polymerisations were to be performed 
under facile conditions, preferably in aqueous solution, without the requirement of 
protecting group chemistry. Consequently a combination of glycosylated methacry-
lates and RAFT polymerisation was chosen. 
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2.1.1 Previous syntheses of methacrylate glycomonomers 
(Meth)acrylate based glycomonomers have been reported several times previously. 
Kitazawa et al. synthesised galactosyl, glucosyl, mannosyl and xylosyl monomers 
by the glycosylation of 2-hydroxyethyl (meth)acrylate (HE(M)A) with their re-
spective methyl glycosides. These reactions were performed at high temperatures 
(> 100 °C) in chlorobenzene with phosphomolybdic acid as a promoter: the re-
sulting monomers were obtained as anomeric mixtures ranging between 2/1 to 4/1 
a/(5. [128] Nakaya et al. synthesised anomerically pure glucosyl methacrylates with 
differing methylene linker chain lengths using the methodology of Helferich and 
Weis. cj-Hydroxyalkyl methacrylates, the alkyl chains having between 2 and 9 car-
bons, were glycosylated with a-D-acetobromoglucose with Hg(CN)2 or .A^ g20 as pro-
moters; yields ranged from 20-60 %. [129] 2-(2',3',4',6'-tetra-C'-acetyl-/i-D-glucosyl-
oxy)ethyl acrylate (AcGlcEA) was synthesised similarly by Li et al. via glycosylation 
of HE A with a-D-acetobromoglucose in the presence of HgBr2. Yoshida et al. syn-
thesised anomeric mixtures of 1-0-methacryloyl maltoheptaoside (1.8 on page 17). 
Peracetylated maltoheptaose was obtained by acetylosis of /^^-cyclodextrin and the 
reducing end deacetylated by benzylamine; the resulting hydroxyl group was reacted 
with methacryoyl chloride to yield peracetylated l-O-methacryloyl maltoheptaoside: 
complete deacetylation was only reported post-polymerisation. [24] Stereoselective 
synthesis of 2-(/3-D-galactosyloxy)ethyl methacrylate (GalEMA) has previously been 
achieved by both enzymatic [130,131] and chemical routes. Enzymatically, a (i-D-
galactosidase was used for transglycosylation of HEMA with either para-nitrophenyl-
/i?-D-galactose or lactose as the glycosyl donor. Although these syntheses result in 
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/?-anomer selectivity, and remove the need for protecting group chemistry, extended 
reaction times (up to 8 days) coupled with low conversions (~ 40 %) and exotic 
enzymes makes enzymatic synthesis less than desirable. Chemically, the coupling of 
u!-D-acetobromo-sugars to HEMA with silver trifiate as the promoter results in a high 
jaelds (80 %) and ,/3-stereoselectivity, but requires extended reaction times (48 h) 
at low temperatures (-40 °C). [118] Alternatively /3-D-galactose pentaacetate in the 
presence of BF3.Et20 at 0 °C results in /^-stereoselectivity but yields are typically 
low (< 45 %) . [78] In both cases deprotection was achieved with sodium methoxide 
prior to polymerisation. Davis et al. synthesised methacryoyl monomers (2.5 and 
2.6), featuring a 1-0-methyl gluco- or manno-pyranose residue, using an enzymatic 
lipase-catalysed synthesis: consequently the carbohydrate moiety is 6-0-substituted 
rather than at the anomeric centre. [132 
2.1.2 Glycopolymers via R A F T polymerisation 
The concept of RAFT polymerisation has already been introduced in section 1.3, 
RAFT's high tolerance to both reaction conditions and monomer functionality make 
it a near perfect choice for the synthesis of glycopolymers and several reports have 
been pubUshed. In 2003, Lowe et al. polymerised the commercially available 
monomer, 2-methacryloxyethyl glucoside (2.10), under aqueous conditions with (4-
cyanopentanoic acid)-4-dithiobenzoate (CPADB, 2.1) as the chain transfer agent 
and 4,4'-azobis(4-cyanopentanoic acid) (ACPA, 2.2) as the initiator; a small amount 
of 1.0 M NaOH was required to improve their solublity. Polymerisations were seen 
to proceed in a controlled manner, with pseudo first order kinetics and a near lin-
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ear relationship between conversion and M^; values of M„ are also very near the 
theoretical ones at lower conversion, but deviate as the polymerisation nears com-
pletion. Further evidence for the level of control is seen in the values of M„/M„, 
which stay below 1.07 throughout the polymerisation. Chain extension and block 
copolymer formation (with 3-sulfopropyl methacrylate (SPMA)) were demonstrated 
using poly[2.10] as a macro-CTA (M„ = 14.2 kDa: M ^ / = 1.07). In both cases 
the reactivation of the thiocarbonylthio groups appears quantitative, with no de-
tectable low molecular weight peak in the SEC, however polydispersities increased 
above 1.5 and some high molecular weight termination products were seen. When 
SPMA was used for macro-CTA synthesis (M„ = 35 kDa; M,„/M„ = 1.04) which, 
in turn, was used for polymerisation of 2.10, the product copolymer retained its 
low polydispersity (final polymer Mn = 68.2 kDa: M ^ / M „ = 1.18). [133 
Davis et al. polymerised 2.5 and 2.6 using the same CTA/initiator combination 
as Lowe et al., but the CTA and initiator were dissolved in EtOH prior to addition. 
The use of EtOH aids the solubility of the CTA and initiator without resorting to 
the use of a base and thus reduces the rate of CTA hydrolj-sis. [134] After a short 
inhibition period, polymerisations were seen to proceed with pseudo-first order ki-
netics and had molecular weights that increase linearly with conversion, albeit with 
values lower than those predicted; polydispersities were consistently low throughout. 
Block copolymers with HEM A were demonstrated with little increase in PDI. [132 
The same group used a similar method for the synthesis of a glucopyranose substi-
tuted vinyladipoyl monomer (2.8), which was subsequently polymerised using both 
dithiocarbamate (2.3) and xanthate (2.4) CTAs in water and MeOH, respectively. 
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Figure 2.1; Structures of monomers and chain transfer agents used in the synthe-
sis of glycopolymers via RAFT polymerisation. 2.1. (4-cyanopentanoic acid)-4-
dithiobenzoate (CPADB): 2.2. 4,4'-azobis(4-cyanopentanoic acid) (AGFA); 2.3. 4-
cyano-4-diethylthiocarbamoylsulfanyl-4-methyl-butyric acid; 2.4. 2-thiopropionyl-
sulfanyl-propionic acid methyl ester: 2.5. methyl 6-0-methacryloyl-Q;-D-glucoside; 
2.6. methyl 6-0-methacryloyl-a-D-mannoside; 2.7. tetra-functional RAFT agent 
used by Stenzel et al.: 2.8. 6-0-vinyladipoyl-D-glucopyranose; 2.9. A/'-acryloyl glu-
cosamine; 2.10. 2-(D-glucosyloxy)ethyl methacrylate; 2.11. 2-gluconamidoethyl 
methacrylate; 2.12. 2-lactobionamidoethyl methacrylate. 
Polymerisations in both solvents gave low pol3'dispersities, particularly in MeOH, 
but conversions were extremely low at 27 % and 14 % for the aqueous and methano-
lic systems respectively. [135] The same monomer was used by Stenzel et al. for the 
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synthesis of glycostars by polymerisation in the presence of t r i - or tetrafunctional 
xanthates, attached to a core via either the R- or Z-group (2.7, see section 1.3 for 
more information on RAFT agent structure). Polymerisations were performed in 
DMAc at 70 °C using ACPA as the initiator. As was seen with the synthesis of 
linear polymers conversions were low, reaching only 35 % after 4 h and a limiting 
conversion of 50 % after 9 h. Molecular weights are seen to increase with conversion 
but are higher than predicted for any given conversion. This may have been due 
to the inadequacies of the SEC calibrants, but is also likely to be contributed to by 
side reactions. [136] 
Ting et al. combined RAFT polymerisation with 'click' chemistry in order to 
synthesise block copolymers of 6-0-methacryloyl mannose and vinyl acetate. Due 
to the difference in reactivity of the monomers each block was synthesised with a 
different RAFT agent; a dithioester for the methacrylate and a xanthate for vinyl 
acetate. The two blocks were then coupled together via the Cu-catalysed Huisgen 
1,3-dipolar cycloaddition reaction. [137 
Stenzel et al. have also described the synthesis of thermoresponsive glycopoly-
mers of various architectures using A^-isopropyl acrylamide (NIPAM) and A^-acryloyl 
glucosamine (2.9) Block copolymers were synthesised using mono- and tri-functional 
trithiocarbonate CTAs. To improve the solubility of the trifunctional CTA in the 
reaction media a short hydroxyethyl acrylate block was synthesised prior to the poly-
merisation of the glycomonomer and NIPAM; considering the complex nature of the 
system control was good (M,„/M„ = 1.3-1.6). [138] Thermosensitive brushes were 
synthesised in a similar manner by submerging a trithiocarbonate functionalised Si 
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substrate in a solution of the appropriate monomer, ACPA and a small quantity 
of the trithiocarbonate: the free RAFT agent suppresses any termination reactions 
when the polymers are unattached to the surface, resulting a greater degree of con-
trol. [139] The molecular weight of the polymer in solution increases linearly with 
conversion, agreeing closely with theoretical values. Similarly, the brush thicknesses, 
as measured by ellipsometry, increased with monomer conversion. [140 
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Figure 2.2: Schematic of the synthesis of thermoresponsive glycopolymer brushes 
by RAFT polymerisation as described by Stenzel et al. 
Narain et al. recently reported the polymerisation of monomers 2.11 and 2.12 
using 5',5'-bis-(Q:,Q:'-dimethyl-Q'"-acetic acid)-trithiocarbonate or 2-dodecylsulfanyl-
thiocarbonylsulfanyl-2-methyl propionic acid as the RAFT agent and ACPA or 2,2'-
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azobis(2-methylpropionamide) dihydrochloride as initiator. Polymerisations were 
performed in aqueous conditions containing 15-40 % organic solvent (MeOH or 
DMF) at 60-65 °C. Polymers formed were of relatively low polydispersity (< 1.5) 
but little can be determined about molecular weight control as the data has not 
been published. [141] The same group used a biotinylated RAFT agent or tert-
butyl dithiobenzoate for the synthesis of poly[yV-acryloylmorpholine] from which 
block copolymers were synthesised with 6-0-acrylamido-6-deoxy-l,2:3,4-di-0-iso-
propylidene-tt-D-galactopyranose; the carbohydrate moiety was deprotected post-
polymerisation with TFA. [142] 
2.1.3 Synthetic methodology 
In this study methacrylate glycornonomers featuring /3-D-glucosyl and /?-D-galactosyl 
moieties (2.14) have been synthesised by glycosylation of the 2-hydroxyethyl meth-
acrylate with the respective peracetylated glycoside in the presence of BF3.Et20 
followed by removal of the acetyl groups with either NaOMe or K2CO3. Poly-
merisations were achieved using RAFT techniques with the commonly used (4-
cyanopentanoic acid)-4-dithiobenzoate and 4,4'-azobis(4-cyanopentanoic acid) as 
the RAFT agent and initiator respectively in an approximately 8:2 mixture of water 
and ethanol at 70 °C. 
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Figure 2.3: Synthesis and RAFT polymerisation of 2-(D-glycosyloxy)ethyl meth-
acrylates: i . 2-hydroxyethyl methacrylate, BF3.Et20, DCM, N2 25 °C, sonication; 
i i . NaOMe or K 2 C O 3 , MeOH; ii i . (4-cyanopentanoic acid)-4-dithiobenzoate, 4,4'-
azobis(4-cyanopentanoic acid), water:EtOH 8:2, N2, 70 °C. 
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2.2 Results and Discussion 
2.2.1 Synthesis of 2-(D-glycosyloxy)ethyl methacrylates 
The synthesis of 2-(D-glycosyloxy)ethyl methacrylates was achieved via a two-step 
synthesis using readily available and relatively cheap starting materials. Firstly, 2-
(2',3\4',6'-tetra-0-acetyl-/?-D-glycosyloxy)ethyl methacrj'lates were synthesised by 
the coupling of peracetylated glycosyl donors (2.13) to glycosyl acceptor 2-hydroxy-
ethyl methacrylate (HEMA) via a boron trifluoride diethyl etherate promoted gly-
cosylation reaction. [78] As with many Lewis acid catalysed glycosylation reactions, 
this proceeds via an S N I type nucleophilic substitution at the anomeric carbon. Ac-
tivation of the glycosyl donor by the boron trifluoride diethyl etherate results in 
formation of a glycosyl oxocarbenium ion, which is stabilised by neighbouring group 
participation of the 2-0-acetyl group (anchimeric assistance, see fig. 2.4). In the 
case of glucosyl and galactosyl species, the carbonyl oxygen of the 2-0-acetyl group 
can attach to the anomeric carbon from the underside of the ring, resulting in a 
as-l,2-acetoxonium species. Attack of the nucleophilic alcohol (HEMA) at C-1 can 
therefore only occur on the top face, trans to the neighbouring group, in an SN2 
type reaction yielding the irans-l,2-glycoside. For D-galacto- and D-glucosylation, 
where the 2-0-acyl group is equatorial, this results in exclusive formation of the 
/?-glycoside. 
Glycosyl 2-0-acetates are considered to be "disarmed'', that is they are relatively 
poor glycosyl donors, and consequently require long reaction times to achieve high 
levels of glycosylation. Conversely, 2-0-benzyl sugars are considered to be "armed" 
and make excellent glycosyl donors. The armed-disarmed effect was first observed 
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Figure 2.4: General mechanism for /3-selective irans-l,2-glycosylation by neighbour-
ing group participation of a 2-0-acyl group. 
Table 2.1: Data for synthesis of anomerically pure 2-(D-glycosyloxy)ethyl meth-
acrylates 
Monomer 
Yield'' 
(%) 
6 i^C {Ht.)^ (ppm) 
a P 
6 ^^C {exv.f 
(ppm) (Hz) Anomer 
GalEMA 40-50 98.8 103.4 104.1 7.5 13 
GlcEMA 40-50 96.6 103.8 102.8 7.8 P 
Overall yield for both glycosylation and deprotection steps; " C chemical shift 
for the anomeric carbon, hterature values from ref. [128]; H-1, H-2 vicinal couphng 
from NMR spectroscopy. 
in glycosylations by n-pentenyl glycosides; the transition state requires nucleophilic 
attack of the anomeric oxygen prior to ejection of the leaving group and formation 
of the oxocarbenium ion. When the substituent in the 2-0 position is a an electron 
withdrawing group, such as an acetate ester, the anomeric oxygen has reduced po-
tential to act as a nucleophile. [143] Similarly, in BF3 promoted glycosylation, the 
anomeric oxygen must first bond datively to the boron centre prior to formation of 
the oxocarbenium ion. Its reduced electron density reduces the rate at which this 
occurs, making this the limiting step of the reaction. Chang et al. recently reported 
increased reaction rate and yield in many common organic reactions, including BF.s 
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promoted glycosylations, by the use of sonication. [144] Using such methods the 
reaction time was reduced dramatically from 36 h to 45 min; after this time the 
mixture was worked-up and treated as usual. Sonication introduces a large amount 
of energy into the reaction compared to conventional mixing and consequently a 
significant increase in temperature was observed during the reaction: enough to pro-
duce a gentle reflux by the end of the reaction. Despite the increased temperature 
and short reaction times no detrimental effect on the a/(3 stereoselectivity was seen: 
as confirmed by ^^ C and NMR spectroscopy. In both cases the -"^ C resonance for 
the anomeric carbon is in good agreement with literature values (table 2.1). [128 
From the NMR spectrum it is possible to confirm the configurations from the size 
of the H1-H2 vicinal coupling for the carbohydrate moiety. For galactosjd and glu-
cosyl structures, J[HI.H2) is typically ~ 8 Hz for the /3 configuration and ~ 4 Hz for 
the a; here they are 7.5 Hz and 7.8 Hz respectively, confirming both are /?-anomers 
(see table 2.1). [145] No resonances for the a-glycosides were observed by either ^H 
or ^^ C NMR spectroscopy (Fig. 2.5). 
BF3.Et20 is moisture sensitive and consequently the use of dry solvent and atmo-
sphere is essential to prevent its decomposition to fluoroboric and boric acids. [146 
Consequently previous syntheses via the BF3 method have typically used an ad-
ditional drying agent, such as molecular sieves, to help maintain the dry reaction 
conditions. Here their addition was found to be unnecessary as the reduced reaction 
times, combined with dry solvent and a constant flow of dry N2 through the appa-
ratus, all but eliminates the possibility of the introduction of water. Performing the 
glycosylation in the absence of molecular sieves also simplifies work-up by remov-
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Figure 2.5: Partial ^^ C NMR of 2-(/?-D-galactosyloxy)ethyl methacrylate. The 
anomeric resonance is clearly seen at ~104 ppm (/3-anomer), no resonance is seen 
at ~99 ppm (a-anomer). 
ing to need to filter the reaction before quenching any residual boron trifluoride. 
Another interesting feature of this synthesis compared to common carbohydrate 
chemistry is the use of an excess of the glycosyl donor. It is usually protocol to 
use either a 1:1 stoichiometry of glycosyl acceptor:donor or an excess of the accep-
tor in glycosylation reactions. This is understandable considering that the glycosyl 
donor being used is often synthetically challenging and/or expensive to produce. 
For the monomers used here it has previously been shown that when an excess of 
the acceptor is used its removal from the glycosylated product can be problematic, 
requiring acetylation by pyridine/acetic anhydride followed by flash chromatogra-
phy before deprotection of the sugar moiety can be performed. [118] As the glycosyl 
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donors used in this study are readily available and relatively cheap - at the time 
of writing /?-D-glucose pentaacetate and its galactose analogue were available for 
approximately £25 and £80 per 100 g respectively - approximately 10 mol % excess 
was used compared to the acceptor. In conjunction with sonication of the reaction 
mixture, this resulted in no detectable HEMA being present in the crude monomer 
by both TLC and ES+ mass spectrometry. Consequently, except when samples were 
required for analysis, crude peracetylated monomers were used directly for synthesis 
of their deprotected analogues, thus reducing the synthetic time required further by 
removing the superfluous acetylation and purification steps. An excess of the glyco-
syl donor also appears to reduce the formation of byproducts of the glycosylation. 
Glycosylations with 2-0-acetyl protected sugars have previously been reported to 
yield products of esterification of the alcohol acceptor, in the case of HEMA leading 
to 2-(acetoxy)ethyl methacrylate. [118] Such products are thought to derive from 
the reaction between the the nucleophilic alcohol and the orthoester intermediate 
formed by neighbouring-group participation resulting in transfer of the acyl moiety 
and regio-selective deacetylation at the 2-0 position; [147,148] no such products 
have been observed when acceptor and donor were used in 1:1 stoichiometry. [149 
Here no such side products were observed and it is fair to assume that the increased 
reaction rate and excess glycosyl donor resulted in complete conversion of HEMA 
to the desired product without the opportunity for side reactions to occur. 
Removal of the acetyl protecting groups was achieved with either NaOMe or 
K 2 C O 3 in MeOH. Despite previous reports, [150] little difference in the reaction 
yield or level of methacrylate cleavage was seen between these methods. Overall, 
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the K2CO3 method was considered to be advantageous as it removes the need for dry 
solvents, in fact reacting more rapidily in damp MeOH due to the increased level of 
dissolved K 2 C O 3 . Its use also removes the precautions required in the use of elemen-
tal sodium for the production of fresh NaOMe. As has been noted before, cleavage 
of the methacrylate ester occurs at a significant level and thus reaction progress 
was monitored by TLC (9:1 MeCNiHiO). [118,150] Here the deprotection was not 
quenched as soon as the cleavage product [Rj ~ 0.15) was detected as this usually 
resulted in a significant quantity of partially deprotected material remaining. As 
well as reducing potential yield this complicates purification as the multiple isomers 
of mono-acetylated material and fully deprotected material run very close together 
on a silica gel chromatography column. In order to remove this complication the re-
action was allowed to proceed until no partially deprotected material was detectable 
{Rf > 0.5) before quenching. At this time undissolved potassium carbonate was re-
moved by filtration and any dissolved base quenched by addition of strongly acidic 
ion exchange resin (Amberjet 1200H or equivalent). To minimise cleavage of the 
methacrylate ester the apparatus required for quenching was assembled prior to the 
deprotection allowing its immediate use when required. Purification was achieved 
by flash column chromatography, initially manually using an isocratic eluent of 8:2 
CHCl3:MeOH and later automatically on a Biotage® SPl Flash Purification system 
running a CHCl3:MeOH gradient elution. Both methods yielded pure product but 
the latter required shorter preparation and running times which, when combined 
with the shortened glycosylation reaction, reduced the overall synthesis time from 
3-4 days to a day. Another advantage of the Biotage® system was its use of pre-
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Figure 2.6: Elution gradient and example UV spectrum for the purification of 
GalEMA. (a) Elution profile: (b) Time-resolved UV spectrum for the purification of 
GalEMA 
packed Si columns making the purification highly repeatable as their was little or 
no variation between packing density reducing the possibility of inadequate sepa-
ration from an inconsistently packed column. The Biotage system is also equipped 
with a dual wavelength UV detector system that allows facile determination of the 
fractions that are most likely to contain the desired product. 2-(/9-D-galactosyloxy)-
ethyl methacrylate (GalEMA, 2.14a) and 2-(/?-D-glucosyloxy)ethyl methacrylate 
(GlcEMA, 2.14b) were isolated as colourless oils that became amorphous solids 
upon lyophilising, although this was generally avoided as some polymerisation often 
occured even in the presence of an organic free radical inhibitor. Instead they were 
dried under high vacuum and dissolved in D2O as 0.5 mol dm"'^ stock solutions. 
An inhibitor was not added to the solutions as its removal prior to polymerisation 
was found to be problematic, instead the solutions were stored frozen at -18 °C to 
prevent any unwanted polymerisation. GalEMA and GlcEMA were characterised 
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by and ^^ C NMR spectroscopy, mass spectrometry, IR spectroscopy and elemen-
tal analysis, all of which agree with literature values. [118,128] Yields were found 
to be heavily dependent on the deprotection reaction, but were typically 40-50 %, 
based on moles of HEMA used, over the two steps. Although these yields were not 
as high as some previous syntheses of glycosyl methacrylates the reduced reaction 
time, cheap substrates and ease of preparation more than compensateds for this 
reduction. 
2.2.2 Synthesis of (4-cyanopentanoic acid)-4-dithiobenzoate 
fVMgB, f \ ^ ' —J^ 
SNa 
S NC 
(iv) 
Figure 2.7: Synthesis of (4-cyanopentanoic acid)-4-dithiobenzoate: i . Carbon disul-
fide, THF, 0 °C; i i . aqueous NaOH: ii i . aqueous K3Fe(CN)6; iv. 4,4'-azobis(4-
cyanopentanoic acid), EtOAc, reflux. 
(4-Cyanopentanoic acid)-4-dithiobenzoate (CPADB, 2.1) was synthesised ac-
cording to a literature procedure. [99] Briefly, sodium dithiobenzoate was synthesised 
by the Grignard reaction between phenylmagnesium bromide and carbon disulfide to 
give dithiobenzoic acid, followed by acidic, basic and organic washes. The resulting 
aqueous solution of sodium dithiobenzoate was then oxidised by excess potassium 
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ferricyanide to give the di(thiobenzoyl) disulfide as a red-purple precipitate. After 
recrystallisation from EtOH, the disulfide was refiuxed in the presence of excess 
4,4'-azobis(4-cyanopentanoic acid) to yield the desired product which was purified 
by flash column chromatography and recrystallisation from toluene. NMR (^H and 
•^^ C) and IR spectroscopies, mass spectrometry and elemental analyses were found 
to be in good agreement with the literature values. 
2.2.3 Polymer Synthesis 
2-(/3-D-galactosyloxy)ethyl methacrylate and 2-(/?-D-glucosyloxy)ethyl methacrylate 
were polymerised using a RAFT system modified from that of Albertin et al. [132] 
Solutions of RAFT agent (4-cyanopentanoic acid)-4-dithiobenzoate and initiator 
4,4'-azobis(4-cyanopentanoic acid) in EtOH were added to stock 0.5 M monomer 
solution; polymerisations were thoroughly deoxygenated by repeated freeze-pump-
thaw cycles and performed under N2 atmosphere. At the end of the polymerisation 
samples (100 /xl) were removed for aqueous SEC and NMR analyses. The re-
maining reaction solution was dialysed (Pierce Snakeskin, 3.5 kDa MWCO) against 
UHQ water (> 18.2 Mfi-cm~^) to remove any low molecular weight impurities such 
as residual monomer and initiator. Molecular weights of the polymers were deter-
mined by both aqueous SEC (see section 2.2.4.1) and end group analysis of the 
purified polymer by NMR. Monomer conversion was determined from the ratio 
of the vinyl and anomeric protons in the NMR spectrum of the crude reaction 
mixture. Polymers were also characterised by and ^^ C NMR spectroscopy. 
The mechanism of free radical polymerisation was outlined in section 1.3.1. One 
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Figure 2.8: Stack plot of the vinyl region of the ^H NMR for the polymerisation of 
GalEMA. Spectra were recorded at 5 minute intervals. 
consequence of this mechanism is that radical concentration is. to a large extent, 
self-regulatory - an influx of radicals into the system due to initiator decomposition 
wil l quickly result in an increased rate of termination and subsequent reduction in 
radical concentration. This results in steady-state conditions and so polymerisa-
tions display pseudo-first order kinetics wi th respect to monomer. Although the 
mechanism of RAFT polymerisation is more complex that than of conventional free 
radical polymerisation, pseudo-first order kinetics are still expected; albeit at an 
overall decreased rate of polymerisation. The kinetics of GalEMA polymerisation 
were determined for three different monomer to RAFT agents ratios by monitoring 
the disappearance of the vinyl protons in the ^H NMR spectrum: monomer con-
centration and RAFT:init iator ratio were kept constant. Spectra were recorded at 
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5 minute intervals and the integrals of the vinyl and anomeric protons used to de-
termine the conversion, and thus kinetics, for the polymerisation. As can be seen 
in figure 2.9, polymerisations at all ratios proceed almost identically. In RAFT 
polymerisations it is usual to see a retardation in polymerisation rate with increas-
ing CTA concentration, here it appears that the lowest polymerisation rate was 
observed in the sample with the lowest concentration of CTA (fig. 2.9d, targeted 
DP„ 97). Observed rate constants (A-obs), calculated by linear regression of the plots 
for t > 20 min., arc given in table 2.2. These, indeed, show this to be the case 
(DP„ 97, kobs = 0.485 x 10~^ s"'), with the two higher CTA concentrations having 
very similar polymerisation rates (A-obs ~ 0.6 x 10"^ s~^). Here, though, the con-
centration of initiator has been scaled with that of the CTA and consequently the 
picture is not necessarily that simple. The decomposition rate of ACPA in D2O has 
been studied previously and values for activation energy ( E q = 132.9 kJ mol~^) and 
the pre-exponential factor {A = 6.43x10^^ s~') have been determined. Decompo-
sition rates of azo-initiators have also been shown to vary little between solvents 
so, [151,152] assuming this to be true for the addition of EtOH, an estimate of the 
number of radicals produced by initiator decomposition may be calculated by use 
of the Arrhenius and first order rate equations. As: 
k = Ae-^^"^^ (2.1) 
thus, using values of 6.21x10 '^^  s-\ [152] 132.9 k.J mo\-\ 8.314 J K"^ mol^^ and 
343 K for A, E ^ , R and T respectively, a value of k^ at 70 °C can be estimated to 
be 3.58x10-5 5"^ 
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Also, as 
thus, 
^ACPAV = (2.3) 
and, as each decomposition produces two radicals, 
[.4CP4.-|.4CP^l. = " (2.4) 
The values derived from equations 2.1 to 2.4 are summarised in table 2.2. It 
must be noted that the concentration of radicals given is not the overall radical con-
centration at t = 120, nor the concentration of initiator derived radicals at this time. 
Instead it is the cumulative concentration of initiator-derived radicals at t = 120 or 
the concentration of radicals the initiator has injected into the polymerisation. From 
these values it is evident that, within the timescale of the reaction, approximately 
25 % of ACPA decomposes to produce a pair of radicals. Initiator efficency for 
ACPA is approximately 0.7, [153] although this will vary with monomer structure 
and concentration, so the number of radicals that may actually initiate polymeri-
sation will be approximately 30 % lower than these values. Despite this, it is clear 
that the number of initiator derived radicals will be far higher in polymerisations 
where lower values of DP„ are targeted. The retardation of propagation rate that is 
expected to increase with increasing CTA concentration does just that; the similar 
values of /cobs for the two higher CTA concentrations, despite the vastly different 
initiating radical concentrations, testifies as such. 
The differing concentrations of ACPA will have particular effect in the early 
stages of polymerisation where monomer concentration, and thus initiator efficiency, 
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Figure 2.9: (a) Conversion and (b - d) Kinetic plots for the polymerisation of 2-(/3-
D-galactosyloxy)ethyl methacrylate at various [Monomer]/[RAFT] ratios: (b)= 25, 
(c) 51, (d) 97. 
is highest. It is common to see a period of induction at the start of RAFT polymeri-
sations, the cause of which is still open to debate, before steady-state conditions 
are reached. [154] Here it is seen to last for approximately 30 minutes (figures 2.9c 
(DP,i 51) and 2.9d (DP,, 97)) and increases with decreasing target DP,,. At the 
highest CTA concentration the induction period is interesting. At first glance it 
appears to be shorter than the lower CTA concentrations with no obvious change of 
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reaction rate during the polymerisation. Upon closer inspection it is arguable as to 
whether a steady-state is ever achieved with the plot never reaching true linearity. 
Similar results have been reported previously in the synthesis of glycopolymers via 
RAFT and it is thought that the length of the non-steady-state period is that time 
required for the CTA to be transformed into a polymeric macroCTA: [155] recent 
hterature in other RAFT systems appears to support this idea. [156 
Table 2.2: Data for polymerisation kinetics of GalEMA an aqueous RAFT poly-
merisation svstem 
DP„ 
[GalEMA] 0 [CPADB]o [ACPA]o kobs [ACPA],° [radicals] t"''' 
(mM) (mM) (mM) (s-1 X 10^) (mM) (mM) 
25 397 15.6 7.8 594 6.03 3.54 
51 397 7.8 3.9 661 3.01 1.77 
97 397 4.1 2.0 485 1.55 0.91 
° i = 120 minutes, calculated as described in text; * cumulative concentration of 
initiator derived radicals. 
In all cases polymerisations proceeded to high conversion (> 95 %) in approx-
imately 2 hours when conducted under the conditions used for kinetic analysis, 
that is the reaction being undertaken was performed in an NMR tube fitted with a 
Young's tap within the probe of the spectrometer. When routine polymerisations 
were performed a Schlenk tube was used and similar levels of conversion were only 
observed after 3 hours. This discrepancy in reaction time is likely to be a product 
of heating and mixing efficiency. In both vessels no agitation was applied, and when 
polymerisations were conducted in an NMR spectrometer only the base of the tube 
is heated directly and thus thermal gradients within the system are larger: conse-
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Figure 2.10: Comparison of conversion in diff'erent polymerisation vessels: Young's 
NMR tube (o): Schlenk tube ( A ) . 
quently convection currents wi l l aid in the mixing. When the polymerisations were 
conducted in a Schlenk tube the reaction mixture was fully submerged in a water 
bath, reducing any anisotropy in the heating and mixing hy convection. Further, 
the increased thickness of glass used in the vessel would increase the time required 
to get the solution to temperature resulting in an increased induction period. From 
fig. 2.10 the difference in induction period between the two reaction vessels is clear, 
for the NMR. tube reaction lit t le, i f any, induction period is seen: in the case of the 
Schlenk tube reaction no conversion is detectable unti l 30 min. into the reaction. 
One of the requirements of a controlled polymerisation is that the molecular 
weight must be predetermined by the ratio of the amount of reacted monomer and 
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the initiating species, thus as a polymerisation proceeds molecular weight should 
incrccise linearly with conversion. Similarly, final molecular weight should be pre-
dictable from the mole ratio of monomer to CTA in the feed. To determine if this 
was true in this system a series of experiments targeting varying molecular weights 
were carried out as well as experiments where Af„ was determined at different lev-
els of monomer conversion. In order to conduct these experiments methods for 
the accurate determination of polymer molecular weight were required, namely size 
exclusion chromatography (SEC) and NMR spectroscopy. 
2.2.4 Polymerisation control 
2.2.4.1 Determination of polymer molecular weight via T r i S E C 
Molecular weight determination of glycopolymers via SEC is not entirely straight-
forward: the use of DMF SEC with conventional calibration (PS standards) having 
been reported to give artificially low values of Mn on several occasions. [136,157,158 
Here aqueous SEC with triple detection (TriSEC) using refractive index (RI), right-
angle light-scattering (RALS) and viscometry detectors was used to remove the 
inaccuracy of inadequate polymer standards. One of the main advantages of the 
TriSEC system is the removal of the need to calibrate with multiple standards, re-
quiring a single calibrant, the nature of which is unimportant, to determine detector 
responses. Using Viscotek's OmniSEC® software it is possible to calculate Af„, 
(and thus M„;/M„) as well as several other parameters; the theory of TriSEC has 
been described in detail previously, [159-161] but is briefly summarised below. 
When light is passed through a solution it interacts with the solvent and solute 
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resulting in scattering. By measuring the intensity of scattered light from both a 
solution of the molecules of interest and pure solvent it is possible to determine the 
excess scattering due to solute by simple subtraction. [N.B. For the purposes of 
this explanation the term solute refers to the macromolecules undergoing analysis 
and the term solvent refers to the eluent used for said analysis. Consequently the 
solvent may also contain dissolved salts such as buffers.] The intensity of excess 
scattering is proportional to the concentration and molecular weight (MW) of the 
solute as seen in eqn. 2.5 where C is the solute concentration, K is an optical 
constant, A2 is the second virial coefficient, Rg is the excess Rayleigh ratio and Pg is 
the particle scattering function, which allows for angular dependence of scattering 
intensity. [160] 
KC 1 
Rg MWPg 
+ 2A2C (2.5) 
At experimental concentrations, A2 may be approximated to zero and Pg is deter-
mined by iteration within the software. Rg is measured during the experiment by 
the RALS detector and thus sample concentration is the only variable required to 
obtain accurate values of molecular weight. At each time point measured by the 
detectors a value of MW is determined and consequently, if the concentration of 
the solute at each point is known, then values of A4n, and M^/Mn may be 
determined. 
Obviously it is possible to prepare accurate solutions of known concentrations of 
each and every polymer that requires analysis, but it is a laborious task requiring 
high purity polymers, making rapid reaction sampling and analysis difficult. Fortu-
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nately there is an alternative method, using the online RI detector, which is essen-
tially a concentration detector, along with the refractive index increment [dn/dc] 
of the sample being analysed to determine concentration, at each chromatogram 
shce, online. For common polymers, dn/dc values are readily available in literature. 
Unfortunately, very few reports on glycopolymers have utilised TriSEC and c/n/dc 
is also specific to solute, solvent, temperature and wavelength; consequently values 
of dn/dc have to be determined prior to analysis. 
Within the OmniSEC® software it is possible to calculate dn/dc values from 
a single sample of known concentration, unfortunately there is no way of gauging 
the accuracy of the value obtained. To determine values of dn/dc for GalEMA and 
GlcEMA, solutions of varying, but known, concentrations were analysed by SEC. 
By plotting the RI detector response area against concentration dn/dc values may 
be calculated using equations 2.6 to 2.8 and the plot provides a visual gauge as to 
the accuracy of the value obtained. 
The RI.Area IS dcscribcd by: 
RI.r.a = ^-''i-V.nrC (2.6) 
nn dc 
where Rlcai, and K„j are the RI detector calibration factor, determined during 
calibration of the system with a standard of known molecular weight and d.n/dc, 
the refractive index of the solvent and the injection volume respectively. The first 
diiferential with respect to concentration is: 
ARlArea Rhal dn 
——— = — • Vinj = gradient (2.7) 
AC ';?.o dc 
As Rlcai, ^inj and 77,0 are all known parameters, d.n/dc may be calculated simply 
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from the gradient by: 
fill gradient • ILQ 
1^ " 
(2.8) 
In order to obtain accurate, and thus meaningful, values of dn/dc high purity poly-
mers must be used in their determination. Consequently, when values of dii/dc 
were determined the polymers were dialyscd thoroughh' against high purity water 
and lyophilised prior to SEC analysis. Solutions of known, accurate concentrations 
were then prepared. Figure 2.11 shows an example plot of RIATCU against c for 
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Figure 2.11: Plot for the determination of dn/dc for pGlcEMA. (—) Linear f i t . 
= 0.999. 
poly[GlcEMA]. I t is clear that a good linear fit was obtained (7?^  = 0.999). Un-
fortunately, when extrapolated to zero concentration the fit does not pass exactly 
through the origin as would be expected from theory. This small discrepancy can be 
easily explained by slight inaccuracies in the preparation of the polymer solutions. 
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Table 2.3: Specific refractive index increments {dn/dc) of synthesised polymers as 
determined by RI method. 
dn/dc 
P^^y^"-^ ml-g-^ 
poly[2-(/?-D-galactosyloxy)ethyl methacrylate] 0.153°''' 
poly[2-(/?-D-glucosyloxy)ethyl methacrylate] 0.146"''' 
poly [GalEMAso-s to^-HEMAso] 0.114"-^  
poly[GalEMA64-siai-HEMA36] 0.113"'^  
poly[GalEMA5o-6/oc/c-DMAEMA25] 0.106"''^  
° Eluent: 0.2 M NaNOa and O.IM NaH2P04 in UHQ water: '' calculated by multiple 
injections of differing, known concentrations: calculated from a single injection 
of known concentration: eluent: 80% HPLC-grade water, 20% methanol, 0.05 M 
NaNOs and 2.5 m l - l ' ^ 1.0 M NaOH. 
Due to their nature glycopolymers are very hygroscopic, ergo the preparation of 
solutions wi th accurate polymer and buffer concentrations can prove problematic 
as, despite thorough drying, samples absorb water quickly upon exposure to air. In 
the case of block and statistical copolymers values of dn/dc were calculated from a 
single injection of known concentration; values are summarised in table 2.3. 
2.2.4.2 Control of M „ during polymerisation 
The evolution of molecular weight during polymerisation was monitored by removal 
of 100 fA samples of the reaction mixture at regular intervals. Upon their removal the 
samples were split in two and quenched by dilution in D2O or the SEC eluent ready 
for analysis. As before, ^H NMR spectroscopy was used to determine monomer con-
version and M„ and M ^ / M „ were determined by aqueous TriSEC. As SEC of very 
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low molecular weight species was found to be at least non-trivial, i f not impossible, 
a DP„ of 200 was targeted as this gave analysable polymers even at low conversions. 
Figures 2.12a and 2.13a contain the SEC RI detector chromatographs for the poly-
merisation of GalEMA and GlcEMA respectively. I t is clear that, as conversion 
increases, there is a shift towards lower retention time and thus higher molecular 
weight; the peaks are also seen to narrow characteristically. There is no evidence of 
any high molecular weight polymer formation, that would manifest as a shoulder on 
the front of the peak, wi th all peaks being unimodal and near symmetrical. Figures 
2.12b and 2.13b are plots of Mn and Myj/Mn vs monomer conversion for the same 
pair of polymerisations; theoretical M „ determined by equation 1.2 is shown for 
clarity. For both monomers the evolution of M„ is seen to be linear with conversion 
{B? > 0.99) but the linear fits do not match the theoretical values precisely. Simi-
lar results have been reported before for the synthesis of glycopolymers via RAFT 
polymerisation. In those cases the discrepancies between measured and theoretical 
values were very large and were attributed to the use of polystyrene standards re-
sulting in inadequate SEC calibration. [132,162] Here the values measured are not 
nearly as far f rom the theoretical, at most being ± 1 0 %, and are probably due to 
small quantities of termination that cannot be detected in the chromatographs or 
slight inaccuracies in their determination. The latter is a distinct possibility as these 
samples were not purified prior to analysis instead being removed from the reaction, 
diluted in the eluent and injected into the SEC. Consequently the analytes contained 
additional, albeit very small, quantities of solutes other than polymer. Such impuri-
ties should be separated on the column but may remain associated with the polymer 
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Figure 2 .12: Data for molecular weight control during the polymerisation of 
GalEMA; (a) Evolution of aqueoua SEC R I signal wi th increasing conversion; (b) 
M„ and M„,/A/„, vs. conversion. (•) (SEC). (—) linear fit of Af„ (SEC) (i?^ = 
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if the interaction is strong enough. Consequently there wi l l be a small change in the 
solution behaviour and thus the values of M, i determined. The polydispersity of the 
polymers was seen to be consistently low throughout the polymerisation (<1.2). 
2.2.4.3 Synthesis of polymers of predetermined molecular weight 
In order to determine if polymers of varying, pre-determined, molecular weights 
could be achieved a series of polymers of different targeted degrees of polymerisation 
were synthesised as detailed in table 2.4 After completion of the reaction samples 
were analysed by aqueous TriSEC and N M R spectroscopy as before. Figures 
2.14 and 2.15 contain SEC data for these series of polymers. Figures 2.14a and 
2.15a are normalised RI response traces from aqueous SEC of a series of polymers 
of different targeted degrees of polymerisation (Table 2.4). In all cases the polymers 
formed have narrow unimodal molecular weight distributions and no high molecular 
weight shoulders are evident, suggesting no bimolecular termination products: sim-
ilarly, no low molecular weight termination products are seen. Molecular weights as 
determined by aq. TriSEC agree well with those calculated by eqn. 1.2, typically 
within 10 %, although some deviation is seen (figures 2.14b and 2.15b). Molecular 
weights calculated by NMR spectroscopy agree closely with those measured by 
SEC at low DP„ but can only be described as erratic when longer chain lengths 
are targeted. This is to be expected as the longer the polymer the weaker the end 
group signals are relative to the rest of the polymer. Even with extended aquisition 
times, acquiring accurate integrals for the aromatic end group of the polymers is 
challenging as the signal to noise ratios are too low. At high molecular weights, 
where end groups only constitute a fraction of a percent of the overall molecular 
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mass, such errors are exaggerated. Polydispersities were calculated using TriSEC 
Table 2.4: Data for the polymerisation of 2-(D-glycosyloxy)ethyl methacrylates 
# Monomer DP, , , / 
Conv,* M, X (kDa) 
(%) Theory^ NMR' ' SEC= Conv^ RALS5 
1 GalEMA 25 92 7.0 8.2 8.2 1.26 1.03 
2 GalEMA 50 98 14.7 13.4 11.0 1.19 1.19 
3 GalEMA 97 95 27.2 20.3 21.8 1.13 1.01 
4 GalEMA 145 97 41.5 44.7 42.4 1.16 1.11 
5 GalEMA 201 95 56.2 39.4 56.6 1.17 1.10 
6 GlcEMA 25 96 7.3 7.0 6.2 1.17 1.12 
7 GlcEMA 50 98 14.7 12.3 12.7 1.14 1.02 
8 GlcEMA 101 97 28.8 35.1 27.8 1.22 1.08 
9 GlcEMA 151 91 40.4 37.7 34.2 1.21 1.02 
10 GlcEMA 201 94 55.6 25.1 50.6 1.12 1.01 
Ratio of [M]:[RAFT], [RAFT]:[I] = 2. * Calculated by NMR spectroscopy 
using the ratio of the integrals of the vinyl and anomeric protons. Calculated 
using equation 1.2 on page 36. Calculated by N M R spectroscopy using the 
ratio of the integrals of the aromatic and backbone protons. ^ Using dn/dc values of 
0.153 ml g - i and 0.146 ml g"^ for GalEMA and GlcEMA respectively; d:n./dc values 
calculated using eqns. 2.7 and 2.8. ^ Determined using conventional cahbration. 
s from TriSEC. 
triple detection ( M , ^ / M „ (RALS)) and using conventional calibration with PEO 
standards [M^/Mn (Conv.)). The two sets of values vary greatl}^, those determined 
via TriSEC are lower than would be expected for polymers synthesised by CRP, 
often below 1.05, and consistently lower than the values determined by conventional 
calibration. In order to determine which of set of values is more realistic a PEO 
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standard (Polymer Labs, M„ = 28.7 kDa, M^jMn = 1-04, dn/dc = 0.133 ml g"') 
was analysed under the same conditions. Here values of M^/Mn were calculated as 
1.02 and 1.19 for TriSEC and conventional calibration methodologies respectively, 
compared wi th the manufacturers quoted value of 1.04. Thus, although the values 
of M^/Mn from TriSEC appear to be lower than the real values they also appear to 
be far more realistic than those calculated by conventional calibration. The cause 
of the artificially low values currently remains unknown. 
2.2.4.4 Chain extension and block copolymer synthesis 
To confirm the presence of the dithioester polymer end groups, p[GalEMA] was chain 
extended wi th GalEMA and 2-(dimethylamino)ethyl methacrylate ( D M A E M A ) . A 
poly[GalEMA] macroRAFT agent (DP„ ~ 50) was synthesised as before and purified 
by dialysis. The macro-RAFT agent was then used in the polymerisation of the 
appropriate monomer in a similar manner. 
Table 2.5: Data for block copolymer synthesis wi th poly[2-(/3-D-galactosyloxy)ethyl 
methacrylate] 
Initial M„ Init ial Mn,thr Mn,SEC 
Polymer (kDa) (kDa) (kDa) 
p[GalEMA-6-GalEMA] 13.2 i . o r 24.9 21.1 1.13" 
p[GalEMA-6-DMAEMA] 15.0 1.03'^  19.1 18.4 1.01" 
" Myj/Mn values as determined by triple detection SEC. 
Figure 2.16 contains the SEC chromatographs for a poly [GalEMA] macroRAFT, 
its chain extension by 2-(/3-D-galactosyloxy)ethyl methacrylate (fig. 2.16a) and block 
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copolymer with 2-(dimethylamino)ethyl methacrylate (fig. 2.16b). In both cases it 
is clear that the copolymers elute at lower retention volume and thus have increased 
in molecular weight compared to the init ial block and the copolymers have narrow, 
unimodal molecular weight distributions. Neither displays either a high molecu-
lar weight shoulder, the result of bimolecular termination, or obvious residual ho-
mopolymcr. suggesting that reinitiation of the polymerisation is quantitative and 
still controlled. Chain extension of p[GalEMA] with GalEMA results in an increase 
in polydisperity as is commonly seen with block copotymer synthesis (table 2.5). 
W i t h D M A E M A the polydispersity decreases although, rather than being a true 
value of Myj/Mn, this is more Hkely caused by an inaccurate value of dn/dc which 
was calculated from a single injection SEC experiment. 
1:5 16 17 18 
Retention Volume / mi Retention Volume /mi 
(a) 
Figure 2.16: SEC chromatographs for poly[2-(/?-D-galactosyloxy)ethyl methacrylate] 
block copolymers: (a) chain extension with GalEMA: (b) block copol.ymer wi th 2-
(dimethylamino)ethyl methacrylate. 
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2.2.5 Synthesis of statistical copolymers with H E M A 
In order to produce polymers of reduced carbohydrate density, statistical copolymers 
with 2-hydroxyethyl methacrylate were synthesised at varying G a l E M A / H E M A feed 
ratios (table 2.6). Polymerisations were conducted as before but the reaction time 
was increased to 16 h and an increased [CTA]: [Initiator] ratio to increase control 
over the extended reaction time. After this time the reaction solution was diluted 
with UHQ water and dialysed as before. Except for the H E M A homopolymer (entry 
4, table 2.6), which precipitated upon dilution, all polymers were found to be water 
soluble. Overall monomer conversion was determined by N M R spectroscopy of 
the crude reaction mixture using the ratio of vinyl and backbone/methyl protons. 
As the vinyl peaks of GalEMA and HEMA overlap closely the conversion of the 
individual monomers was not determined although i t is expected that, considering its 
usual reactivity, the conversion of GalEMA wil l approximate to 100 %. Composition 
of the polymers was determined by integration of the anomeric and backbone/methyl 
protons in the ^H N M R spectra of the purified polymers. 
For feed ratios of up to 50 % HEMA the conversions were high (> 95 %) but 
were limited when the feed ratio reacheds 75 % HEMA. Polymer compositions agreed 
well with the monomer feed ratios when 25 and 50 % GalEMA were used but were 
somewhat reduced where 75 % GalEMA was used with a glycomonomer content of 
69 mole %. The reduced incorporation of GalEMA was unexpected as i t was thought 
to be the more reactive monomer under the polymerisation conditions, requiring an 
increased reaction time to reach similar conversion. Although the reason for this 
remains unknown one explanation lies in the solubility of HEMA. HEMA is water 
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Table 2.6: Data for the statistical copolymerisation of 2-hydroxyethyl methacrylate 
and 2-(/?-D-galactosyloxy)ethyl methacrylate 
Run 
[GalEMA]" 
(mM) 
[HEMA]" 
(mM) 
/ GalEMA*-
Thr N M R (%) 
MjkB 
Theory*^ 
l a 
SEC 
1 296 99 75 69 98 12.2 18.3 1.05 
2 197 197 50 50 95 10.3 18.3 1.07 
3 99 296 25 26 80 6.9 e e 
4 0 395 0 0 _ / _ / _ / 
" Added as 0.5 M solutions; ''Thr, monomer fraction from feed ratio; NMR, feed ratio 
as calculated f rom N M R spectroscopy of purified polymer; monomer conversion 
as calculated from N M R spectrum of crude polymerisation solution; calculated 
using eqn. 1.2 on page 36 with allowance for the differing monomer compositions; 
sample too small to analyse accurately by SEC; ^ polymer insoluble in D2O. 
soluble but the solubility of its homopolymers is highly dependent on chain length 
and temperature wi th relatively short polymers displaying a lower critical solution 
temperature. [163] Thus, at polymerisation temperatures, a propagating polymer 
chain containing a large amount of HEMA wi l l have a reduced rate of propagation as 
it wil l be less hydrated and accessible to monomer, particularly bulky monomers such 
as GalEMA. This reduced reactivity is evident in the comparatively low conversion 
seen in the 75-25 HEMA-GalEMA polymer even after 16 h of reaction. When lower 
feed ratios of H E M A are used the propagating chains wi l l have a solubility nearer 
that of a GalEMA homopolymer and chain terminus should be more accessible to 
monomer. Also, the lower rate of HEMA polymerisation is probably not due to it 
being inherently less reactive, in fact its smaller size and less hindered nature would 
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suggest a higher reactivity than GalEMA. Consequently its slower propagation rate 
is probably due to reduced polymer solubility whereas when the polymer chain is 
solubilised by the presence of saccharides the true reactivity of H E M A may be seen. 
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2.3 Conclusions 
Synthesis of anomerically pure 2-(D-glycosyloxy)ethyl methacrylates has been demo-
nstrated by modification of literature procedures. Although such monomers have 
been synthesised on multiple occasions reaction conditions have often been laborious 
and materials expensive. The combination of sonication and an excess of the glycosyl 
acetate allowed multi-gram quantities of peracetylated glycomonomers to be synthe-
sised in hours, rather than days, and at a level of purity that was high enough to use 
in further synthetic steps without the need for chromatography. Post-deprotection, 
the use of automated flash column chromatography increases the repeatability of 
producing high purity glycomonomers whilst further reducing the synthetic time. 
Reversible addition-fragmentation chain transfer polymerisation has been demon-
strated to polymerise these monomers, under aqueous conditions, to yield polymers 
of defined molecular weight and narrow polydispersity, two aspects that may be 
required for good manufacturing practice were such polymers to be used in pharma-
ceuticals. Equally, the ' l iving' nature of the these polymerisations has been demon-
strated by chain extension and block copolymer synthesis allowing the construction 
of more complex polymer architectures without needing to resort to more challenging 
polymerisation techniques or protecting group chemistry. 
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2.4 Experimental 
2.4.1 General 
2.4.1.1 Materials 
/?-D-Galactose pentaacetate (98 % ) , /?-D-glucose pentaacetate (98 % ) , phenylmagne-
sium bromide ( I M in THE) , carbon disulfide (98 % ) , potassium ferricyanide (98 % ) , 
2-hydroxyethyI methacrylate (98 %, HEMA) and potassium carbonate (99 %) were 
purchased from Aldrich. Boron trifluoride diethyl etherate (purum, dist.), 4,4'-azo-
bis(4-cyanopentanoic acid) (98 %) and 2-(dimethylamino)ethyl methacrylate (98 %) 
were purchased f rom Fluka, Amberjet 1200H strong acid cation exchange resin was 
purchased from Fisher. A l l solvents were Fisher HPLC grade, when anhydrous 
solvents were required they were passed through alumina columns prior to use. 
2-Hydroxyethyl methacrylate and 2-(dimethylamino)ethyl methacrylate were chro-
matographed on basic alumina to remove inhibitors prior to polymerisation. A l l 
other chemicals were used without further purification. Flash column chromatogra-
phy was performed using a Biotage SPl automated purification system using pre-
packed silica columns. 
2.4.1.2 Analysis 
N M R spectra were recorded using a Varian Inova 500 spectrometer at 499.87 (^H) 
and 125.67 MHz (^^C, decoupled at 500 MHz) or using a Bruker Avance 400 
spectrometer at 400,13 MHz (^H) or 100.26 MHz (^^C, ^H decoupled at 400 MHz). 
NMR spectra were analyzed using the Varian V N M R 6.1C or MestRe Nova 5.2 soft-
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ware. IR spectra were recorded on a Perkin-Elmer 1600 Series FT-IR spectrometer 
by casting a film on NaCl plates from either DCM or MeOH. Mass spectra were ac-
quired using a Micromass LCT spectrometer using ES+ and ES- modes of ionization. 
Elemental analyses were obtained using an Exeter Analytical Inc. E-440 Elemental 
Analyzer. Aqueous SEC was performed using a triple detection method (with an-
gular correction) and measurements were performed on a Viscotek T D A 301 triple 
detection SEC fitted wi th two (300 x 7.5 mm) G M P W x l methacrylate-based mixed 
bed columns wi th an exclusion hmit of 5x10^ g m o r \ having refractive index, vis-
cometer and RALLS detectors. The eluent was 0.2 M NaNOg and O.IM NaH2P04 
in UHQ water, unless otherwise stated, at a fiow rate of 1.0 ml/minute and a con-
stant temperature of 30 °C. Calibration (for detector response) was achieved using 
a single narrow PEG standard (Polymer Labs) of 82,500 g mol~^ and a dn/dc value 
of 0.133 ml g~^ Conventional calibration was achieved using a selection of narrow 
PEG standards (Polymer Labs, Mp = 400-126500 Da). Molecular weights were 
determined using the Omnisec 4.0 for Windows software wi th dn/dc values as given 
in table 2.3. 
2.4,2 Synthesis of 2-(2',3',4',6'-tetra-0-acetyl-/?-D-galactosyl-
oxy)ethyl methacrylate 
/?-D-Galactose pentaacetate (5.0 g, 12.8 mmol) and 2-hydroxyethyl methacrylate 
(1.4 ml, 1.5 g, 11.5 mmol) were dissolved in anhydrous dichloromethane (20 ml) and 
sonicated under a blanket of anhydrous N2 for 5 minutes; subsequently, BF3.Et20 
(5.0 ml, 5.75 g, 40.5 mmol) was added via syringe and the solution was sonicated for 
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Figure 2.17: 2-(2',3\4',6'-tetra-0-acetyl-/?-D-galactosyloxy)ethyl methacrylate. 
a further 45 min. The reaction mixture was washed wi th brine (30 ml) , the organic 
layer dried over MgSO^ and butylhydroxytoluene was added as an inhibitor. The sol-
vent was removed under reduced pressure, yielding crude AcGalEMA as a yellow oil; 
this was used directly for the synthesis of 2-(/?-D-galactosyloxy)ethyl methacrylate 
(GalEMA). A sample for analysis was purified by flash column chromatography 
(7:3, hexane:ethyl acetate). 
Found C, 51.88; H, 6.18; C20H28O12 requires C, 52.17; H, 6,13. FT-IR i / /cm-^: 
1751 ( C = 0 of acetate groups) 1719 ( C = 0 of methacrylate ester) 1637, 1320, 1298 
(C=C). SH: (400 MHz, CDCI3) 1.98 (3H, s, 3 x H-3), 2.01, 2.04, 2.05, 2.15, (3H x 
4, 4s, Ac X 4), 3.84 ( I H , ddd, Jga.eb 11-5 Hz, J^a.^a 7.5 Hz, Jjb.ca 4.0 Hz, H-6a), 3.92 
( I H , td, Jt = Js'M' = J^'fib' 6.6 Hz, Jrf = J4^5' 1.1 Hz, H-5'), 4.06 ( I H , ddd, J^afib 
11.6 Hz, 756,66 5.9 Hz, J5a,66 3.7 Hz, H-6b), 4.10 ( I H , dd, -h.^^'b 10.3 Hz, Js'.e'a 6.7 
Hz, H-6'a), 4.18 ( I H , dd, J6'a,6'6 10.9 Hz, J5',6'6 6.5 Hz, H-6'b), 4.29 (2H, m, H-5a,b), 
4.55 ( I H , d, .7i',2' 8.05 Hz, H-1'). 5.01 ( I H , dd, J^.s' 10.4 Hz, J3'.4' 3.6 Hz, H-3'), 5.23 
( I H , dd, J2',,3' 10.4 Hz, Jy^2' 8.0 Hz, H-2'), 5.39 ( I H , dd, Jy^^, 4.5 Hz, J4',5' 1-2 Hz 
H-4'), 5.59-5.61 ( I H , m, H-1 Z to Me-C=C), 6.13-6.14 ( I H , m, H-1 E to Me-C=C). 
8c- (100.26 MHz, decoupled, ^H 400 MHz; CDCI3) 18.25 (C-3), 20.6, 20.8, 21.0 (4 
X H3CCO2, 2 resonances overlap), 61.3 (C-6'), 63.5 (C-5), 66.8 (C-4'), 67.4 (C-6), 
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68.7 (C-20, 70.7 (C-30, 70.9 (C-5'), 101.3 (C-1'), 125.9 (C-1), 136.1 (C-2), 167.1 
(C-4), 169.4., 170.2, 170.3 (MeCOj) . LR-MS (ES+) m/z requires 483.4, found 483.2 
(M + Na+). 
2.4.3 Synthesis of 2-(/?-D-galactosyloxy)ethyl methacrylate 
Figure 2.18: 2-(/9-D-galactosyloxy)ethyl methacrylate. 
Typically, crude AcGalEMA (2.5 g, 5.5 mmol) was stirred in damp MeOH 
(20 ml) . K2CO3 (1.0 g, 7.2 mmol) was added and the reaction was monitored 
by T L C (9:1, MeCN:H20). When the product of methacrylate ester cleavage was 
seen in the T L C (R/ = 0.15) the reaction was neutrahzed by filtering into a fiask 
containing Amberjet 1200H (H"*") cation exchange resin and the mixture was stirred 
for 15 minutes. [NB: The deprotection reaction can proceed very rapidly: to prevent 
loss of the product because of methacrylate cleavage, ensure that the apparatus for 
fil tration and neutralization are set up and ready for use before addition of K2CO3 . 
The resin was removed by filtration and the solvent was removed under reduced pres-
sure, The resulting oil was purified by column chromatography (CHCl3 :MeOH, gra-
dient elution) to yield a colorless oil which became a white amorphous solid upon 
lyophilising. The resulting GalEMA was dissolved in D2O to give a 0.50 M solution 
that was stored at -18 °C. 
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Found C, 49.12; H, 6.94: C12H20O8 requires C, 49.31; H, 6.90. FT-IR (NaCl 
Plates) iz /cm-^: 3360 (br, OH), 1708 ( C = 0 of methacrylate ester) 1636, 1320, 1298 
(C=C) . SH- (500 MHz: D 2 O ) 1.94 (3H, m, 3 x H-3), 3.48 ( I H , dd, J2',3' 9.7 Hz, 
J3',4' 3.3 Hz, H-3'), 3.53 (2H, dt, Jt 5.09 Hz, Jd 5.7 Hz, H-5'), 3.74 (2H, m, H-6') 
3.84 ( I H , m, H-4') 3.86 ( I H , ddd, J^aM 11.8, Jsbfib 6.0, J^^fia 3.8 Hz, H-6a) 4.12 ( I H , 
ddd,J6a,66 11.6, J56,66 5.9, J.afib 3.7 Hz, H-6b) 4.29 ( I H , d, 7.5, H-1') 4.35 (2H, m, 
H-5) 5.64 ( I H , m, H-1 Z to Me-C=C) 6.14 ( I H , m, H-1 E to Me-C=C); Sc- (100.62 
MHz; decoupled ^H 500 MHz; D jO) 18.4 (C-3), 62.5 (C-6'), 65.3 (C-5), 68.5 (C-6), 
70.3 (C-4'), 72.4 (C-2'), 74.9 (C-3'), 76.7 (C-5'), 103.2 (C-1'), 126.4 (C-1), 137.7 
(C-2), 168.8 (C-4). LR-MS (ES+) m/z requires 315.3, found 315.1 ( M + Na+). 
2.4.4 Synthesis of 2-(2',3',4',6'-tetra-0-acetyl-/^-D-glucosyl-
oxy)ethyl methacrylate 
AcO A 
Figure 2.19; 2-(2',3',4',6'-tetra-0-acetyl-/3-D-glucosyloxy)ethyl methacrylate. 
AcGlcEMA was synthesised using an identical procedure to AcGalEMA from 
glucose pentaacetate and HEMA. Crude AcGlcEMA was isolated as a yellow oil 
and used directly in the synthesis of GlcEMA. 
Found C, 51,79; H, 6.75; C20H28O12 requires C, 52.17; H, 6.13. FT-IR i^/cm- i ; 
1756 ( C = 0 of acetate groups), 1716 ( C = 0 of methacrylate ester), 1637, 1320, 1298 
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(C=C) . (400 MHz, CDCI3) 1.98 (3H, s, 3 x H-3), 2.00, 2.02, 2.04, 2.12, (3H x 
4, 4s, Ac X 4), 3.65 ( I H , td , J4',5' 10.4 Hz,J( = J^'M' 2-4 Hz, J5',66' 4.6 Hz, H-5'), 
3.84 ( I H , ddd, J6a,66 11.5 Hz, Jsa.ea 7.2 Hz, J56,6a 3.6 Hz, H-6a), 4.08 (2H, m, H-6) 
4.24 ( I H , dd, J&afi'b 12.4 Hz, Js'^ e'i 4.6 Hz, H-6'b), 4.26-4.32 (2H, m, H-5a,b), 4.55 
( I H , d, Jv.T 8.05 Hz, H- r ) , 5.02 ( I H , dd, Jr,2' 8.0 Hz, J2',3' 9.8 Hz, H-20, 5.10 
( I H , dd, J3',4' 1 1 Hz, J4',5' 10.4 Hz H-40 5.21 ( I H , dd, Joj^z' 9.8 Hz, Js'.a' 1 1 Hz, 
H-3'), 5.60-5.63 ( I H , m, H-1 Z to Me-C=C), 6.11-6.13 ( I H , m, H-1 E to Me-C=C). 
6c: (100.26 MHz, decoupled, ^H 400 MHz: CDCI3) 18.3 (C-3), 20.6, 20.9, 21.1 (4 
X H3CCO2, 2 resonances overlap), 61.6 (C-6'), 63.4 (C-5), 67,6 (C-6), 68.1 (C-4'), 
68.9 (C-20, 71.7 (C-50, 72.8 (C-3'), 100.7 (C- l ' ) , 127.4 (C-1), 136.3 (C-2), 168.1 
(C-4), 169.4, 170.2, 170.3 (MeCOa). LR-MS (ES+) m/z requires 483.4, found 483.3 
( M + Na+). 
2.4.5 Synthesis of 2-(/3-D-glucosyloxy)ethyl methacrylate 
Figure 2.20: 2-(/?-D-glucosyloxy)ethyl methacrylate. 
2-(,5-D-glucosyloxy)ethyl methacrylate was synthesised using an indentical pro-
cedure to GalEMA from AcGlcEMA and was isolated as a colorless oil which became 
a white amorphous solid upon lyophilising. The resulting GlcEMA was dissolved 
in D2O to give a 0.50 M solution and stored in a freezer. Found C, 49.12; H, 6.94: 
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C12H20O8 requires C, 49.31; H, 6.90. FT-IR (NaCl plates) u/cm-^: 3360 (br, OH), 
1708 ( C = 0 of methacrylate ester) 1636, 1320, 1298 (C=C) ; 6H: (500 MHz; D2O) 
1.90 (3H, m, 3 X H-3), 3.16 ( I H , dd, Jva' 7-81 Hz, J2',3' 9.27 Hz, H-2'), 3.32-3.47 
(3H, m, H-3', H-4\ H-5'), 3.68 ( I H , dd, J6'a,6'6 11,96 Hz, Jy^e'a 5.37 Hz, H-6'a), 
3.74 ( I H , dd, Jexe'h 11-96 Hz, J^.s't 7.0 Hz, H-6'b), 3.79-3.86 (2H, m, H-4', H-6a), 
4.07 ( I H , ddd, J6a,6b 11.65 Hz, 5.80 Hz, J5a,66 3.78 Hz, H-6b), 4.26-4.35 (2H, 
m, H-5a, H-5b), 4.29 ( I H , d, Jr,2' 7.81 Hz, H-1'), 5.61-5.71 ( I H , m, H-1 Z to Me-
C=C) , 6.04-6.14 ( I H , m, H-1 E to Me-C=C); 6c: (100.62 MHz; decoupled ^H 500 
MHz; D2O) 18.4 (C-3), 62.5 (C-6''), 65.3 (C-5), 68.5 (C-6), 70.3 (C-4'), 72.4 (C-2% 
74.9 (C-3'), 76.7 (C-5'), 103.2 (C- l ' ) , 126.4 (C-1), 137.7 (C-2), 168.8 (C-4). LR MS 
(ES+) m/z requires 315.3, found 315.1 (M + Na+). 
2.4.6 Synthesis of (4-cyanopentanoic acid)-4-dithiobenzoate 
(4-Cyanopentanoic acid)-4-dithiobenzoate was sj'nthesised according to a literature 
procedure. [99 
2.4.6.1 Synthesis of di(thiobenzoyl) disulfide 
s 
.s 
Figure 2.21: Structure of di(thiobenzoyl) disulfide 
Typically, a solution of phenylmagnesium bromide in THE (300 ml, 1.0 M, 
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O 
s 
O H 
S N C ' 
Figure 2.22: Structure of (4-cyanopentanoic acid)-4-dithiobenzoate 
0.30 mol) was stirred under nitrogen at 0 °C. Carbon disulfide (25.65 g, 0.34 mol) 
was added dropwise and the mixture was stirred for a further hour. After this time 
the reaction was allowed to warm to room temperature and stirred for a further 
30 min.; diethyl ether (500 ml) was then added. Hydrochloric acid (0.1 M) was 
added unti l the aqueous phase changed from red/brown to colourless. The purple 
organic phase was washed twice wi th distilled water, then NaOH (1 1, 0.1 M ) . The 
aqueous phase was then washed with diethyl ether, resulting in an aqueous solution 
of sodium dithiobenzoate. To this solution, potassium ferricyanide (99 g, 0.3 mol) in 
distilled water (1 1) was added over the course of 1 h. wi th stirring. The resulting red 
precipitate was filtered and washed with water until the washings were colourless. 
The precipitate was dried overnight and used for the synthesis of (4-cyanopentanoic 
acid)-4-dithiobenzoate without further purification. 
2.4.6.2 Synthesis of (4-cyanopentanoic acid)-4-dithiobenzoate 
Di(thiobenzoyl) disulfide (26 g, 85 mmol) and dry 4,4'-azobis(4-cyanopentanoic acid) 
(36 g, 126 mmol) in ethyl acetate (500 ml) were refluxed under nitrogen overnight, af-
ter cooling the solvent was removed under reduced pressure. T L C showed three spots 
(2:3 ethyl acetate:hexane) with the product spot being the middle one, R/ = 0.3, 
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R = galactoside or glucoside 
Figure 2.23: Structure of poly[2-(/?-D-glycosyloxy)ethyl methacrylate 
The product was purified by flash column chromatography in the same solvent sys-
tem, fractions which were red in colour were combined. Removal of the solvent left 
a red, viscous, oily residue which crystallised overnight in the freezer. The target 
compound was then recrystallised from toluene at 80 °C (14.9 g, 31%). 
Found: C, 55.68: H 4.57; N , 4.78: S, 22.98; C13H13NO2S2 requires C, 55.89; H, 
4.69: N , 5.01: S, 22.95. FT-IR (NaCl plates) v / cm '^ : 3350-2600 (broad, COO-H): 
2234 (CN); 1710 ( C = 0 ) ; 1048 (C=S). 5H (-500 MHz, CDCI3) : 1.93 (s, 3H, Me), 
2.35-2.78 (m, 4H, 2 x CH2) , 7.38 (m, 2H, llmeta,arom.), 7.55 (m, I H , H p , , „ „ . ) , 
7.83 (m, 2H, }iorl.ho,arom.)-
2.4.7 Polymerisation of 2-(/3-D-galactosyloxy)ethyl methacr-
ylate 
For a typical polymerisation, a GalEMA solution (1.0 ml, 0.5 M , 0.5 mmol) was 
introduced to a small Schlenk tube and ethanol solutions of (4-cyanopentanoic acid)-
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4-dithiobenzoate (175 / i l , 0.015 M , 5.0 /xmol) and 4,4'-azobis(4-C3'anopentanoic acid) 
(83 fj.], 0.015 M , 2.5 ^mo\) were added. The flask was sealed and the solution was 
degassed by 3 freeze-pump-thaw cycles, back-filled wi th N2 and placed in an oil bath 
at 70 °C. Aliquots (100 / i l ) of the polymerisation solution were removed at regular 
intervals under N2 flow, split in two and quenched by freezing in liquid nitrogen: 
the pairs of samples were analysed by ^H N M R and aqueous SEC to determine 
conversion and molecular weight respectively. The remainder of the solution was 
dialysed against high purity water (Pierce Snakeskin dialysis tubing; MWCO 3,5 
kDa) and the purified polymer solution was lyophilized to yield a pink hygroscopic 
sohd. 
6H (500 MHz, D2O) 0.61-1.50 (3H, br, m CH3-C), 1.53-2.41 (2H, br, backbone 
CH2), 3.37-3.62, 3.62-3.72, 3,72-3.86, 3.86-4.02, 4.02-4.16, 4.16-4.36 (lOH, protons 
of carbohydrate and methylene side chain), 4.44 ( I H , br, anomeric proton), 7,52 
( H „ j e t a , a r o m , ) , 7,70 (Hpa^a.arom,) , 7.99 (Hort/xo.arom)• Awmatic resouauces from termi-
nal dithiobenzoate moiety.. 
2.4.8 Polymerisation of 2-(/3-D-glucosyloxy)ethyl methacryl-
ate 
GlcEMA was polymerised using a protocol identical to that used in the polymerisa-
tion of GalEMA. 
6H (500 MHz, D2O) 0.61-1.50 (3H, br, m CH3-C), 1.53-2,41 (2H, br, backbone 
CH2), 3.37-3.62, 3.62-3,72, 3.72-3.86, 3.86-4.02, 4.02-4.16, 4.16-4.36 (lOH, protons 
of carbohydrate and methylene side chain), 4,44 ( I H , br, anomeric proton), 7,52 
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(Hmeta .arom.) , 7 . 7 0 {lipara.arom..), 7 . 9 9 {Eortko,arom)• Awmatic resonauces fwm termi-
nal dithiobenzoate moiety.. 
2.4.8.1 Kinetics of polymerisation 
Experiments for the determination of polymerisation kinetics were prepared as de-
scribed in section 2 . 4 . 7 but in an NMR tube fitted wi th a Young's valve. After 
degassing and backfilling with N2, the tube was placed in an N M R spectrometer 
at 7 0 °C and ^H N M R spectra were acquired at 5 minute intervals. The resulting 
spectra were analysed and conversion levels were calculated from the ratio of the 
integrals for the vinyl protons and the carbohydrate protons. 
2.4.9 Chain extension of 2-(/3-D-galactosyloxy)ethyl meth-
acrylate 
Typically, a macroRAFT agent of poly[GalEMA] was synthesised by polymerisation 
of GalEMA as described in section 2 . 4 . 7 . Upon completion of the polymerisation the 
reaction vessel was opened to air and an equivalent quantity of the second monomer 
added as a solution in D2O; an additional quantity of ACPA ( 2 . 5 /xmol) was added 
as an EtOH solution. The reaction vessel was then resealed and degassed by three 
freeze-evacuate-thaw cycles before back-filling wi th N2. The flask was then placed 
in a water bath at 7 0 °C for 4 h. After this time samples were removed for analysis 
by ^H N M R and SEC and the remaining solution was dialysed against UHQ water. 
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2.4.10 Statistical copolymers of 2-hydroxyethyl methacryl-
ate and 2-(/3-D-galactosyloxy)ethyl methacrylate 
R = mixture of galactoside and H 
Figure 2.24: Structure of statistical copolymer of GalEMA and HEMA 
Table 2.7: Quantities used in the synthesis of statistical copolymers of 2-(/3-D-
galactosyloxy)ethyl methacrylate and 2-hydroxyethyl methacrylate 
[GalEMA]" 
(mM) 
[HEMA]" 
(mM) 
[CPADB]'' 
(mM) 
[AGFA]'' 
(mM) 
c 
[M]/[CTA] [CTA]/[Init] 
1 296 99 7.9 3.1 50 2.6 
2 197 197 7.9 3.1 50 2.6 
3 99 296 7.9 3.1 50 2.6 
4 0 395 7.9 3.1 50 2.6 
As 0.5 M solutions in D2O; '' as solutions in EtOH: " based upon total monomer 
concentration. 
Statistical copolymers were synthesised as detailed in Table 2.7. Typically (en-
try 2 in Table 2.7), GalEMA (500 /zl, 0.50 M , 0.25 mmol) and HEMA (500 
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0.50 M , 0.25 mmol) were added to a small Schlenk tube. CPADB (175 / / . I , 0.058 M, 
10.0 fimol) and ACPA (90 /xl, 0.043 M , 3.8 /umol) were added as solutions in EtOH 
and the mixture was degassed by three freeze-evacuate-thaw cycles and backfilling 
with N2. The flask was then placed in an oil bath preheated to 70 °C overnight 
(approximately 16 h). A sample of the solution was removed and the conversion 
level was calculated by N M R spectroscopy and the remainder of the solution was 
diluted and dialysed against high purity water (Pierce Snakeskin dialysis tubing: 
MWCO 3.5 kDa) and lyophilised. 
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3.1 Introduction 
The importance of multivalency in carbohydrate binding events was discussed briefly 
in section 1.1.2 and methods for the synthesis of glycopolymers of varying valency 
have been described in Chapter 2. Several reports investigating multivalent inter-
actions in both carbohydrate and non-carbohydrate systems have been published 
previously (prominent examples include [17,164]) and the area has been recently 
reviewed. Despite the considerable quantity of research in the area, the mecha-
nisms behind the cluster glycoside/multivalency effect are stil l not completely de-
termined. [15j In order to probe what parameters affect avidity, quantitative methods 
for its measurement are required. Two methods are commonly used to investigate 
binding interactions quantitatively; isothermal t i tration calorimetry (ITC) and sur-
face plasmon resonance (SPR) and these have been used here in order to understand 
further the interaction of glycopolymers wi th lectins. 
3.1.1 Isothermal titration calorimetry 
Isothermal t i trat ion calorimetry is a technique that can be used to determine binding 
energies through classical thermodynamics. During any binding event heat is either 
released or absorbed. ITC measures the heat change in a system allowing for the 
determination of the binding constant ( A ' a ) , reaction stoichiometry (n), enthalpy 
change ( A / / ) , entropy change ( A 5 ) and Gibbs energy change (AG) . 
An ITC calorimeter consists of a pair of cells in an adiabatic enclosure (fig. 3,1). 
The first of these cells is the reference and contains only the solvent in which the 
binding event is to be measured; the second contains a solution of the macromolecule, 
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Figure 3.1: Schematic of an isothermal t i t rat ion calorimeter 
usually a protein, whose binding properties are under investigation. The ligand 
under investigation is injected into the cell by a computer controlled syringe allowing 
repeat injections, of accurate volumes, at specific time intervals. To maintain the 
cells at constant temperature, a small heater is attached to each and controlled 
by a power feedback system. In the case of an exothermic event, heat is released 
when the ligand and macromolecule bind resulting in increased temperature in the 
sample cell. I f the cells are to remain at the same temperature, less heating must 
be applied to the sample cell compared to the reference. When endothermic events 
are investigated the situation is reversed. The difference in the power apphed to the 
cells as a function of time is what is measured by an I T C experiment. Integration 
with respect to time provides the heat generated by each successive injection of 
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ligand solution. Early additions result in the formation of a large number of ligand-
macromolecule complexes and similarly large heat changes. As the macromolecule 
binding sites start to become saturated the heat produced at each injection is reduced 
until complexation is not the main contributor to the signal and ligand dilution and 
mixing effects dominate. A / / , K^. and n can be calculated by means of a non-
linear least squares curve-fitting using an appropriate model; AS and A G may be 
calculated from these. 
In order to calculate accurate values the curve needs to be reasonably sigmoidal, 
but the curve shape is affected by K^, n and the concentration of binding sites ( [M]) . 
To aid the design of ITC experiments the so-called Wiseman parameter, c, is used 
(eqn. 3.1). 
c = n.[M].K^ (3.1) 
Figure 3.2 contains simulated isotherms in the range 0.1 < c < 500, such isotherms 
can only be deconvoluted to produce accurate values for the range ca. 1 < c < 1000. 
[165] 
3.1.2 Surface plasmon resonance for the study of binding 
events 
Surface plasmon resonance is a phenomenon that is observed when light is reflected 
from thin metal surfaces or interacts with metal nanoparticles. In the latter case, 
the electromagnetic field causes a resonating polarisation of the conduction band 
electrons of the particle, yielding the intense colours seen in the solutions of such 
particles. For planar surfaces, at a particular angle, dependent on the refractive 
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Figure 3.2: Simulated isotherms with varying parameter c. Reprinted from ref. [165 
with permission from Elsevier. 
index of the reverse side of the film, a fraction of the light energy interacts with 
the conduction band electrons resulting in a decrease in reflected intensity. Binding 
events can be probed by functionalising the backside of the film with a molecule to 
be investigated and incorporating the film into a flow cell, as seen in the BIAcore® 
systems. When an analyte solution is flowed through the cell then a shift in the 
refractive index occurs if the analyte binds. This results in a shift in the resonance 
angle which may be quantified to give the strength of binding. For a schematic of 
the experimental setup see Fig. 3.3. 
Typically, the flow cell has four channels on the chip allowing different substrates, 
or varying levels of a single substrate, to be tested with a ligand within an individ-
ual experiment. I t is also common to make allowances for non-specific binding by 
allocating one channel as a "blank" where, at the stage where a substrate would 
usually be attached, instead a simple molecule, such as ethanolamine, is used. 
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Figure 3.3: Schematic of a surface plasmon resonance experiment. 
3.1.3 Ricinus communis agglutinins 
Ricin and Rictnus communis agglutinin 120 (RCA120) are lectin containing glyco-
proteins found in the seeds of the castor bean plant Ricinus communis. Ricin is a 
60 kDa heterodimeric protein consisting of a pair of chains. 'A' and 'B' ~30 kDa 
each, linked by a disulfide bridge. Ricin is a Type I I ribosome-inactivating pro-
tein (RIP): it is able to enter cells and. in turn, ribosomes. The B chain is the 
lectin component of the protein and binds terminal ,3-D-galactosyl or A^-acetyl-ii-D-
galactosamino residues, allowing ricin to enter the cell via endocytosis. Once inside 
the cell, the A chain is released via reduction of the disulfide bridge. 
The A chain is A/'-glycosidase that, once within the ribosome, depurinates an 
adenosine residue from ribosomal RNA resulting in inactivation of the ribosome 
and subsequent cell death through inhibition of protein synthesis. The target of 
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depurination is within the sarcin-ricin loop, an area that is highly conserved in 
eukaryotic cells; consequently ricin is a potent toxin. Due to its high toxicity and 
relatively easy availability (a large quantity of contaminated material is a byproduct 
of castor oil production) ricin is classified as a Schedule 1 agent under the Chemical 
Weapons Convention. [166 
RCA120 is a 120 kDa tetrameric protein formed by the non-covalent association 
of two identical 60 kDa heterodimeric subunits. Like ricin, these are comprised of 
'A' and 'B' chains and are closely related to those of the ricin heterodimer (93 % 
and 84 % amino acid homology respectively). [167] Despite this close relationship 
the toxicity of RCA120 is considerably lower than that of ricin (~ 2000 fold [168]) 
but displays increased agglutination activity. [169] The reduced toxicity is not due 
to low yV-glycosidase activity of the A chain as, in cell free assays, protein synthesis 
inhibition is only one order of magnitude lower than that of the ricin A chain and 
when the RCA120 A chain is combined with the ricin B chain the resulting het-
erodimer has a cytotoxicity nearing that of native ricin. Instead its reduced toxicity 
appears to be due to the differing quaternary structure resulting in a diminished 
ability to enter cells. [170 
3.2 Results and Discussion 
The binding between RCA120 and a series of /?-D-galactose bearing ligands was sub-
jected to two forms of analysis: surface plasmon resonance and isothermal titration 
calorimetry. Although these techniques provide similar information regarding bind-
ing events, they are complementary, allowing investigation of different aspects of the 
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event occuring. ITC allows the determination of the thermodynamics of a binding 
event and can thus provide an insight into its mechanism, for example entropically 
driven events are likely to involve the displacement of water or other small ligands 
from the protein binding site. [171] SPR is more comparable to how the binding 
event may occur in vivo, where it is likely that lectins will be clustered on a cell 
surface with the ligand flowing past transiently. Ricinus communis agglutinin 120 
(RCA120) was chosen because initial SPR studies using Peanut agglutinin (PNA) 
found the binding to be so weak as to be undetectable by this method. This is 
unlikely to be due to genuinely weak interaction with the polymers as their binding 
to PNA has previously been demonstrated by ITC. [164] Instead, it is likely to be 
due to the lectin binding preferentially to the carboxylated methylcellulose coating 
on the SPR chip to which the lectin is attached covalently. Similar effects have been 
reported before by Kamerling et al. [172 
3.2.1 I T C studies on the binding between glycopolymers 
and RCA120 
Isothermal titration calorimety has previously been used to investigate the binding 
of p[GalEMA] to the PNA. The polymers investigated were synthesised by standard 
free radical polymerisation, consequently molecular weight was uncontrolled and 
those investigated were disparate: one low (M„ ~ 3 kDa, My^/M^ = 2.15), the other 
high {Mn ~ 461 kDa, M ^ / M „ = 2.21). [164] Here a set of polymers of intermediate 
molecular weights (20 < Mn < 60 kDa), in addition to the monomeric species, were 
compared with respect to their binding to RCAi2o- Experiments were conducted by 
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a standard protocol and heats of dilution/mixing were determined by titration of tiie 
carbohydrate ligands into buffer alone and subtracted from the values for Ugand-
lectin binding. In all cases the Wiseman parameter, c, was in the range 1-100. 
Calorimetry data was analysed using Origin Labs Origin 7.0. Due to its potential 
toxicity, RCA120 is not available as a lyophilised powder, only as a buffered solution. 
The high sensivity of ITC requires that both ligand and macromolecule be dissolved 
in the same buffer to minimise the effect of solute dilution. As the accuracy of the 
buffer in which RCA120 was supplied could not be guaranteed it was buffer exchanged 
using gel filtration prior to use. The concentration of the resulting solution was 
determined by UV spectroscopy using a value of A^'^" of 15.7 at 280 nm. [173] Some 
RCA120 precipitation was observed upon storage, consequently concentrations were 
redetermined prior to each experiment. 
The previous study on poly[2-(/3-D-galactosyloxy)ethyl methacrylate] binding to 
PNA utilised a complex model to fit the data, noting that the "single set of sites" 
model within the ITC software did not produce adequate fitting to derive thermody-
namic parameters; a problem attributed to precipitation of polymer:protein aggre-
gates formed upon binding. [164] Brewer et al. have reported successful derivation 
of thermodynamic parameters with multivalent ligands using the single sites model 
when the concentrations of ligand and macromolecule were such that no precipita-
tion was observed. [174,175] Here, although a small quantity of precipitation was 
observed when the largest ligand was used, a single site model was found to fit ad-
equately. Figure 3.4 contains example raw calorimetry data, binding isotherm and 
curve of best fit for the binding between p[GalEMA]i44 and RCAi2o- Despite the 
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Figure 3.4: Isothermal titration calorimetry data for the binding of p[GalEMA]i44 
to RCAj2o 
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relatively poor quality of the raw data (fig. 3.4a), baseline correction and processing 
within the software resulted in an isotherm with the expected sigmoidal shape and 
fitting with the single set of identical sites model resulted in a curve in close agree-
ment to the data. As the RCA120 tetramer is known to have two identical binding 
sites [173] n was fixed at 2 for monomeric GalEMA to simplify fitting. Ideally, each 
ligand:lectin binding event would have been measured in triplicate and mean values 
calculated. Here only a single experiment has been performed for each ligand due to 
the cost and availability of RCAi2n- Although this means the values determined may 
not be considered completely accurate they certainly allow for the determination of 
general trends. An estimate of the accuracy of these values may be taken when the 
value of Ka, for the monomeric species is compared to that of its binding to PNA as 
well as other monomeric galactose-ligands to RCAi2o- Ambrosi et al. determined 
Ka for GalEMA:PNA binding to be 5.65x10^ M"^ at 25 °C [164] and Sharma et al. 
determined K^. for methyl /3-galactoside and galactose binding to RCA120 as 7.7x 10^  
and 2.2xl0'^ M"^ respectively at 15 °C. [173] An earlier report found similar values 
for the binding between RCA120 and galactose. [176] Here GalEMA was found to 
have a binding constant of 8.7x10^ at 25 °C, within the expected range for a 
monovalent galactoside ligand binding to RCAi2o-
3.2.1.1 Avidity 
Values of K^, determined by various methods are given in table table 3.1. From 
these data it is clear that binding avidity to RCA120 is greatly enhanced through 
raultivalency with rising rapidly with molecular weight. The largest polymer here 
(DP„ 193) has an overall avidity over 4000-fold greater than the monomeric ligand. 
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On a per sugar basis this 22-fold increase is no less striking (fig. 3.5a). The non-
linear behaviour observed is similar to that demonstrated by Kiessling et al. [177] 
with mannosylated polymers, who found a limiting molecular weight, after which 
avidity no longer increased. This may also be the case here but would require 
larger polymers to be synthesised. Kiessling et al. attributed the large increase 
on the longer polymers' ability to bridge binding sites on a single lectin. This is 
possible here as there is a particularly prominent increase in avidity between DP„ 
144 and 193. The fully extended chain lengths for these polymers are ~36 and 47 nm 
respectively; assuming a C-C bond length of 1.54 A and a dihedral angle of 109.5°. 
These are maximum lengths and solution conformations are likely to be considerably 
smaller with hydrodynamic diameters of ~8 and 11 nm respectively. The binding 
sites of RCA120 are approximately 11 nm apart (measured with Jmol [178,179] using 
the Protein Data Bank file from reference [180]) so, in solution, it seems hkely that 
the 144 unit polymer is unlikely to be able to bridge both binding sites whereas the 
longer polymer would be able to do so, albeit with some loss of degrees of freedom. 
Figure 3.5b plots 1/n, the number of lectins bound per ligand molecule (assuming 
both sites to be bound, the number of sites per hgand is equal to 2/n), against ligand 
valency. As is expected the number of bound lectins increases with valency of the 
ligand, although it appears that there is a slight decrease between the DP„ 68 and 
144 polymers. It is unlikely that this is a real effect and is likely to be due to 
an inaccuracy in the model fitting in one case as values of n were easily affected 
with little change to other parameters. Considering the experimental error on these 
values it may be assumed that there is no increase in the number of ligands/sites 
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Figure 3.5: Dependence of K^, and 1/n on the valency of carbohydrate ligands 
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Table 3.1: Binding affinities and polymer sizes from different analyses. 
Ligand 
K / M--1 
ITC (rel) Scatchard ITC (rel) (nm) (nm) 
GalEMA 8.74x10^ (1) 7.19x10'^  8.74x10^ (1) — — 
pGalEMAes 1.24x10^ (142) 1.06x10^ 1.82x10" (2) 17.2 6.2 
pGalEMAi44 1.01x10^ (1156) 9.87x10^ 7.01 xlO'' (8) 36.2 8.3 
pGalEMAi93 3.69x10^ (4222) 3.58x10" 1.91 xlO^ (22) 46.6 11.4 
°- Approximate fully extended chain length assuming C-C bond length of 1.54 A 
and a dihedral angle of 109.5°; Hydrodynamic diameter as measured by TriSEC. 
bound between these polymers but there is still a 4-fold difference in per sugar. 
If the number of simultaneous binding events is not responsible for increased avidity 
then another factor must be. It is proposed that the increase in affinity is due to 
the increased probability of rebinding: i.e. if a lectin-carbohydrate interaction is 
broken there is a higher probabiHty of a second interaction occuring in the longer 
polymer as there is larger local concentration of sugars available to bind. 
3.2.1.2 Cooperativity? 
Cooperativity in binding events is of great importance in biological systems. Binding 
cooperativity falls into three categories: positively cooperative, or synergistic, where 
one binding makes a latter more energetically favourable; non-cooperative where 
binding has no effect on subsequent binding(s): and negatively cooperative where 
binding makes a latter binding event less favoured. The most famous and well-
studied case of cooperativity is the binding of oxygen to hemoglobin which displays 
positive cooperativity with each of the oxygen molecules binding having a greater 
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affinity than the previous. 
Whitesides et al. have suggested that, in a polyvalent system, free energies may 
be considered thus: [181] 
AGP°^ = aAG"^°"° (3.2) 
NAGl°^J = AGP;''^  = aNAG'"""" (3.3) 
where ACP°g^ is the average free energy of each interaction in a polyvalent interac-
tion, AG""""" is the free energy of the monovalent interaction, AG^°'^' is the overall 
free energy of a polyvalent interaction, yv is the valency and a is the degree of 
cooperativity. Similarly, affinities may be considered thus: 
K^/y = (/CPf • )^ = {K""'"°y^ (3.4) 
where K^°^^ is the overall affinity of a polyvalent interaction, Kl°e^ is the average 
affinity and A'''"°"° is the affinity of the monovalent interaction. [181] In a positively 
cooperative system, one where a > 1, it would be expected that a doubUng of 
valency would result in at least a squaring of affinity. Values of K'^^^ are given in 
table 3.2 and these data make it clear that, although binding is increased greatly 
through polyvalency, K^^^ < ( / ^ ' " o i o ) ^ and thus binding is negatively cooperative. 
This result is expected because, to date, no multivalent system has been shown to be 
positively cooperative and a linear polymeric system is likely to be highly negatively 
cooperative due to steric crowding of the binding moieties. 
3.2.1.3 Scatchard analysis 
Modified Scatchard plots, based upon the method of Brewer et al. (see section 
3.4.1.1 for details), [174,175] are shown in figure 3.6. This methodology introduces 
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Figure 3.6: Scatchard plots for binding of GalEMA based ligands to RCAi2o- (a) 
monomeric GalEMA; (b) pGalEMAgg; (c) pGalEMAi44; (d) pGalEMAigg. Circled 
points were discounted from analyses: (—) linear regression of linear segment of 
plot, /?2 > 0.99. 
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an additional term to allow for multivalent ligands and thus: 
Xb('i)[average functional valency of ligand] ,^ 
'^'^ ^ m ^ 
where the average functionaUty of Hgand is the value 1/n given in table 3.2, r(7;) is 
the ligand occupancy after the ith injection, Xb{i) concentration of bound ligand 
after the ith injection and Mt{i) is the total concentration of lectin . Scatchard 
plots may then be constructed by plotting r{i)/Xf{i) versus r (7 ' ) . To confirm the 
applicability of the method to this system values of Kf^^^ were calculated by re-
gression analysis of the linear section in each plot. These values may be found in 
table 3.1 and are in good agreement with those directly calculated using the Origin 
software. The Scatchard plots for all Ugands studied are given in figure 3.6. All 
plots feature a maximum at the second or third point with a downward trend at 
low Hgand occupancy (/ (/)). Normally this would be indicative of positively coop-
erative binding but it has been noted before that, at low occupancies, Scatchard 
plots of calorimetry data are extremely sensitive to measurement errors. It has been 
estimated that an error of just 0.4 % in the initial heat measurements can result in 
such behaviour. [182] Consequently, these initial points (circled in the plots) were 
discounted from the analyses. Ignoring these points allows us to see that all plots are 
fundamentally linear with some deviation at high levels of occupancy. In the case 
of the polymer ligands there is a decrease in gradient at high occupancy, suggesting 
again that the binding is negatively cooperative. [183] In the case of the monomeric 
species there is an increase in gradient at high occupancy. This is unlikely to be a 
real effect and is probably due to the poor quality of data in the latter injections of 
such a weakly binding ligand. 
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3.2.1.4 Thermodynamic basis of binding 
Table 3.2: Thermodynamic parameters for the binding between RCA120 and P-D-
galactose bearing ligands 
Ligand 
A / / o b s ° A Gobs T A 5 o b s ° 
T^poly b 
1/n kJ mol-1 kJ mol-^ kJ mol-i (rel.) 
GalEMA -42.4 -22.5 -19.9 8.74x10^ (1) 2" 0.5 
pGalEMAes -159 -34.8 -124 1.24x10^ (140) 0.224 4.46 
pGalEMAi44 -245 -40.7 -204 1.01x10^ (1155) 0.255 3.92 
pGalEMAi93 -391 -43.7 -347 3.69x10^ (4222) 0.130 7.69 
pGalEMAf44 -242 -40.1 -202 1.07x10' (1224) 0.260 3.85 
As molarities rather than activities were used the values are reported as observed; 
values relative to monomer are shown in brackets; stoichiometry with respect 
to lectin, i.e. number of ligands per RCA120 tetramer; n was fixed during curve 
fitting to allow calculation of the K and AH; ^ Calculated from isotherm without 
subtraction of heats of dilution. 
The full thermodynamic parameters, as measured by ITC, are given in table 
3.2. From these it is clear that for all ligands binding is enthalpically favoured yet 
entropically opposed. This is in contrast to both modelled behaviour of multivalent 
binding [184] and the binding of p[GalEMA] to PNA, which showed enthalpically 
and entropically driven multivalent binding. [164] The difference in thermodynamics 
between to the two lectin bindings is probably due to a combination of effects. Am-
brosi et al. partly attributed the entropic factor to displacement of water from the 
protein surface through aggregation. As aggregation was only observed to a slight 
degree here less of an entropic factor is likely. Similar behaviour has been reported 
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Figure 3.7: Compensation plot (AH vs. TAS) for the binding of galactosyl ligands 
to RCA120. (—) Linear fit. R- = 0.999, slope = 1.06. 
by Brewer et al. for lectin binding of dendritic multivalent carbohydrates when 
aggregation was absent. [174,175,182] The cnthalpic driving force is confirmed by 
the compensation plot (fig. 3.7) which is linear with a slope near unity (1.06 ±0.02: 
= 0.999). As the value is greater than unity it suggests that the free energy is 
marginally more sensitive to changes in enthalpy, conversely a value less than unity 
would suggest a greater sensitivity to changes in entropy. Ambrosi et al. also noted 
that thermodynamic parameters were heavily influenced by ionic strength of the 
buffer used in the titration. Higher concentrations of salts resulted in an increased 
enthalpic contribution and a reduced entropic contribution: A'a was also reduced 
dramatically. This was particularly prominent when tris buffer was used, instead 
of citrate, with the binding becoming entropically disfavoured. It should also be 
noted that, due to the high heat of ionisation of tris {AHion ~ 46 k.J mor^ [185]). 
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values may not have been completely accurate. Here phosphate-buff'ered saline was 
used for all experiments due to the high solubility of RCA120 in this solution and 
heats of ionisation are relatively low ( - 1 < A//ion < 4 kJ mol~' depending on 
ionic strength [185]). The minimal effect of buffer ionisation is confirmed by com-
parison of the thermodynamic parameters calculated with and without correction 
for heats of dilution/mixing (entries 3 and 5 in table 3.2) confirming that the lack 
of entropic contribution is not due to buffer choice. Entropic favourability would 
be likely if lectin binding leads to dispersion of polymer aggregates via increased 
degrees of freedom of the polymer chains. Glycopolymers have already been shown 
to self-associate in aqueous solution [186] with association attributed to intcrmolec-
ular hydrogen bonding and hydrophobic interactions by the polymer backbone. No 
polymer aggregates have been detected, via SEC, for the polymers here so it can 
assumed that their disaggregation is not of concern. Overall binding would be ex-
pected to be entropically disfavoured as a bound polymer will have fewer possible 
solution conformations and thus a reduced number of degrees of freedom. 
Interestingly, as molecular weight increases, the ratio A / / / - T A 5 decreases and 
tends towards 1 (black squares in figure 3.8). Similar behaviour has been noted in 
dendritic systems where IS.H was seen to scale approximately with valency, i.e. for a 
tetravalent system A / / was approximately 4-fold that of the monovalent, but -TAS 
became more positive disproportionately. [187] This behaviour was attributed to the 
inability of a relatively rigid ligand to fill both binding sites on an individual lectin, 
instead binding one lectin for each ligand presented, resulting in a greater entropic 
cost. The same explanation is possible here as, although it appears that the longest 
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3.2.2 SPR studies on glycopolymers 
Several reports of SPR studies on glycopolymers have been published previously. 
Unfortunately, all but one of these studies immobilised the polymer on the surface, 
only allowing determination of the multivalent to monovalent interaction. [188-190 
Kiessling et al. have utilised polymer solutions in competitive assays by measur-
ing Con A binding to mannosylated surfaces in the presence or absence of other 
mannosylated hgands. [177] Again, this does not allow elucidation of multivalent-
multivalent interactions that are likely to occur between a multivalent polymer and 
a biological surface where receptors are clustered and not discrete. For the exper-
iments RCA 120 was attached to the surface of a sensor chip at various levels of 
functionalisation (ca. 200, 2000 and 5000 response units) using a standard amine 
coupling protocol. The final channel was modified with ethanolamine and used as a 
blank. Initially, a series of poly[2-(/^J-D-galactosyloxy)ethyl methacrylate] polymers 
of varying molecular weights and compositions as synthesised in Chapter 2 was as-
sessed to determine whether binding was detectable and if there was any difference 
within the group. It was found that, of all the polymers tested, two general groups 
were found; one polymer in each group was selected for full analysis (p[GalEMA]37, 
M„ 11.0 kDa, M ^ / M „ 1.10 and p[GalEMA]i44, M„ 42.4 kDa, M ^ / M „ 1.11). Solu-
tions of each polymer, ranging from 500 pM to 10 / iM, were prepared and analysed 
for the binding to each channel. Initial test runs found the binding too tight, with 
very long off times. To reduce this time, allowing rapid acquisition of another sam-
ple, a 30 s injection of methyl /^-D-galactoside solution was performed. The blank 
was substracted from the functionalised channels to allow for non-specific binding. 
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Table 3.3: Kinetic and thermodynamic parameters of binding between RCA120 and 
poly[GalEMA] as calculated by surface plasmon resonance 
Ligand 
k A Gobs" Par am. Ratio* 
1/Ms 1/s M - i kJ mol"^ 1.6 
p[GalEMA]37 9.54x10^ 5.28x10"^ 1.81x10^ -47.1 o^ff 0.2 
p[GalEMA]i44 1.56x10^ 1.12x10-'' 1.39x10^ -52.2 7.7 
" Calculated from K^,; p[GalEMA]i44 /p[GalEMA]37-
The channels wi th the lowest and highest levels of RCA120 modification were found 
to give too weak or too strong binding respectively. Sensorgrams were thus acquired 
on channel 2 (ca. 2000 RU RCA120) by a 180 s injection of the ligand and a 240 s 
off period. Between acquisitions a 30 s injection of methyl /?-D-galactoside and 60 s 
off period were performed to return the surface to its background level. 
Sensorgrams for the two polymers at various concentrations are shown in figure 
3.9. The data from these was fitted within the BIAcore software using a single sites 
model. For each polymer five consecutive concentrations were chosen from those 
analysed; 5 n M - 1 fxM for the DP„ 37 polymer and 500 pM-50 nM for DP„ i44 
polymer. The highest concentrations were removed as the binding was too rapid 
to enable accurate f i t t ing. In the case of the shorter polymer, the lowest two con-
centrations were removed as the response was too weak to allow accurate fitt ing. 
Thermodynamic and kinetic parameters for these polymers are shown in table 3.3. 
As was seen with the ITC experiment, there is a large increase in with increased 
molecular weight, here a 4-fold increase in M n / D P „ leads to a near 8-fold increase 
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in avidity. The larger polymer also displays more than a 130-fold increase in A'a 
compared to the value measured by ITC (1.39x10*^ M - ^ c.f. 1.01x10^ M " ^ ) . This 
increase is due to a multivalent ligand interacting with a multivalent receptor (the 
surface of the sensor chip) and supports the hypothesis that increased avidity is a 
product of both multipile binding events and the increased probability of increased 
rebinding if an interaction is lost. In the ITC experiment, this relied on rebinding 
of a sugar to the same receptor as, at experimental concentrations, few proteins 
would be in close proximity. Here, the immobilisation of the receptor on a surface 
results in a high local concentration and more opportunity for a rebinding event 
to occur. Although an increased number of simultaneous bindings per polymer is 
also likely in this system they wil l still be limited by the polymer dimensions. For 
poly[GalEMA]i44 the fully extended chain length is ~ 36 nm and its hydrodynamic 
diameter is 8.3 nm, although i t is likely to be more extended in the shear present 
in the flow cell. Despite this, the lectins are not presented here at particularly high 
density, the surface modification may be at least 2.5-fold higher (5000 versus 2000 
RU), so i t seems unhkely that binding of multiple sites wi l l be possible. 
More interesting are the kinetic parameters for the two ligands. Despite the 
large difference in there is less than a 2-fold difference in kon, the rate of binding. 
Looking at this value alone i t would be expected that these ligands would have sim-
ilar avidities. However, the smaller ligand has a value of kos 5-fold higher than that 
of the larger ligand and, consequently, has a far lower avidity (A'a = ^on/^off)- The 
smaller polymer has a fully extended chain length of ~ 9 nm and a hydrodynamic 
diameter of 4.4 nm, from SEC, and is simply too small to bind multiple RCA120 moi-
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Figure 3.9; SPR sensorgrams for poly[GalEMA] binding to a RCAi2o-modified sensor 
chip, (a) p[GalEMA]37: (b) p[CxalEMA]i44. 
122 
3.2. Results and Discussion 123 
Flow 
Figure 3.10: Schematic representation of polvmer 'rolling' across lectin rnodifiecl 
SPR sensor chip. 
eties unless they are in ver>' close proxnnit>-. Its small size also means it cannot bind 
both sites of a single R C A j o n chmer either, as the distance between them is too gi'cat. 
As the polymer is too short to bind to several sites, it supports the assertion that 
one factor affecting increased avidhy is the increased probabilit\' of binding. The 
longer polymer may he able to bind both sites simultaneously-, but to do so \\-ould be 
highl}- entropicalh- disfax'oured due to the restriction on its degrees of freedom. The 
reduced dissociation rate of the larger polymer, and hence its greater avidity, must 
be due to the increased probability of rebinding. If the pol\-mers arc approxiiiiated 
to being a deformable sphere then they can be considered to ha\-e a footprint that 
will be proportional to their radius. In the same manner, a tyre of a larger diame-
ter will maintain a larger contact area with the road than a smaller one: assuming 
all other factors to be the same. Defonnable spheres have been modelled to roll 
along 'sticky', i.e. interacting, surfaces. |i91.1!)'2j a phenomenon that has also been 
modelled and observed experimentally in leukocytes. [193,194] An increased contact 
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area during rolling wil l result in a greater probability of secondary binding events 
occuring, resulting in increased retention on the surface. Thus smaller polymers, 
with their reduced footprints wi l l be shed more readily, increasing kofs valuess. 
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3.3 Conclusions 
In order to investigate further the binding of multivalent glycoconjugates to lectins, 
isothermal t i tration calorimetry and surface plasmon resonance were used in combi-
nation. I T C experiments found, as has been demonstrated previously, that poly[Gal-
EMA] does bind strongly to an appropriate lectin. Additionally, binding strength 
was shown to be highly dependent on molecular weight and, although not deter-
mined, a l imit ing value of valency is likely based on the increasing entropic cost of 
increasing avidity. Together wi th surface plasmon resonance data i t appears that 
increased affinity is not due solely to an increased number of simultaneous lectin-
carbohydrate interactions but through the increased probability of a multivalent 
ligand to form a secondary binding interaction i f the init ial binding interaction is 
broken. To confirm this hypothesis and determine whether there is a limiting avidity 
gain through increased valency, additional experiments comparing a wider range of 
polymer molecular weights by both ITC and SPR are required. 
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3.4 Experimental 
3.4.1 Isothermal titration calorimetry 
Isothermal t i trat ion calorimetry was conducted using a MicroCal VP- ITC calorime-
ter equilibrated at 298 K. Ligands for analysis were prepared in aqueous buffer (10 
m M phosophate buffer, 137 mM NaCl, 2.7 mM KCl) and allowed to equilibrate for 
24 h and degassed at 297 K. RCA]2o (Vector Labs, supplied as 5 mg/ml solution 
in PBS) was buffer exchanged by use of centrifugal size exclusion columns (Pierce 
Zeba Desalting Columns) prewashed with the required buffer. After buffer exchange 
RCA120 was further diluted in buffer and its concentration measured by UV absorp-
tion using an A^"^" value of 15.7 at 280 nm. RCA120 showed some solution instability 
and subsequently, prior to each experiment, the stock solution was centrifuged to 
remove aggregated protein and the concentration redetermined. The lectin solution 
was added to the sample cell ensuring no trapped air bubbles and the mixture was 
equilibrated to 298 K. Ligand solutions were added to RCA120 as a series of injec-
tions (25 aliquots of 5 //.I) at 3 min. intervals by means of a computer controlled 
syringe wi th constant stirring at 307 rpm. The resulting data was analysed using 
Origin 7.0 Pro (OriginLabs) and fit ted using the single site model incorporated into 
the software. 
3.4.1.1 Modified Scatchard analysis 
Scatchard analysis was performed by the modified methodology of Brewer et al. [174] 
Briefly, the total concentrations of ligand { X t { i ) ) and lectin (Mt('i)) after the Jth 
injection and the heat evolved in that injection {Q{i)) were extracted directly from 
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the raw ITC file. The concentration of bound ligand is given by: 
W ) = [Q{i)/AH-V] + Xb{i - 1) (3.6) 
where is AH is the enthalphy of binding (in J mol~ ') and V is the volume of the 
sample cell (in ml) . This allows the calculation of the concentration of free ligand 
after the zth injection { X f { i ) ) from: 
X j i i ) = Xt{t) - X,{z) (3.7) 
In a normal Scatchard analysis, the average number of ligands bound per lectin ( r ( i ) ) 
is the ratio Xb{i)/Mt{i). The modified Scatchard analysis introduces an additional 
term to allow for multivalent ligands and thus: 
Xfc(7) [average functional valency of ligand] , , 
''^'^ = J W ) ^^-^^ 
where the average functionality of ligand is the value 1/n given in table 3.2. Scatchard 
plots may then be constructed by plotting r { i ) / X f { i ) versus 7-(7;). 
3.4.2 S P R studies on glycopolymers 
Al l SPR measurements were performed on a BIAcore 3000 system. A CM5 sen-
sor chip was equilibrated with HEPES buffer (10 m M HEPES pH 7.4, 150 mM 
NaCl, 0.005 % P20 surfactant) then activated by a flowing a mixture of 0.1 M 
A^-hydroxysuccinimide and 0.1 M A'^-ethyl-A^'-(dimethylaminopropyl)carbodiimide 
over the chip for 5 minutes at 25 °C at a flow rate of 5 /.d min~^ RCA120 was 
immobilised on channels 1, 2 and 3 via injection of a solution (67 /.d of 5 mg-ml"^ 
solution diluted in 1ml 10 m M acetate buffer pH 4): contact times of 7, 3 and 1 
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min. respectively resulted in functionalisation of the surface at 5000, 2000 and 200 
response units (RU). A l l channels were then modified by a solution of ethanolamine 
to produce a blank on channel 4 and remove remaining reactive groups on channels 
1-3. 
Solutions of polymers were prepared in the same HEPES buffer. Sensorgrams for 
each polymer concentration were recorded with a 180 s injection of polymer solution 
(on period) followed by 240 s of buffer alone (off period). After this time the chip 
was regenerated by a 30 s injection of methyl /3-D-galactoside (1 mg-ml~^) and 60 s 
of buffer alone. After regeneration was complete the next sample was injected. For 
each polymer 5 consequetive concentrations were used for kinetic analysis using a 
single set of sites model in the BIAevalulation software. 
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Not to be absolutely certain is, I think, one of the essential things 
in rationality. 
Bertrand Russell (1872-1970) 
Synthesis and properties of glycopolymer 
::unctionalised gold nanoparticles. 
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4.1 Introduction 
Colloidal gold has been used since ancient Roman times, but was not truly studied 
until Faraday's work in the 1850s. In 1857 Faraday described the "Experimental Re-
lations of Gold (and other Metals) to Light" in a Royal Society lecture; within this 
he described a multitude of results in the area that has more recently become known 
as solid state nanotechnology. One aspect of Faraday's lecture, under the subtitle 
"Diffused particles of gold-production-proportionate size-colour-aggregation and 
other changes", he described what is now regarded to be the first scientific synthesis 
of gold nanoparticles (AuNPs) from aqueous gold solutions, phosphorous and car-
bon disulfide (figure 4.1a). Despite, by today's standards, the primitive nature of 
Faraday's equipment he, as his chosen title implies, knew that the resulting ruby-red 
solutions were not truly solutions but very fine suspensions. [195 
[Referring to his gold sols] The latter, when in their finest state, often 
remain unchanged for many months, and have all the appearance of 
solutions. But they never are such, containing in fact no dissolved, but 
only diffused gold. 
Since Faraday, the nanosciences have progressed hugely and in 2006 more than 
2000 academic articles were published on the synthesis of gold colloids/nanoparticles 
(figure 4.1b). [197] Despite this huge quantity of hterature, the vast majority fall 
into one of two categories: those synthesised by the method of Turkevich, [198-201 
later refined by Frens, [202] or those synthesised by the method of Brust. [203] Both 
of these methodologies have previously been applied to the synthesis of glycosylated 
AuNPs, glycoNPs, and are briefly described below. 
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Figure 4.1: (a) Photograph of Faraday's colloidal gold, reproduced from rcf. |196[: 
(b) Citation and publication data for papers on gold colloids/nanoparticlcs. Copy-
right Wile>--\'CH Vcrlag GmbH Co. KGaA. Reproduced \\-ith permission from 
reference [1971. 
4 . 1 . 1 S y n t h e s i s o f g o l d n a n o p a r t i c l e s 
4.1.1.1 Turkev ich /F rens m e t h o d 
In the early 195()s Turkevich developed a procedure for the synthesis of gold nanopar-
ticles by the reduction of an aqueous solution of a gold salt, usually hydrogen tetra-
chloroaurate (HAtiCF). b\- a reducing agcnt/stabilising ligand. typically a carboxylic 
acid or carboxylate sudi as sochuiii citrate. acr>'late or ascorbic acid, j 198-2011 Later. 
Frens improved upon this method allowing the synthesis of particles with controlled 
diameter (10 - 200 nin) hx var\'ing the 'Au]:jcitratcj ratio, unfortunately polydisper-
sity also tends to increase with particle size. [202] As the particles are only charge 
stabilised b>- the reducing group. the\- arc susceptible to precipitation b\^  changes 
1.31 
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in pH or addition of salts. This feature also means they can be easily function-
alised by ligand transfer with appropriate molecules, usually thiols due to their high 
aurophilicity. 
4.1.1.2 Brust method 
In the early 1990s Brust et al. developed an alternate method for the synthesis 
of gold nanoparticles using a biphasic system of toluene and water. A U C I 4 was 
transferred into toluene by use of tetraoctylammonium bromide as phase-transfer 
catalyst and then a mercaptoalkane was added to the same phase; addition of ex-
cess NaBH4 resulted in rapid formation of a dark brown solution of alkyl capped 
nanoparticles. [203] Although originally apphed to the synthesis of organically solu-
ble AuNPs this method may also be applied to the synthesis of hydrophilic AuNPs 
in a single phase system using a water soluble thiol as a stabilising hgand. 
4.1.2 Application of Frens and Brust methods to the syn-
thesis of glycoNPs 
A large part of AuNP, and other metal or semiconductor particle, research has 
been fuelled by the interesting catalytic, electronic and optical properties many dis-
play. At the biological end of the spectrum, research has been more concerned 
with the use of nanoparticles as nanoscale scaffolds to which biological functional-
ity could be added. I f the intrinsic properties of the particles could, in addition, 
be exploited then that was an additional advantage. The area has recently been 
reviewed [204] and here only a few examples wil l be highUghted. GlycoAuNPs were 
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Figure 4.2: Lactosyl disulfide as synthesised by Penades et al. [205 
first reported by Penades et al. in 2001, who utilised a Brust-type methodology 
to produce gold nanoparticles decorated with the saccharides lactose and Lewis". 
These were synthesised by in situ reduction of the correspondingly glycosylated 
disulfide (see 4.1 in figure 4.2 for the lactosyl disulfide) in the presence of HAuCU 
in aqueous methanol by NaBH4. The resulting suspension was dried under vacuum 
before dissolution in water and purification by centrifugal filtration. Particles func-
tionalised with Lewis" were found to aggregate in the presence of calcium ions and 
show potential as models of cell-cell interactions. [205,206] Penades et al. have also 
used the same methodology for the synthesis of bifunctional nanoparticles where 
additional functionality, such as a fluorophore, has been incorporated by performing 
the reduction in the presence of a small quantity of the appropriately functionalised 
disulfide. J207] Gervay-Hague et al. have attempted to probe the binding of the 
HLV-associated glycoprotein gpl20 to glycosylated cellular receptors by synthesis of 
galactosyl-functionalised nanoparticles using the same methodology. [208 
Penades et al. have also proposed the use of glycosylated particles as therapeutic 
agents for the treatment and prevention of cancer. Glyconanoparticles presenting 
133 
4.1. Introduction l. 'i4 
(•<HiIro|.<;NP l.»cto.<;NP 
[90 JIM) 190 | iM) 
Figure 4.3: Image of lung metastases after treatment with lactos\'l and giu(;os\-l 
nant)particles. In the Iactos>'l group (nglit ) far fewer metastases (dark areas) arc 
seen. Copyright Waley-VCH Verlag GmbH k Co. KGaA. Reproduced with permis-
sion from reference [209 
glucose or lactose were investigated as anti-adhesive cancer therapies in a mouse 
model. Mice were administred an intravenous injection of murine melanoma cells. 
B16F1() line, or the same cells that had been pre-iiicubated with giycoNPs. It was 
found that, when the cells were pretreated with lactose-l^earing nanoparticles. th(^ 
mice produced siginificanth' fewer lung metastases than those treated u i t h glucos\'l 
particles or the control group (figure 4.3). '2()9| A cancer vaccine system has t)ecn 
proposed by synthesising particles that present two carbohydrate cancer antigens. 
sial\4-Tii and Lewis- '^. and a peptide designed to promote immune response. |2in| 
Currently- no report on the efficacy of such a x'accine has been reported. Bare hi ct al. 
lia\-e reported the synthesis of nanoparticles dispku'ing the Thomson-Fricdcnrcich 
antigen (TFa„). another tumour-associated carbohydrate antigen, using the same 
inethodolog\- as Penades et al. [2111 Recently- they have also synthesiscd particles 
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presenting a glycopeptide featuring TFag. [212] 
Field and Russell have utihsed the Frens method to produce near monodisperse 
AuNPs which were then functionalised with carbohydrates. AuNPs were synthesised 
from HAuCl4 and trisodium citrate at such a ratio as to produce particles of 16 nm 
average diameter. These were then functionalised, via hgand transfer, by addition 
of a carbohydrate ligand wi th a thiol, or disulfide, terminated linker. Particles of 
this type were found to still display the brilliance of colour seen in the original gold 
sols but had the benefit of increased stability and functionality. The applicability of 
such particles as colorimetric sensors was first demonstrated by addition of the lectin 
Concanavalin A (Con A) to a solution of mannosylated particles. After addition the 
particles were seen to aggregate resulting in a shift in the plasmon band and a colour 
change. [213] After this proof of principle they demonstrated that cholera toxin [214 
and RCA120, as a surrogate for ricin, [215] could be detected in a similar manner by 
adjusting the carbohydrate used. 
4.1.3 Application of R A F T e d polymers in the synthesis of 
metal nanoparticles 
Considering the nature of one terminus of RAFTed polymers i t is unsurprising that 
they have been utihsed in the synthesis of gold, and other noble metal, nanopar-
ticles. Lowe et al. first reported the synthesis of metal nanoparticles wi th RAFT 
polymers in 2002, although their methodology is less than clear. Polymer coated 
gold nanoparticles were synthesised not from a solution of the gold salt, but instead 
by the reduction of dithioester terminated polymers in the presence of a commeri-
135 
4.1. Introduction 136 
cally obtained gold sol. Particles of Ag, Pt and Rh were synthesised by simultaneous 
reduction of the corresponding metal salt and polymer. [216 
Tenhu et al. investigated several methods for the synthesis of polymer-AuNP 
conjugates from thiol and dithioester terminated polymers. Poly[A^-isopropylacryl-
amide] (p[NIPAM]) was synthesised using either cumyl dithiobenzoate (CDB) or 
CPADB as the R A F T agent. Thiol-terminated p[NIPAM] was synthesised by hy-
drazinolysis of the dithioester terminated p[NIPAM] or conventional free radical 
polymerisation initiated of N I P A M by ACPA and modification of the carboxylic 
acid end group by coupUng to cysteamine. The thiol and dithioester terminated 
polymers were then used in the synthesis of AuNPs by l i thium triethylborohydride 
(Super-Hydride®) reduction of HAUCI4 in their presence. Overall i t was found that 
direct synthesis of AuNPs from HAuCU and dithioester terminated polymers was 
not only synthetically less challenging than either the prior end group reduction 
or cysteamine functionalisation methods, but also resulted in the greatest level of 
control over the size of gold core synthesised. [217] AuNPs featuring a mixture of 
pNIPAM and poly[styrene] chains were synthesised by the same methodology. [218] 
Narain et al. recently synthesised glycosylated AuNPs from RAFTed glycopoly-
mers (for polymer details see section 2.1.2). Particles were synthesised by reduc-
tion of polymer and H A u C ^ by NaBH4, in the presence or absence of biotin-PEG-
SH. The particles were then purified by dialysis wi th a 3500 M W C O membrane, 
which appears inadequate considering the polymers used were reported as having 
M„ > 20 kDa; thus if any free polymer remained in solution i t would not have 
been removed. [141] The same group also synthesised glyconanoparticles by a pho-
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Figure 4.4: Photochemical reduction of A u " ' as demonstrated by Scaiano et al. [219 
tochemical method first introduced by Scaiano et al. (figure 4.4). Irgacure® 2959 
(l-[4-(2-hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-l-propane-l-one, 4.2), a photo-
chemical initiator, decomposes homolytically under UV irradiation to produce ketyl 
radicals. Subsequently these reduce A u " ' to Au° resulting in stable aqueous gold 
nanoparticles even in the absence of a capping ligand; functionalisation may be 
achieved by addition of such a ligand. [219] Narain et al. used a combination of 
RAFTed pNIPAM, thiol-terminated PEG and the glycosylated block copolymer de-
scribed earlier (section 2.1.2) in the presence of the photoinitiator and HAUCI4. 
137 
4.2. Results and discussion 138 
4.2 Results and discussion 
4.2.1 Synthesis of gold particles stabilised by glycopolymers 
Gold nanoparticles were synthesised as previously demonstrated by Lowe et al. and 
Tenhu et al. [216-218] In init ial experiments, HAuCU was reduced by NaBH4 in the 
presence of poly[2-(/?-D-galactosyloxy)ethyl methacrylate] ( M „ = 24.1 kDa, M^lMn 
= 1.09) at a mole ratio of 1:2 ([Au]:[dithioester end groups]). Upon addition of the 
reducing agent a rapid colour change from orange-yellow to golden brown was ob-
served (see fig. 4.5a). Typically gold nanoparticle solutions have a characteristic 
instense red-violet hue, dependent on particle diameter, due to plasmon resonance. 
However, gold sols of very small diameter (below ~ 3.5 nm) typically display a 
yellow-brown colouration dependent on concentration. [220] I f was found that, 24 h 
after reduction, a small quantity of macroscopic aggregates had formed and these 
were removed by filtration (0.2 /xm PTFE membrane). The absence of free poly-
mer was confirmed by SEC. The synthesised particles were analysed in solution by 
dynamic light-scattering (DLS) and transmission electron microscopy (TEM). DLS 
gave a peak diameter of 11.5 nm and T E M gave a diameter of the gold core as 1-3 nm 
(figures 4.5c and 4.5b respectively). Extremely small particles such as these have 
been synthesised previously by Brust et al. from sulfide-terminated poly(methacrylic 
acid) using a similar protocol. [221] DLS produces a larger diameter than T E M as 
the former measures the hydrodynamic radius and therefore includes the polymer 
corona whereas the T E M method only measures the gold core. 
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Figure 4.5: Photograph (a), T E M (b) and DLS (c) of gold nanoparticlcs initially 
synthesised by modified Brust procedure from poh-[GalEMA| 
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Table 4.1: Data for the synthesis of pGalEMA-coated gold nanoparticles of varying 
size 
[polvmer] Diameter / nm" 
(mM) [Au]:[polymer] -
1 0.161 1.25 1.98±0.03 559 ± 7 
2 0.081 2.50 S.lliO.OS 34.0±3.1 
3 0.040 5.0 3.26±0.05 34.0±3.8 
4 0.020 10.0 3.29±0.06 41.9±0.9 
5 0.010 20.0 3.36±0.06 48.3±0.7 
" ± one SEM, values determined after fi l tration through 0.2 fim membrane but prior 
to purification by centrifugal filtration. 
4.2.2 Particle size control and functionality 
Some control over the size of particles formed by the Brust-type synthesis has been 
demonstrated previously by varying the ratio of thiols to gold. [221] To determine 
if such control could be achieved in this system a series of experiments were per-
formed wi th varying gold:polymer ratio (table 4.1). H A u C ^ solutions of the same 
concentration were stirred vigorously in the presence of varying concentrations of 
poly[GalEMA] ( M ^ ~ 9.8 kDa). Upon reduction with NaBH4 the solutions were 
seen to change colour rapidly from pale yellow to colours ranging from yellow-brown 
to violet (see fig. 4.6a). UV-visible absorbance spectra for the particle samples are 
shown in figure 4.6b and i t is clear from these that, as the ratio of gold to polymer 
increases, a peak absorbance appears in the region of 525-540 nm, characterisitic of 
gold colloids and suggesting an increasing core diameter. Particle diameters were 
measured by both T E M and DLS, giving the core and hydrodynamic diameters 
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respectively. Core diameters were determined by image analysis of multiple T E M 
micrographs using ImageJ software. [222,223] ImageJ does not measure particle di-
ameter directly unless each individual particle is measured manually. Instead, core 
areas were measured using a circularity range of 0.70-1.00, where a value of 1 indi-
cates a perfect circle, and core diameters determined using equation 4.1. In all cases 
at least 200 particles were measured. 
area ,, ,, 
diameter = 2 • W (4.1) 
The mean particle diameters, and appropriate error bars, are plotted against Au:pol-
ymer ratio in figure 4.7a. At all ratios there is quite a large range of particle sizes 
in the samples as is clearly seen by the size of the standard deviation (bars), al-
though, as the standard errors (boxes) are small, the mean values are representative 
of the populations being investigated. A sharp increase in particle diameter is seen 
between the two lowest ratios (highest polymer concentrations) and then a slight 
increase across the remaining range although statistical analysis (Student t-test) 
implies that the differences between the higher polymer concentrations is insignifi-
cant. Overall i t appears that, although some control of particle size is achievable, 
it is not possible to produce particles larger than ~3.5 nm via this methodology. 
DLS analysis gave an anomalous result for the the diameter of the particles with 
the lowest ratio wi th a diameter of ~ 560 nm despite samples being filtered through 
a 0.2 fim telfon membrane prior to analysis. Such a large value is likely to be due 
to weakly associated aggregates that may be deaggregated by filtration but rapidly 
reaggregate as is seen with high molecular weight glycopolymers. [186] The other 
diameters are equally curious showing no significant difference between the 2.5 and 
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5 Au:polymer ratio but a significant difference between these and the higher ratios. 
To ensure no free polymer was remaining in the samples they were purified by 
repeated centrifugal filtration through a membrane with a M W C O of 30 kDa. In 
the cases of the two highest gold:polymer ratios considerable precipitation was seen 
on the polyethersulfone filtration membrane and these samples were discarded. The 
remaining three samples were analysed by thermal gravimetic analysis to determine 
their mass percentage of gold and this was used to determine the average number of 
polymer chains per particle. Hostetler et al. have previously calculated the number 
of gold atoms in a particle of a given core diameter {TLAU)- [224] These figures were 
used to determine the number of hgands per particle as follows: 
MAU = rMn-196.96 (4.2) 
Mtotai = 1^-100 (4.3) 
Mpoly = Mtotai - MAU (4.4) 
npo.. = ^ (4.5) 
n 
Where Mtotai, MAU and Mpoiy are the total mass, mass of gold and mass of polymer 
per particle; 9oAu is the weight percentage gold from TGA; HAU is the number of 
gold atoms per particle core and ripoiy is the number of polymer chains per particle. 
The number of ligands per particle calculated in this manner (table 4.2) is surpris-
ingly low when compared to polymer modified clusters of a similar size. Brust et al. 
reported 60-70 capping ligands for 2 nm diameter particles and 200-500 for those 3 -
4 nm in diameter when calculated using the Hostetler data and the Au:S ratio from 
atomic emission spectroscopy. [221] The poly[methacrylic acid] used as the capping 
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Figure PliotuftTMph (a) and UV'- \ ' iy spectra (b) of gold i ia i iopart iek ' solutions 
synthesised at difiereni gold to polymer ratios, (a) L-R: 20, 10. 5, 2.5. 1.25. 
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Figure 4.7: Particle diameters as measured by (a) transmission electron microscopy 
and (b) dynamic light scattering. Small squares represent mean values; boxes, stan-
dard error of the mean: and bars, standard deviation. * p < 0.05. =(=* p < 0.01. 
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Figure 4.8: T E M micrographs of gold nanoparticles synthesised at varying 
gold:polymer ratios 
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agent was of a similar molecular weight and DP„ to the polymer used here (M„ 
5 kDa, DP„ 50 c.f. M „ 9.7 kDa, DPn 32) but the nature of the polymers is signif-
icantly different. Poly[GalEMA] is far more sterically bulky than poly[methacrylic 
acid] and likely to shield a greater surface area for a single point of attachment; it has 
a greater steric footprint. Additionally polyanions, such as poly[methacrylic acid], 
are known to form relatively extended structures at high pH and ionic strength, par-
ticularly when tethered to a surface. Consequently, during the particle synthesis the 
steric footprint of such polymers on the surface should be minimal. Poly[GalEMA 
has no inherent charge and is thus less affected by pH and ionic strength and is 
likely to be a random coil, almost globular, in solution. Once attached to a surface 
p[GalEMA] wi l l act like an umbrella, shielding a relatively large surface area for a 
single point of attachment. This does not, however, explain why the larger particles 
with a greater surface area have fewer tethered polymers than the smaller particles. 
The answer may lie in the difference in the radii of curvature of the different sizes. 
The smaller a particle the smaller its radius of curvature and thus the more curved 
its surface. Figure 4.9 is a schematic of the packing of polymers on the surface of 
particles of radii 1 and 3. As can be seen the reduced curvature at the surface of a 
large particle wi l l reduce the density of packing, the number of ligands per unit area, 
as steric hinderance is increased in the corona. This phenomenom is documented 
in the calculations of Hostetler et al. who found that surface coverage decreased 
with increasing particle radius: [224] however, the number of ligands still increased 
greatly wi th increasing particle size. 
Although the above factors do not explain completely the low level of function-
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Table 4.2: Thermal gravimetric analysis and ligand density data for the 
poly[GalEMA] functionalised gold nanoparticles 
Sample % A u " "-Au Surface area / nm^ "poly Area per ligand / nm^ 
1 40 225 15.19 6.9 2.2 
2 82 976 40.02 4.4 9.1 
3 87 1289 47.22 3.7 12.8 
°- From thermal gravimetric analysis; from Hostetler et al. ref. [224 . 
alisation of larger particle surfaces, they may provide some insight, in combination 
with Ostwald ripening, into the apparent l imiting core size of ~3.5 nm and the 
instability of the larger particles during purification by centrifugal fil tration. Ost-
wald ripening is a process by which large larger particles in an emulsion grow at 
the expense of smaller ones, resulting in an increased mean size of particles within 
the system. This competitive growth is due the Gibbs-Thomson effect whereby the 
higher the curvature of a surface, the higher its chemical potential. [225] For the 
particles synthesised at the lowest Au:polymer ratio, the high surface energy of the 
particles is stabilised by the relatively high concentration of bound polymer; there is 
a polymer for every 2.2 nm^ of surface. For lower polymer concentrations stabilisa-
tion of smaller particles is not possible and larger ones form at their expense. If the 
levels of polymer adsorption measured are correct, it would suggest the low polymer 
concentrations result in particles that are vulnerable to agglomeration; each polymer 
has to protect 12.9 nm"'^  of surface. In the two highest Au:polymer ratio examples, 
where the particles were seen to agglomerate on centrifugal fil tration, the area each 
chain would be required to protect would increase further if this trend continued. 
Consequently, i t is likely that these particles are only metastable, kept discrete due 
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to the high dilution of the solution onl\- to aggregate upon eoncentration. 
Figure 4.9: Sehematie of polMueric lisand packuig on the surface of partieles of 
radii 1 and 3. On larger particles, hgands (triangles) paek less clenseh- as the lower 
curvature of the surface results in increased steric hinderance in the corona. 
Figure 4.10: .Agglutination of lectin functionalised beads by p GalEMAl-modihed 
gold nanoparticles. A. PNA-modified agarose beads: B. 5 minules after addition 
of glycoNPs; C. 30 minutes after addition of glycoNPa; D. redispersion of particles 
after addition of free methyl ,J-D-galactoside. Al l scale bars reprcisent 500 //m. 
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4.2.3 Are glycosylated particles still ligands for lectins? 
To determine whether particles still retain lectin affinity and confirm that the syn-
thesis did not inadvertantly cleave the carbohydrate moieties, a simple agglutination 
assay was performed. A suspension of agarose beads functionalised with the lectin 
Peanut agglutinin was added to a microscope slide (fig. 4.10 A) and a solution of 
poly[GalEMA]-modified particles added. The slide was monitored over a period of 
30 minutes via optical microscopy and the agarose beads were seen to aggregate (fig. 
4.10 B and C). To determine if the agglutination was carbohydrate specific a solu-
tion of methyl /^-D-galactoside or methyl /3-D-glucoside was added to the aggregates. 
In the former case the beads were seen to redisperse (fig. 4.10 D) whereas in the 
latter no change was seen. This specificity was confirmed by repeating the experi-
ment using nanoparticles coated with poly (methyl 6-0-methacryloyl-Q;-D-glucoside) 
synthesised in an identical manner. Methyl a-D-glucoside is not a ligand for PNA 
and additionally the 6-0 linkage presents the sugar in a unnatural conformation. 
In this case the particles were not seen to agglutinate confirming that binding is 
galactose-specific and was not a result of binding to a polyol. 
4.2.4 In vitro cell studies of glycosylated nanoparticles 
Nanoparticles modified wi th biological moieties have many potential applications as 
pharmaceuticals, models and visualising agents. The last of these is already used 
widely in the form of immunogold labelling where gold particles are modified with 
antibodies and used to determine the localation of the complementary antigen. 
To investigate the cytotoxicity and labelling ability of poly[GalEMA]-modified 
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nanoparticles, in vi tro studies were performed on HepG2 cells. HepG2 cells are a 
human hepatic carcinoma cell line and consequently carry the galactoside-binding 
asialoglycoprotein receptor (ASGPR). Confluent cultures were trypsinised, washed 
and resuspended, counted on a haimocytometer and plated at equal densities into 
standard 6-well plates in the presence or absence of nanoparticle solutions as detailed 
in 4.11. Nanoparticle solutions were prepared by repeated centrifugal filtration and 
resuspension in deionised water. After the third fil tration they were resuspended in 
D M E M buffer and filter sterilised. Three independent replicates were performed. 
/ Hep G2 \ 
1 ml NPl 
\ 2 ml DMEM / 
/ Hep G2 \ 
1 ml NP2 
\ 2 ml DMEM / 
/ Hep G2 \ 
1 ml NP3 
\ 2 ml DMEM / 
/ HepG2 1 
1 3 ml DMEM 1 ^ ^ ^ ^ ^ ^ 
^^^^^^ 
Figure 4.11: Schematic of cell culture plates and well contents 
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4.2.4.1 C e l l viability 
Cell viability after 4 and 7 days incubation was determined using the CellTiter 96(R) 
AQueous Non-radioactive cell proliferation assay (MTS) from Promega. This is a 
modernised version of Mosmann's M T T assay that produces a water-soluble for-
mazan product, removing the need to add DMSO to improve solubility (fig. 4.12). 
The results of the MTS assays are shown in figure 4.13. After 4 days i t was clear that 
there was lit t le diff'erence in the viabilities of cells cultured with or without nanopar-
ticles. Statistical analysis (Student t-test) gives a significant diff^erence between cells 
incubated with the smallest particles (NPl ) and the positive control (p<0.05) but 
this difference is marginal. After 7 days all three nanoparticle solutions had sig-
nificantly higher viabilities compared to the positive control; however the positive 
control is a similar level to the negative (i.e. no cells) suggesting that the control 
cells are dead. When culturing HepG2 cells the media is typically replaced every 3-4 
days but due to the limited quantities of nanoparticles solutions available the media 
was not replaced for the duration of the experiments so i t is unsurprising that after 
7 days the control cells were unviable. I t is unlikely that the nanoparticles had such 
a pronounced effect on cell viability and it is more likely that they instead interfere 
with the MTS assay. The formazan product formed during the assay was measured 
by UV-Visible spectroscopy at 490 nm and it is possible that residual particles in 
the media were increasing absorption at this wavelength; an effect that would be 
more pronounced when the level of formazan produced is low due to few viable cells. 
Other assays of cell viability, such as albumin determination may allow elucidation 
oof particle toxicity. 
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Figure 4.12: Formation of forniazan dye from MTS substrate 
4.2.4.2 T E M imaging of incubated cells 
To further determine the condition of the cells and also determine whether nanoparti-
cles could be visualised, the cells were analysed by T E M . After incubation for 7 days, 
cells were fixed, scraped from the plates and pelleted. The pellets were stained, de-
hydrated and then embedded in resin from which ultra-thin sections were produced 
after setting. The sections were then mounted on a T E M grid and imaged. Repre-
sentative images of the four samples are shown in figure 4.14. The positive control 
(fig. 4.14a) and cells incubated with the smallest nanoparticles (fig. 4.14b) contain 
recognisable intracellular organelles including nuclei (N), mitochondria (mt) and 
the rough endoplasmic reticulum ( r E R ) ; but overall cell condition is poor. The 
micrographs from the samples incubated with the two larger nanoparticle solutions 
also contain recognisable nuclei but other organelles are not easily identified. There 
are also areas of what appear to be aggregated nanoparticles (circled) as well as 
numerous small dark spots that may be the same. In these images the cells are 
clearly in very poor condition. Higher magnification images of the positive control 
and first nanoparticle solution cells are shown in figure 4.15. From these it is not 
possible to determine conclusively whether any nanoparticles are present. Figure 
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Figure 4.13: Cell \-iabilitics after ineubation with poly[GalEI\lA]-niodifiGd gold 
naiioparticlcs. (a) After 4 days: (b) after T days. Large error bars represent ±SD, 
small error bars i tSEM, * p< 0.05 eomparcd to positive control. 
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(a) (b) 
(c) (d) 
Figure 4.14: TEM micrographs of HepG2 cells cultured in the presence or absence 
of poly[GalEMA]-modified gold nanoparticles. (a) Positive control, cells only: (b) 
nanoparticle solution 1; (c) nanoparticle solution 2; (d) nanoparticle solution 3. 
Annotations: nuclei (N), mitochondria (mt), rough endoplasmic reticulum (rER). 
Circled areas denote possible aggregated nanoparticles. 
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4.15b does appear to contain nfiore areas of high electron density (darkened areas) 
compared to the figure 4.15a. These areas appear to made up of small particles, 
but they are too large to be the particles under study and are probably a biological 
entity also evident in the control sample. 
The condition of the cells in the T E M micrographs agrees well wi th the hypoth-
esis that the MTS assay after 7 days does not determine accurately the viability of 
the cells. The control cells appear to be the most healthy by T E M but fair very 
poorly via MTS whereas the nanoparticle incubated cells appear to be of increasingly 
poor quality as the particle size increases yet the MTS assay places them approxi-
mately equal. This further supports the hypothesis that the nanoparticle solutions 
themselves are interfering with the measurement; either directly, by absorbing at 
the same wavelength, or indirectly, by somehow catalysing the production of the 
formazan product. The former is certainly feasible as these particle solutions were 
shown to absorb reasonably strongly at 490 nm (see fig. 4.6b). The magnitude of 
this absorption also increases with particle size and larger particles could make very 
poor condition cells appear as viable as reasonably healthy ones. 
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(a) (b) 
Figure 4.15: High magnification TEM micrographs of HepG2 cells cultured (a) in 
the absence of nanoparticles, (b) in presence of nanoparticle solution 1. 
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4.3 Conclusions 
The synthesis of multivalent carbohydrate-modified gold nanoparticles has been 
demonstrated by the simultaneous reduction of RAFTed glycopolymers and HAuCl.i. 
Some control of particle size has been demonstrated although, as has been seen 
in similar particle syntheses there appears to be a maximum hmiting core size of 
~ 3.5 nm. I t may be possible to increase the core diameter of these particles through 
Ostwald ripening as has been demonstrated for alkanethiol-modified particles. [226] 
Particles synthesised in this manner retain their ability to bind specifically to lectins 
as demonstrated by a simple agglomeration assay. In vitro experiments were incon-
clusive wi th regard to the cytoxicity of such particles and further investigation is 
required. Additional imaging of cells cultured in the presence of gold nanopar-
ticles using X-ray microanalysis T E M would enable detection of gold within the 
samples. [227] Additionally, comparative labelhng of ASGPR positive and ASGPR 
negative cell lines without prior culture may be of interest. Use of an alternative 
labelling stategy, such as immunofluoresence, would allow elucidation of specificity 
by determining the locahsation of ASGPRs for comparison. 
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4.4 Experimental 
4.4.1 Materials and Methods 
4.4.1.1 Materials 
Hydrogen tetrachloroaurate (> 99.9 %, 49 % Au by mass) was purchased from 
Alfa Aesar. Sodium borohydride (> 98 %) was purchased from Sigma Aldrich and 
used without further purification. Poly[2-(/?-D-galactosyloxy)ethyl methacrylate] 
was synthesised as described in chapter 2. RAFT synthesised poly(methyl 6-0-
methacryloyl-a-D-glucoside) was kindly provided by Dr Luca Albertin. [132 
4.4.1.2 Methods 
Dynamic light-scattering measurements were conducted using a Brookhaven Instru-
ments 90 Zeta-Plus particle size analyser. Before analysis all samples were filtered 
through a 0.2 ^ m syringe filter to minimise contamination with dust. Transmission 
electron microscopy was conducted on a Hitachi 7600 instrument. Samples were pre-
pared by deposition of a drop of the particle solution on to a carbon-coated copper 
grid and allowing the solvent to evaporate leaving a thin film of particles. Thermal 
gravimetric analyses were performed on a Perkin Elmer Pyris 1 T G A under nitrogen 
gas; heating from 20 °C to 800 °C at 10 °C/min 
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4,4.2 Synthesis of glycopolymer functionalised gold nanopar-
ticles via modified Brust synthesis 
Solutions of hydrogen tetrachloroaurate (0.5 mM) , poly[2-(^-D-galactosyloxy)ethyl 
methacrylate] (M„ = 9.8 kDa, 5.0 mM) and sodium borohydride (50 mM) were 
prepared in UHQ water (resistivity > 18.0 Mf^) . The HAuCU and polymer solutions 
were combined and diluted to equal volume as described in table 4.3. W i t h vigorous 
stirring, the NaBH4 solution was added as 1 ml aliquots to each solution and stirring 
was continued for 2 h. After this time the particle solutions were initially filtered 
through a 0.2 /im syringe filter and then separated from any residual free polymer 
by repeated centrifugal filtration (Sartorious Vivaspin 15, MWCO 30 kDA) and 
washing wi th UHQ water. 
Table 4.3: Experimental data for the synthesis of glycopolymer functionalised gold 
nanoparticles via modified Brust synthesis 
# 
Vol. HAuCU 
(Ml)" 
Vol. Polymer 
( M I ) " ^ 
Vol. Water 
(Ml) 
Vol. NaBH4 
(Ml)" 
[Au]/[polymer]'' 
1 10000 400 0 2000 1.25 
2 10000 200 200 2000 2.50 
3 10000 100 300 2000 5.00 
4 10000 50 350 2000 10.00 
5 10000 25 375 2000 20.00 
[HAuCU] = 0.5 m M ; [Polymer] = 5.0 mM, M„ = 9.8 kDa; [NaBH4] = 50 mM. * 
Based on a Au content of 49 % for HAUCI4 
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4.4.3 Agglutination assay 
Prior to these experiments, the nanoparticles were analysed by SEC to confirm 
the absence of free polymer. A suspension of agarose beads coated with peanut 
agglutinin (PNA) (20 / i l , 2-4 mg P N A / m l solution) was pipetted onto a microscope 
slide. 40 lA of p[GalEMA]-coated nanoparticle solution was added to the beads 
and the aggregation was monitored by optical microscopy; after 30 min. the beads 
appeared to agglomerate completely. Redispersion experiments were attempted by 
addition of 10 / i l of a 0.072 M solution of methyl /:/-D-galactopyranoside or methyl p-
D-glucopyranoside. A control experiment was also conducted in an identical manner 
using gold nanoparticles stabihzed with poly[6-0-MAMGlc . 
4.4.4 Cell viability and uptake studies on glycopolymer-
AuNP conjugates 
4.4.4.1 Preparat ion of particles 
Gold nanoparticles were synthesised as described in previously. After synthesis 
the particles were purified and concentrated using centrifugal filtration (Sartorius 
Vivaspin 15 PES, 30 kDa MWCO) at 2000 g for 30 mins and repeated washing 
with UHQ water. After 4 washings the particles were concentrated once again and 
resuspended in 15 ml of D M E M . Nanoparticle suspensions were then filter sterilised 
by passing through a 0.2 ixm membrane. 
160 
4.4. Exper imenta l 161 
4.4.4.2 Hepatocyte C e l l Cul ture 
The human hepatic carcinoma cell line, Hep G2, was obtained from the American 
Type Culture Collection (ATCC) and maintained in D M E M . Confluent cultures of 
Hep 02 cells were washed with PBS, detached with t rypsin/EDTA solution and 
counted wi th a haemocytometer. Cell suspensions were then seeded in the 6-well 
plates (Nunc) at a density of 5x10^ cells per well. Media and nanoparticle suspen-
sions were added as detailed in fig. 4.11. 
4.4.4.3 Determination of viable cell number 
The viable cell number was determined using the commercially available colorimetric 
assay CellTiter 96® AQueous One Solution Cell Proliferation Assay (Promega®). 
Culture samples were incubated with the assay solution for 4 h before transferring 
to 96-well plates (Nunc); the viable cell number was then determined by measuring 
the absorbance of the formazan product at 490 nm. 
4.4.4.4 Preparation of tissue samples for transmission electron microsc-
opy 
Culture samples were prepared for T E M by removal of the culture media, washing 
with PBS and fixing wi th 2 % paraformaldehyde and 2.5 % glutaraldehyde in Soren-
son's phosphate buffer for 2 h at 4 °C. After this time the cells were scraped from the 
plates, pelleted at 10,000 g for 5 min. The pelleted cells were then washed with O.IM 
phosphate buffer before staining with 1 % O S O 4 solution in 0.1 M phosphate buffer 
for 1 h. The stained pellets were then washed twice with 0.1 M phosphate buffer 
before dehydration in 25 %, 50 %, 95 % and 100 % ethanol solutions for 10 minutes; 
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each dehydration step was repeated three times. After dehydration, samples were 
immersed in a 50/50 mixture of ethanol/resin (Agar Scientific LR White) overnight. 
The resin solution was then replaced with pure resin and changed periodically over 
the following 2 days. The samples were then cured by placing in an oven overnight. 
Once set, the samples were cut into ultra-thin sections and imaged via T E M (Hitachi 
H6700). 
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5.1 Conclusions 
This thesis initially aimed to determine whether the synthesis of bioactive glyco-
sylated polymers could be performed in a controlled manner. I t has been demon-
strated that reversible addition-fragmentation chain transfer polymerisation of 2-
(D-glycosyloxy)ethyl methacrylates produces the corresponding glycopolymers with 
predictable molecular weight, narrow polydispersity and in high yield. Additionally, 
block and statistical copolymers have been synthesised. Despite these successes 
more study of the R A F T synthesis of glycopolymers is required. In addition to the 
glucosyl and galactosyl monomers described in Chapter 2 the a-mannosyl deriva-
tive was synthesised by identical methods. I t was found that polymerisation under 
identical conditions did not yield any polymer and that conversions were limited to 
< 10%. Owing to time constraints no further study of this monomer was possible, 
hence its exclusion from the bulk of this thesis, and so the reasons for its inactivity 
remain unknown. 
Methods for producing glycopolymers of controlled, pre-defined structures allows 
the study of the effect said structure has on properties and here this has been 
investigated wi th respect to the cluster glycoside effect. Studies have confirmed 
previous findings that avidity scales with valency but in a non-linear manner and 
that there is a large increase in avidity once a ligand is able to bridge multiple 
binding sites on the same receptor. Additionally, combining the calorimetry and 
plasmon resonance data supports the hypothesis that avidity is increased through 
many, individual and sequential transient bindings between a receptor and several 
ligands, because of an increase of the local concentration of ligands, as well as 
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mulitple simultaneous bindings. 
In order to further increase multivalency glycopolymer-coated nanoparticles have 
been synthesised in a facile way and found to maintain carbohydrate-specific binding 
to lectins. Unfortunately, i t appears that, apart from in the smallest examples, 
they are of limited stability and have poor cytocompatibility, making them poor 
candidates as either imaging agents or therapeutics. 
5.2 Future work 
Although R A F T polymerisation has been shown to be a viable method for the syn-
thesis of glycopolymers, the carbohydrates utilised in this study are simple and of 
lit t le biological significance. If R A F T polymerisation is to be utilised for the pro-
duction of biologically relevant glycopolymers (for example, polymers that display 
antigens such as sialyl-Lewis^) then its applicability to the polymerisation of such 
moieties is required. The synthesis of complex oligosaccharides is non-trivial, usually 
resulting in low quantities of material (10-lOOs of milligrams), and is a challenge to 
be overcome if a thorough investigation of polymerisation is to be achieved. 
To investigate further the factors affecting the multivalency effect a more thor-
ough investigation is required. A comparative study, utilising both ITC and SPR, of 
a large range of polymers of diflferent chain lengths and carbohydrate densities would 
allow further elucidation of the mechanisms by which multivalent ligands interact 
with multivalent receptors. This would also produce a 'map' of polymers that could 
be used to tailor polymers for a particular application. 
Synthesis of glycoNPs from RAFTed glycopolymers is facile but is in need of 
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a far deeper investigation. The small core sizes synthesised here, and their high 
polydispersities, makes the particles unsuitable for use either in vitro, as labels, or 
in vivo, as pharmaceuticals. Synthesis of glycoNPs by two-step method where first 
a larger particle of controlled size is synthesised (e.g. by the Frens methodology) 
and this is functionalised by ligand transfer wi th a RAFTed glycopolymer should 
yield particles of greater potential. In fact, this methodology is routinely used by 
Brust for the synthesis of biologically relevant particles, [228-230] despite being the 
inventor of the alternative method. 
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